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Calcium phosphates (CaPs) are widely studied as scaffolds for hard tissue regeneration due to 
their similar composition to the inorganic component of native mineralized tissues. 
Unfortunately, their poor mechanical properties and the limited dissolution of hydroxyapatite 
(HA), the most ubiquitous CaP in bone tissue engineering, restricts their application to the 
treatment of non-load bearing defects. In order to improve patient outcomes, a major emphasis 
has been placed on the controlled delivery of growth factors, such as bone morphogenic proteins 
(BMPs), from CaPs, to accelerate regeneration and recruit cells capable of resorbing HA. 
However, the added expense, poor shelf life, and the unknown side effects of treatment with 
increased amounts of growth factors are the major limitations of this approach. 
In an attempt to reduce the requirement to deliver increased amounts of growth factors, 
more resorbable CaP phases, such as β-tricalcium phosphate (β-TCP), have been studied. Recent 
work has shown that scaffolds prepared with β-TCP may be at least equally capable of inducing 
in vivo bone regeneration in comparison to autologous bone grafts and BMP-2, delivered from a 
collagen sponge. This favorable response is believed to be due to the capability of β-TCP to 
degrade in a more clinically relevant time frame, similar to the rate at which native tissues are 
regenerated, and release bioactive Ca2+ and PO43- ions in close proximity to the defect site.  
In addition to Ca2+ and PO43-, mineralized tissues are composed of several other elements 
which play a key role in regulating their structure and function. Therefore, in the current work 
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 v 
the influence of ionic substitutions using two biologically relevant cations, Mg2+ and Sr2+, in 
CaPs on their physicochemical and biological properties was studied. It was hypothesized that β-
TCP scaffolds prepared with various amounts of Mg2+ and Sr2+ would provide 
microenvironments suitable for promoting osteogenic differentiation in comparison to 
commercially available β-TCP. In addition to bulk scaffolds, cationic substituted β-TCP was 
explored as a bioactive coating on a biodegradable metallic substrate. The influence of coating 
composition and structure on corrosion protection and cytocompatibility was assessed. Finally, 
the influence of cationic substitution on the physicochemical properties and cytocompatibility of 
an injectable self-setting HA cement was also evaluated.     
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1.0  INTRODUCTION 
1.1 BONE DEVELOPMENT, STRUCTURE, AND REPAIR 
During embryonic development, the mineralized tissues of the skeleton are formed by two 
distinct processes, endochondral and intramembranous ossification [1]. During endochondral 
ossification, rather than directly forming bone tissue, cell aggregates first form cartilage. The 
differentiation of the perichondral derived cells to form osteoblasts then results in the 
mineralization of cartilage and subsequent formation of mature bone tissues [2]. This process 
occurs for all of the bones which comprise the appendicular skeleton, such as the pelvis, clavicle 
and the bones of the legs and arms. In contrast, during intramembranous ossification, aggregates 
of mesenchymal stem cells differentiate to form bone forming cells, or osteoblasts, without 
forming cartilage as an intermediate [3]. The majority of the bones which comprise the axial 
skeleton, such as the rib cage and the vertebral column, are formed by endochondral ossification 
[4]. Interestingly, the bones which comprise the skull and mandible are formed by both 
endochondral and intramembranous ossification. Despite these differences in origin, the bone 
tissues in the skull are indistinguishable from those found elsewhere in the body [5]. 
The primary role of bone tissue is to provide structural support and protection to more 
fragile organs and tissues. Mineralized tissues, which include bone, enamel, and dentin, consist 
of both organic and inorganic components and possess a hierarchical structure at multiple length 
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scales, all of which contribute to their function, illustrated in Figure 1.1 [6]. The major inorganic 
component of mineralized tissues consists of carbonated hydroxyapatite (HA) while type-I 
collagen is the major organic component [7]. The carbonated HA found in bone tissues is 
composed of 2-6 nm thick elongated crystals [8]. These relatively small elongated crystals ensure 
that the mineral component of bone is less sensitive to flaws [9]. Subtle variations in the 
composition and hierarchical structure of mineralized tissues exist depending on their function. 
For example, the mineral content of dentin is slightly higher than that of bone. As a result, dentin 
has a reduced toughness or ability to absorb energy in a plastic range in comparison to bone [10, 
11]. 
Despite the impressive structural and mechanical properties of mineralized tissues, failure 
due to either disease or trauma often leads to the formation of fractures and defects. Once a 
defect or fracture is formed, a series of events take place in an attempt to regenerate the native 
bone tissues and restore complete function. This process begins with the formation of a 
hematoma, or blood clot [3]. Hematoma formation results in the migration of mesenchymal stem 
cells to the defect site. Once mesenchymal stem cells have migrated to the defect, a soft callus 
composed of cartilage is initially formed [12]. The cartilage is then slowly mineralized and 
replaced by bone as a result of the differentiation of mesenchymal stem cells to osteoblasts and is 
eventually remodeled by osteoclasts, or bone resorbing cells [13]. Irrespective of the formation 
of a defect, bone tissue is constantly remodeled throughout life [14, 15]. Subtle variations in the 
homeostasis of this remodeling process lead to the occurrence of various bone diseases. The 
origins and roles of the three major cell types involved in the function of bone tissues will be 
described in the following sections. 
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Figure 1.1 The hierarchical organization of bone at multiple length scales. At the macroscopic level, the 
cortical bone forms a dense outer layer which encapsulates the trabecular, or spongy, bone within the 
marrow cavity. At the microscopic level, both trabecular and cortical bone are comprised of lamellar type 
structures. At the nanoscale, bone is a composite of collagen fibers and plates of mineral dispersed between 
these fibers providing structural reinforcement [16].  
1.1.1 Osteoblasts 
Osteoblasts are the cells found in bone tissue which are responsible for the formation of the 
organic non-mineralized bone matrix [17]. The sources for osteoblast precursor cells include 
mesenchymal stem cells, adipocytes, lining cells, and perivascular pericytes contiguous to a bone 
wound (Figure 1.2) [13]. Mature osteoblasts express proteins such as alkaline phosphatase 
(ALP), type I collagen (Col-1), bone sialoprotein (BSP), and osteocalcin (OCN) [18, 19]. Due to 
their role in the formation of mineralized tissues, osteoblast precursor cell interaction with 
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synthetic scaffold materials is most often studied in the development of materials for the 
regeneration of mineralized tissues. In addition to bone formation, osteoblasts secrete signaling 
molecules, such as osteoprotegrin (OPG), which play a key role in also regulating the resorption 
of mineralized tissues [20]. 
1.1.2 Osteoclasts 
Osteoclasts are the cells responsible for the resorption of mineralized tissues. They are derived 
from quiescent osteoclast precursors and hematopoietic progenitors which also give rise to both 
macrophages and monocytes (Figure 1.2) [21]. Mature osteoclasts form large multinucleated 
motile cells and are relatively rare in comparison to the other cell types found in bone. Receptor 
activator of nuclear factor kappa-B ligand (RANKL) is a molecule necessary for the formation of 
mature osteoclasts from monocyte precursor cells [22]. The interactions in vivo between RANKL 
and OPG play an important role in regulating both the resorption and formation of mineralized 
tissues. During resorption, osteoclast podosomes form a dense ring resulting in the formation of a 
sealing zone that tightly anchors the osteoclast to the mineral surface [23]. The compartment 
beneath the cell is resorbed due to the acidic environment created. As a result of the harsh 
conditions required to resorb bone tissues, osteoclasts are capable of functioning in extremely 
harsh environments with an extremely low pH [19]. In addition to their morphology, mature 
osteoclasts are often characterized by their increased expression of tartarate resistant acidic 
phosphatase (TRAP) [24]. 
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Figure 1.2 On the left of the figure, osteoclasts are derived from hematopoietic stem cells and quiescent 
osteoclast precursors (QoP). On the right of the figure, osteoblasts are formed from mesenchymal stem cells, 
pericytes, and lining cells.  On the bottom of the figure, osteocytes are entrapped within the bone matrix and 
directly communicate with osteoblasts and osteoclasts [19].   
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1.1.3 Osteocytes 
Osteocytes are terminally differentiated osteoblasts which are entrapped within the bone matrix 
(Figure 1.2). They are the most abundant cell type found in bone [21]. The function of osteocytes 
remains largely unknown since they have not been studied as much as either osteoblasts or 
osteoclasts. However, they have been shown to be sensitive to mechanical stimulation [25]. As a 
result of their sensitivity to mechanical stimulation, they are believed to play a role in the 
signaling of both, bone formation and resorption. A direct link between osteocytes and bone 
formation was discovered when it was observed that mature osteocytes secrete sclerostin, a 
potent inhibitor of bone formation [26]. Osteocytes have also been observed to secrete OPG, 
which is involved in the regulation of bone resorption through interactions with RANKL and its 
receptor [27]. Due to the fact that these cells account for as much as 90% of the cell population 
found in bone, a greater understanding of their function and the mechanisms through which they 
regulate bone formation and resorption is required. 
1.2 OVERVIEW OF BONE TISSUE ENGINEERING 
Bone loss as a result of disease and trauma affects millions globally. Furthermore, the projected 
increase in life expectancy in more developed countries is expected to increase the occurrence of 
both musculoskeletal and dental diseases [28]. Bone grafts are often required to treat the defects 
caused by both disease and trauma in instances where natural bone healing, described in Section 
1.1, is insufficient to restore complete function. They are routinely used in procedures such as 
alveolar ridge augmentation, sinus augmentation, and spinal fusions, to name a few. Autologous 
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bone grafts, or autografts, are the current gold standard for the treatment of a myriad of bone 
defects [29]. Unfortunately, donor site morbidity, increased recovery time due to the multiple 
surgical procedures often required, and limitations on the amount of material that can be 
harvested are the major limitations of this approach [7].  
Allografts are an alternative option to autografts. However, in addition to some of the 
disadvantages previously outlined, the risk for disease transmission and variation in the quality 
of the graft material, depending on donor health and age also exist [30]. The 3D structure, cells, 
and extracellular matrix (ECM) proteins such as bone morphogenic proteins (BMPs), insulin-like 
growth factor (IGF), transforming growth factor β (TGF-β), vascular endothelial growth factor 
(VEGF), and platelet derived growth factor (PDGF) in these harvested tissues enhance their 
capability to induce bone formation, or osteoinductivity, and remain a challenge to mimic 
synthetically [31]. 
In an attempt to maintain osteoinductivity, while reducing the risk for disease 
transmission, allografts have been processed to produce a demineralized bone matrix (DBM) 
which retains much of the proteinaceous content of native bone [32]. Unfortunately, the 3D 
structure, cells, and the ensuing mechanical properties are commonly lost during the 
demineralization process. DBM has been further processed to form injectable pastes, sheets, and 
other clinically relevant constructs resulting in DBM based products being used in approximately 
20% of current bone grafting procedures [33]. However, batch to batch variation exists with 
DBM based products due to the varying quality of donor tissues. Protein conformation may also 
change depending on the demineralizing process and, similar to autografts and allografts, the 
amount of graft material that can be produced is limited by the amount of donor material 
available [34, 35].  
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As a result, a need for improved bone grafting technologies currently exists. Ideally, bone 
grafts should be capable of both inducing and supporting bone regeneration. They should also 
provide sufficient mechanical stability throughout the regeneration process and degrade at a 
similar rate with which mineralized tissues are regenerated. In addition, neither the graft material 
nor its degradation products should put patients at risk of an undesired immune response, 
particularly when a substantial amount of graft material is necessary. Therefore, it remains a 
challenge to develop bone grafts which satisfy all of these criteria. However, through advances in 
the synthesis and processing of synthetic materials, using techniques such as 3D printing and 
bioreactors, significant improvements in the performance of synthetic based bone graft 
substitutes have been made. As a result, synthetic materials, either on their own or in 
combination with naturally derived products, such as DBM, may have the potential to satisfy the 
criteria outlined for the next generation of bone graft materials. The advantages and limitations 
of the synthetic materials currently used as bone graft substitutes will be described in Section 
1.3. 
1.3 SYNTHETIC MATERIALS USED IN BONE TISSUE ENGINEERING 
1.3.1 Polymers 
Polymeric materials have been widely used in bone tissue engineering. Although their 
mechanical properties may not be ideal for the temporary replacement of mineralized tissues 
(Figure 1.3), their capability to degrade and deliver both cells and biological molecules in a 
controlled manner to a defect site is particularly of interest [36, 37]. The polymers studied in 
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bone regeneration can be classified into two categories, natural and synthetic polymers. These 
materials will be discussed in the following two sections.   
1.3.1.1 Natural Polymers 
Natural polymers can be classified into either protein or polysaccharide derived based on their 
origin. A few of the more common naturally derived polymers from both protein and 
polysaccharide sources used in bone tissue engineering include chitosan, alginate, hyaluronic 
acid, silk, fibrin, and collagen [38-40]. Due to their structural similarity to ECM proteins, 
particularly with respect to protein derived natural polymers, these materials are considered 
biocompatible and in some cases can also be classified as bioactive [41]. Many natural polymers 
have also been demonstrated to be biodegradable. Unfortunately, in addition to their poor 
mechanical properties, batch to batch variation exists depending on the source of the material. As 
a result, additives in the form of either plasticizers or particulates are often combined with 
natural polymers to enhance their mechanical properties and functionality among other desired 
biofunctional characteristics [42]. 
Collagen, due to its abundance in the human body, is perhaps the most widely used 
natural polymer for bone tissue engineering applications [43]. Bone tissue itself is a composite of 
collagen fibrils reinforced with mineral particles (Figure 1.1) [7]. As a result, type I collagen is 
the most abundant extracellular protein found in bone [44]. Collagen based coatings, hydrogels, 
and scaffolds have all been studied in the regeneration of mineralized tissues. One of the major 
disadvantages of collagen is the relatively high degree of swelling collagen undergoes upon 
exposure to physiological environments [45]. As a result, chemical modifications, usually in the 
form of cross-linking, are required to tailor the swelling and degradation characteristics of 
collagen based coatings, hydrogels, and scaffolds.  
 10 
 
Figure 1.3 The mechanical properties of some of the more common materials used in bone tissue 
engineering in comparison to mineralized tissues [46].  
 
Of the non-protein derived natural polymers, chitosan is one of the more abundantly 
studied natural polymers in bone tissue engineering [41]. Chitosan is a linear polysaccharide 
derived during the deacetylation of the shells of crustaceans [47]. Similar to collagen, chitosan 
coatings, hydrogels, and scaffolds have been studied in the regeneration of mineralized tissues. 
Acidic conditions are however required to dissolve chitosan and a viscous gel is formed upon 
increasing the solution pH to near physiological conditions. Due to the cationic nature of 
chitosan, the electrostatic interactions between chitosan and negatively charged structural 
molecules, such as glycosaminoglycans and proteoglycans, have been used to achieve the 
sustained release of these and other bioactive molecules [48]. Interestingly, chitosan has also 
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been shown to possess antimicrobial properties [49]. This is particularly of interest in bone tissue 
engineering since infection is a major cause of bone graft failure.  
In summary, natural polymers provide several beneficial properties for applications in 
bone tissue engineering. Unfortunately, the mismatch in mechanical properties of naturally 
derived polymeric scaffolds with mineralized tissues limits their wider application. In addition, 
their expense, depending on the source and procedure required to isolate these molecules, 
provides further challenges. As a result, these materials are often used in combination with either 
metallic or ceramic biomaterials rather than on their own for applications in bone tissue 
engineering.  
1.3.1.2 Synthetic Polymers 
In comparison to natural polymers, synthetic polymers are of interest in bone tissue engineering 
due to the capability to chemically modify their structure leading to greater control with respect 
to degradation, swelling, and mechanical properties. As a result of chemical modification, 
synthetic polymer scaffolds with significantly increased mechanical properties can be prepared 
in comparison to natural polymers. Synthetic polymers also provide a reduced risk of batch to 
batch variation in comparison to natural polymers and are more flexible with respect to the 
processing techniques that can be utilized [50]. Some of the more common synthetic polymers 
used in bone tissue engineering include poly(methyl methacrylate) (PMMA), poly(lactic-co-
glycolic) acid (PLGA), polycaprolactone (PCL), and polyethylene glycol (PEG), to name a few 
[51]. 
Similar to natural polymers, synthetic polymers have been processed to form coatings, 
hydrogels, and scaffolds. One of the more interesting applications of synthetic polymers in bone 
tissue engineering is the use of PMMA bone cements [52]. Upon mixing a powder and a liquid 
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component which contain methylmethacrylate, the monomer of PMMA, and initiators of the 
PMMA polymerization reaction, a viscous paste is formed. Over time, the paste hardens as the 
polymerization reaction proceeds. These cements are widely used in spinal surgical procedures, 
such as percutaneous vertebroplasty [53]. One of the major drawbacks of PMMA bone cements 
is the exothermic polymerization reaction of PMMA. The recorded temperatures during the 
polymerization reaction can exceed 70˚C leading to concerns over the health of the surrounding 
tissues upon exposure to such elevated temperatures [54]. In addition, antibiotics and other drugs 
loaded into these bone cements intended for delivery during healing may become denatured 
during the polymerization process. However, PMMA, once fully polymerized, is extremely 
biocompatible but exhibits poor integration with surrounding bone tissues and limited resorption 
leading to long term complications [55].   
In addition to their application in bone cements, synthetic polymers are most often 
utilized for their tunable degradation properties which facilitate the controlled delivery of 
therapeutic agents [56]. This capability has been widely used with degradable PLGA which can 
be processed to form particles of varying size to deliver ECM proteins, such as BMP-2 [57]. 
Although biocompatible and biodegradable, a major disadvantage of these synthetic polymers is 
that these materials on their own are not considered bioactive, in contrast to many of the protein 
derived natural polymers. As a result, either expensive growth factors with limited shelf lives, 
such as BMP-2 and VEGF, or bioactive particles are required in combination with synthetic 
polymers to achieve the desired therapeutic response [51, 58].  
The wide ranging tunable properties of synthetic polymers make them an attractive 
choice of material for bone tissue engineering applications. Unfortunately, their poor bioactivity 
is a major disadvantage in comparison to naturally derived polymers and other choices of 
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material. As a result, similar to naturally derived polymers, synthetic polymers are often used in 
combination with either metallic or ceramic biomaterials rather than on their own for 
applications in bone tissue engineering. 
1.3.2 Metals 
In contrast to natural and synthetic polymers, metals are capable of providing the mechanical 
stability necessary to support load bearing bone defects, illustrated in Figure 1.3 [46, 59, 60]. As 
a result, they are frequently used in hip implants, knee replacements, and spinal procedures. 
Several non-degradable metallic alloy based medical devices have been approved by the FDA 
for bone fixation. On the other hand, degradable metallic alloys, although having been reported 
since the early 1900s, are only recently gaining increased attention in bone tissue engineering 
[61]. To date, a degradable metallic device for the treatment of bone defects is yet to be approved 
by the FDA. A brief overview of the developments in both non-degradable and degradable 
metallic alloys for the treatment of bone defects will be discussed in the following two sections.  
1.3.2.1 Non-Degradable Metals 
Non-degradable metals, such as stainless steel, titanium and its alloys, and cobalt-chrome alloys, 
are known for their exceptional biocompatibility with mineralized tissues [62]. As a result, they 
have been machined to form screws, plates, and constructs of varying sizes and geometries for a 
wide range of applications in both orthopedic and craniofacial bone fixation. Non-degradable 
metals are generally considered bio-inert. Therefore, relatively large amounts of material can be 
used without inducing an undesired foreign body response. In order to facilitate the increased 
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integration with bone tissues, also referred to as osseointegration, bioactive coatings containing 
either growth factors or ceramic particles are often required [63, 64]. 
As previously mentioned in Section 1.1, degradability is one of the desired properties of 
the ideal bone tissue engineering scaffold. Due to the fact that this classification of metallic 
biomaterials does not degrade, complications exist for many metallic implants after longer 
periods due to the mismatch in mechanical properties between metallic biomaterials and native 
mineralized tissues [65]. In addition, the accumulation of non-degradable wear debris from these 
implants can lead to an undesired inflammatory response. As a result, follow up surgeries are 
often required after the implantation of non-degradable metallic scaffolds [61]. However, their 
desirable mechanical properties and relatively inert characteristics in comparison to both 
polymers and ceramics make them a necessity in the current treatment of load bearing bone 
defects. 
1.3.2.2 Biodegradable Metals 
Biodegradable metals have only recently gained significant attention for a wide range of clinical 
applications in addition to both orthopedic and craniofacial bone regeneration. The alloys 
developed to date which are considered biodegradable are typically either Mg or Fe based [62]. 
Mg and Fe can both be found in the human body. Mg2+ is the fourth most abundant cation in the 
human body and is involved in several key enzymatic reactions [66]. It is also necessary for cell 
proliferation and ATP synthesis [67]. Interestingly, the role of Mg2+ ions on the differentiation of 
osteoblast progenitor cells and human mesenchymal stem cells towards mature osteoblasts, or 
bone forming cells, remains poorly understood [68]. Fe2+ ions are involved in both the storage 
and activation of molecular oxygen and can be found in a wide number of Fe containing 
enzymes and proteins [69]. Upon degradation, Fe based alloys may release both Fe2+ and Fe3+ 
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ions. Unfortunately, hemoglobin containing Fe3+ rather than Fe2+ is incapable of binding oxygen 
[70]. As a result, Mg based alloys are more commonly studied for bone tissue engineering 
applications. 
The degradation of Mg alloys occurs through corrosion mechanisms where Mg(OH)2 and 
H2 gas are formed as the corrosion products, illustrated in Equation 1.1. The majority of alloys 
developed to date undergo a rapid and uncontrolled corrosion in vivo. This is primarily due to the 
presence of Cl- ions which destabilize the protective Mg(OH)2 passivation layer initially formed 
upon exposure to physiological environments during the corrosion process. 
Equation 1.1 
Mg + 2H2O       Mg(OH)2 + H2 
Therefore, a substantial emphasis has been placed on tailoring the corrosion properties of Mg 
based alloys either by the application of protective coatings, by the modification of the alloy 
microstructure, or by the development of new alloy compositions which form more stable 
hydroxides upon exposure to Cl- containing environments. 
1.3.3 Non-Calcium Phosphate Based Ceramics 
Ceramic materials are widely studied in bone tissue engineering applications either on their own 
or as bioactive components in combination with polymers and metals. Many of these materials 
are degradable and capable of supporting the regeneration of bone tissue, or considered 
osteoconductive [29]. In addition, several ceramic systems in recent years have been 
demonstrated to be osteoinductive in relevant animal models while very few polymers or metals 
have demonstrated this capability [71]. Unfortunately, in contrast to metals, ceramic based 
biomaterials are incapable of supporting load bearing bone defects and are relatively brittle 
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(Figure 1.3) [72]. Bioceramics can be described as either calcium phosphate (CaP) based or non-
calcium phosphate based. However, CaPs are more widely used in bone tissue engineering than 
any other ceramic material due to their chemical similarity to the mineral component of native 
bone tissues [7]. Non-CaP based ceramic materials will be described in the current section while 
CaPs will be discussed in Section 1.4. 
Zirconia, magnesia, and alumina are ceramic materials widely used in the regeneration of 
mineralized tissues. However, the most widely used non-CaP based ceramic materials in bone 
tissue engineering are silicate based bioactive glasses. These amorphous materials are prepared 
using either melt-quenching or sol-gel based approaches [73]. The favorable interactions of these 
materials with bone tissues were first described by Hench and coworkers [74]. Bioactive glasses 
are believed to support bone formation due to the release of bioactive dissolution products, such 
as silicate ions, and subsequent formation of a hydroxycarbonate apatite layer on their surface 
upon exposure to physiological environments [75, 76]. Due to their capability to support rapid 
mineralization, bioactive glass powders are often used in toothpaste formulations for the 
treatment of hypersensitivity [77]. While many different compositions have been reported, the 
bioactive glass prepared using 46.1 mol. % SiO2, 24.4 mol. % Na2O, 26.9 mol. % CaO, and 2.6 
mol. % P2O5, also referred to as Bioglass 45S5, is the most well-known and has been FDA 
approved for use in the regeneration of mineralized tissues in various forms [78].   
The processing of bioactive glasses to form granules and porous scaffolds has led to an 
increased clinical acceptance. A more detailed description of the techniques used to form porous 
bioceramics scaffolds will be provided in Section 1.4.2. Unfortunately, the inability to mold 
bioactive glass based scaffolds into the desired shapes to fill irregularly shaped bone defects and 
their poor degradation rate has restricted their wider use [74]. Sintering at elevated temperatures 
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is required to enhance the mechanical stability of ceramic scaffolds. However, many of the 
traditionally used bioactive glass compositions cannot be sintered without inducing their 
crystallization which alters their dissolution behavior and subsequent bioactivity. 
1.4 CALCIUM PHOSPHATES IN BONE TISSUE ENGINEERING 
As mentioned previously, CaPs are more widely used in bone tissue engineering than any other 
ceramic material due to their chemical similarity to the mineral component of native bone 
tissues. In addition to the advantages outlined for non-CaP based ceramics, including bioactive 
glasses, CaPs can also be processed to form self-setting injectable bone cements which can be 
delivered in a minimally invasive fashion to fill irregularly shaped bone defects. CaP based self-
setting cements will be described in Section 1.4.2.3. The use of a wide range of CaP phases, 
which will be described in the following Section, enables the formation of CaP based scaffolds 
with varying rates of degradation which can be tailored for specific applications. A summary of 
the advantages and disadvantages of the synthetic materials discussed to treat bone defects thus 
far is illustrated in Table 1.1. 
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Table 1.1 The advantages and disadvantages of the synthetic materials used in bone tissue engineering. 
 
1.4.1 Calcium Phosphate Phases 
The CaP phases widely studied in the development of synthetic bone graft substitutes are 
illustrated in Table 1.2. Interestingly, of the 7 phases listed in Table 1.2, only 3 are stable under 
aqueous conditions. Dicalcium phosphate dihydrate (DCPD) is stable under acidic conditions 
while calcium deficient hydroxyapatite (CDHA) and HA are stable under neutral and basic 
conditions, respectively. The instability under aqueous conditions of tetracalcium phosphate 
(TTCP), β-tricalcium phosphate (β-TCP), α-tricalcium phosphate (α-TCP), and dicalcium 
phosphate anhydrous (DCPA) indicates that these phases cannot be synthesized under aqueous 
conditions. Therefore, alternative approaches, such as solid state synthesis and sol-gel based 
techniques, have been developed [79, 80]. However, DCPD, CDHA, and HA can be prepared 
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under aqueous conditions using chemical precipitation techniques with controlled conditions of 
temperature, pH, and concentration [81, 82]. 
  
Table 1.2 The properties of the calcium phosphate phases widely studied in bone tissue engineering 
[83]. 
     
 
Due to their instability under aqueous conditions, TTCP, β-TCP, and α-TCP are also known to 
hydrolyze to form CDHA upon exposure to physiological conditions [84, 85]. With respect to 
DCP and DCPD, additional Ca2+ ions are required to provide the stoichiometry needed to form 
CDHA under aqueous conditions [86]. 
In addition to pH stability, a wide range in the solubility of the phases listed can be 
observed. DCP and DCPD are the most soluble phases while CDHA and HA are the least 
soluble. The increased solubility of DCPD, DCP, β-TCP, and α-TCP are particularly of interest 
in regenerative medicine due to their capability to degrade under physiological conditions 
through dissolution in addition to cell mediated degradation [87-89]. Unfortunately, the 
relatively rapid and acidic degradation products of DCP and DCPD may also lead to an 
undesired inflammatory response. However, the release of Ca2+ and PO43- ions during CaP 
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degradation is known to support the differentiation of osteoblast progenitor cells and 
mesenchymal stem cells towards mature osteoblasts which favors regeneration [90]. 
1.4.2 Formation of Clinically Relevant Forms of Calcium Phosphate  
Calcium phosphates have been processed into various forms to enhance their wider clinical 
application in the treatment of orthopedic, craniofacial, and dental bone defects. A few of the 
more widely used forms include granules, preformed porous scaffolds, injectable self-setting 
cements, and coatings. The development and applications of these forms of calcium phosphate 
will be discussed in the following sections.    
1.4.2.1 Calcium Phosphate Granules 
CaP granules are aggregates of CaP powders typically ranging from a few hundred microns to 
less than 5 mm in diameter. This form of calcium phosphate is widely used in dental and 
craniofacial applications since they can be tightly packed into bone defects while allowing the 
flow of biological fluids throughout the defect [74]. CaP granules are typically made porous by 
the addition of highly soluble salts which are leached out prior to implantation. The formation of 
porous rather than dense scaffolds allows the infiltration of cells and various physiological fluids 
more closely mimicking the 3D structure of mineralized tissues [7].  
CaP granules are often composed of HA, β-TCP, or a biphasic mixture of HA and β-TCP. 
The sieving of either sintered dense CaP tablets or fully set CaP cements, which will be 
described in Section 1.4.2.3, is performed to achieve the desired particle size distribution. Prior 
to implantation, it is common for clinicians to combine CaP granules with blood to accelerate 
regeneration and improve their handling properties [91]. CaP granules are also often combined 
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with polymeric components, which can serve as binders and drug delivery vehicles [92, 93]. The 
addition of polymeric components provides improved mechanical stability and allows the 
composite mixture to be easily molded to fill irregularly shaped defects.  
1.4.2.2 Preformed Porous Scaffolds 
Porous rather than dense scaffolds are favored in bone tissue engineering. Ideally, a large number 
of macropores, considered to be greater than 10 μm, are required to allow the host cells to 
infiltrate the scaffold. The pores formed should also be interconnected to increase the interaction 
of host cells within the scaffold and to enhance the transport of both nutrients and waste [94, 95]. 
Therefore, several techniques to form porous bulk ceramic scaffolds, larger than the granules 
describe in Section 1.4.2.1, have been developed. One approach is to combine CaP powders with 
particles which are either highly soluble or volatile and can be lost to create pores either during 
sintering or upon exposure to aqueous environments from sintered CaP scaffolds [96]. Although 
scaffolds with a well-defined pore size distribution can be formed using this technique, the 
formation of interconnected pores is not guaranteed.  
3D printing is an approach used to process CaP powders into structures with a controlled 
architecture enabling the formation of interconnected pores [97]. Scaffolds are constructed by 
using a print head containing a binder solution that builds up a desired 3D structure using CaP 
powders. When using a polymeric binder solution, subsequent heat treatment is required to sinter 
the scaffold and burn off the remaining organic binder solution. However, the need to sinter 
scaffolds after 3D printing can be avoided when using CaP powders that undergo a cement-like 
setting reaction upon exposure to the binder solution [98]. One major advantage of 3D printing is 
that patient specific bone grafts can be prepared. However, since these scaffolds are preformed, 
they cannot be molded prior to implantation to fill bone defects. In most cases, heat treatment to 
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temperatures in excess of 800˚C is required to achieve adequate sintering and mechanical 
properties. Processing at such temperatures also restricts the capability to incorporate either 
proteins or growth factors prior to implantation.  
1.4.2.3 Calcium Phosphate Self Setting Cements 
Similar to the polymeric PMMA cements, described in Section 1.3.1.2, CaP powders can be 
combined with aqueous solutions to form a workable paste. The exposure to aqueous 
environments initiates the dissolution of CaP powders followed by the precipitation of crystals of 
either HA (Equation 1.2) or DCPD (Equation 1.3) which become intricately embedded within 
the initial precursors with an invariable moderate rise in temperature sufficient to cause the 
bonding of the particles resulting in the solidification or setting of the paste. HA forming CaP 
cements were first discovered by Brown and Chow in the 1980s while DCPD forming cements 
were introduced by Lemaitre in the 1990s [99, 100].  
Equation 1.2 
Ca4(PO4)2O + CaHPO4•2H2O       Ca5(PO4)3OH + 2H2O 
Equation 1.3 
Ca3(PO4)2 + Ca(H2PO4)2•H2O + 7H2O       4CaHPO4•2H2O 
In both cases, they have since been engineered to form injectable pastes which can be 
administered in a minimally invasive fashion to fill irregularly shaped bone defects and fully set 
in the presence of physiological fluids (Figure 1.4). HA forming cements are more widely 
studied than DCPD forming cements due to their improved mechanical stability and less acidic 
setting conditions. However, as previously described, DCPD cements are much more degradable 
in comparison to HA forming cements [101].  
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Figure 1.4 An example of an injectable calcium phosphate self-setting cement prior to and after setting 
using cylindrical molds of varying size. 
 
HA forming cements have been prepared using a wide range of precursors due to the 
hydrolysis of several CaP phases to form HA under physiological conditions. They are most 
commonly prepared either by the hydrolysis of α-TCP or an acid-base reaction between TTCP 
and either DCPD or DCPA. The cements formed using these reaction mechanisms exhibit 
compressive strengths which range from 10-100 MPa [83, 102]. Therefore, they are incapable of 
supporting load bearing defects (Figure 1.3). Nonetheless, their similar compressive strengths to 
that of spongy, or trabecular bone, which is approximately 10 MPa, limits the risk for implant 
rejection due to a mismatch in mechanical properties as is commonly observed with both 
metallic and polymeric biomaterials in bone tissue engineering [83]. 
Although CaP cements were first developed for over thirty years ago, several key 
advancements have only recently been reported. One of the more recent advances in CaP 
cements is the development of premixed cements. These cements are packaged in the form of a 
premixed paste, rather than separate liquid and powder components, and can be directly 
administered without mixing and set in the presence of blood and other physiological fluids 
[103]. The controlled delivery of growth factors and drugs from injectable CaP cements, either 
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with or without polymeric carriers, is also a field with significant potential [104]. Due to the 
brittle nature of CaP cements, reinforcement with polymeric fibers to increase the flexural 
strength and achieve mechanical properties closer to that of native mineralized tissues is also 
widely studied [105].  
1.4.2.4 Calcium Phosphate Coatings 
Calcium phosphate coatings are often applied to metallic bone fixation devices to enhance their 
integration with mineralized tissues [106, 107]. Several approaches to deposit a wide range of 
calcium phosphate phases on metallic substrates have therefore been developed. Although many 
of these techniques have been optimized for the deposition of calcium phosphate coatings on 
non-degradable metals, they have only recently been applied to degradable magnesium and iron 
based alloy substrates. These processes include aqueous biomimetic approaches, organic based 
sol-gel methods, electrochemical techniques, and plasma assisted techniques [108-110]. A 
summary of the advantages and disadvantages of each of these techniques is described in Table 
1.3.   
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Table 1.3 A summary of the advantages and disadvantages of the various processes used to deposit 
calcium phosphate coatings on metallic substrates. 
 
 
Biomimetic coatings are deposited by immersing metallic substrates in solutions 
containing Ca2+ and PO43- ions kept at physiological temperatures for extended periods of time 
[111]. Pretreatment with either acidic or basic precursors is often required when using 
biomimetic approaches to form a highly reactive layer which calcium phosphates are 
subsequently deposited on [112]. Although biological molecules can be incorporated during the 
coating process due to the relatively mild conditions, the coatings formed often have a very poor 
adhesion to the substrate unless further heat treatment in performed.  
An alternative approach to deposit calcium phosphates is the use of organic solvents by 
the sol-gel method [79]. Calcium and phosphate containing precursors when dissolved separately 
in organic solvents and combined are capable of forming a viscous sol-gel in the absence of 
moisture. The further heat treatment of this gel results in the decomposition of the organic 
components and the formation of calcium phosphate nanoparticles [113]. The sol-gel formed has 
been dispersed on metallic substrates using processes, such as either dip coating or spin coating, 
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and heat treated to sufficient temperatures to fully decompose the organic components resulting 
in the formation of homogeneous calcium phosphate coatings. Unfortunately, biological 
molecules cannot be integrated using this approach due to the high temperature processing 
required [108]. Furthermore, the relatively low melting temperature of biodegradable Mg alloys 
leads to further complications. 
Electrochemical processes are more suitable for depositing calcium phosphate coatings 
on degradable alloys than sol-gel based methods since high temperature processing is not 
required [109]. Techniques such as electrophoretic deposition and cathodic deposition are widely 
studied [114, 115]. In both cases, metallic substrates are immersed in solutions containing Ca2+ 
and PO43- ions and an electrical potential is applied. The coatings formed are typically 
homogeneous and can be formed in a relatively short period of time after applying an electrical 
potential. Although heat treatment after the formation of the coating is not required, heat 
treatment has been found to substantially improve the coating adhesion to the substrate providing 
the mechanical stability necessary for surgical implantation [116]. 
Plasma assisted methods, which include plasma spraying, magnetron sputtering, pulsed 
laser deposition, and ion beam assisted deposition are some of the more widely used techniques 
to deposit calcium phosphates on non-degradable metals, such as titanium [110]. These 
procedures are performed under vacuum conditions and at various temperatures to adjust the 
crystallinity of calcium phosphate coating formed [64]. Due to the processing conditions, dense 
homogeneous coatings with excellent adhesion to the substrate can be formed [117]. However, 
plasma assisted methods deposit calcium phosphates on metallic substrates by line of sight. 
Therefore, it is difficult to deposit homogeneous calcium phosphate coatings on 3D porous 
scaffolds using this approach.  
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1.4.3 Limitations of Calcium Phosphates 
Although CaP scaffolds have been demonstrated to be biodegradable, osteoconductive, and 
osteoinductive, several limitations, in addition to their relatively poor mechanical properties, 
currently exist. HA is the most widely used CaP phase in the regeneration of mineralized tissues. 
Unfortunately, the poor solubility and limited cell mediated degradation of HA often leads to the 
formation of cracks throughout HA scaffolds. This is due to a mismatch between the rate of 
degradation of the scaffold and the rate of regeneration of the native mineralized tissues. As a 
result, more soluble CaP phases, such as DCPD and β-TCP, have gained increasing interest. 
However, their rates of resorption may also not be ideal for many applications. Although they are 
cheaper and provide a lower risk of undesired side effects, CaPs alone are also unable to 
regenerate mineralized tissues as rapidly as scaffolds containing the ECM proteins described in 
Section 1.1. Therefore, techniques to improve the bioactivity of CaP scaffolds and cell 
recruitment to the defect site enhancing the differentiation of osteoblast progenitor cells using 
reduced concentrations of expensive growth factors and ECM molecules remains a topic of 
interest.  
1.4.4 Ionic Substitution in Calcium Phosphates 
One approach to address the limitations of CaP scaffolds, outlined in Section 1.4.3, is the use of 
ionic substitutions. The inorganic components of mineralized tissues are composed of several 
elements in addition to Ca and P, which are known to play a key role in regulating both their 
structure and function. The elemental compositions dentin, enamel, and bone are illustrated in 
Table 1.4 [118]. A few of the more noticeable differences are the reduced CO32- and F- content in 
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enamel in comparison to dentin and bone and the increased amount of Mg in dentin. In an 
attempt to mimic the structure and composition of native mineralized tissues, the synthesis of 
ionic substituted CaP scaffolds for bone tissue engineering applications has been explored. 
  
Table 1.4 The elemental composition of enamel, dentin, and bone [118]. 
 
 
The biologically most relevant cationic substitutions for Ca2+ include Mg2+, Sr2+, and 
Zn2+. Sr2+ is specifically of interest since oral supplements of containing strontium have been 
shown to increase bone density and are currently used in the treatment of osteoporotic patients. 
Unfortunately, larger doses of strontium have also been shown to cause rickets disease, defective 
bone mineralization, and renal failure [119]. In vitro, Sr2+ has been shown to enhance ostoegenic 
differentiation. However, the role of strontium in modulating these mechanisms remains 
unknown [118]. Cationic substitutions with Mg2+ are also of interest since, similar to Sr2+, Mg2+ 
also influences osteoblast and osteoclast activity [118]. Furthermore, the increasing interest in 
the use of biodegradable Mg alloys in bone tissue engineering suggests that a greater 
understanding of the role of Mg2+ in regulating osteogenic differentiation is needed. Thus the 
present thesis has been outlined with the major goals to primarily address several of the issues 
discussed above comprising bulk scaffold type materials. These aspects, both in terms of 
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material characteristics as well as the in vitro biological response, will be discussed in the 
subsequent chapters.   
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2.0  THESIS GOALS 
2.1 SPECIFIC AIM 1  
SYNTHESIS AND CHARACTERIZATION OF MAGNESIUM SUBSTITUTED Β-
TRICALCIUM PHOSPHATE 
Background: Single phase β-TCP cannot be synthesized under aqueous conditions due to its 
instability in aqueous environments. However, the substitution of Ca2+ with Mg2+ ions in the β-
TCP crystal structure is known to stabilize β-TCP under aqueous conditions and enhances the 
temperature at which β-TCP converts to α-TCP enabling increased sintering and densification 
[120]. Sintering is required in the manufacturing of commercially available β-TCP granules and 
3D printed scaffolds to provide the mechanical stability necessary for clinical use. The traditional 
synthesis of Mg2+ substituted β-TCP (β-TCMP) requires either precipitating Mg2+ substituted 
CDHA and heat treating the precipitate formed to at least 800˚C (Equation 2.1) or the hydrolysis 
of single phase DCPD or DCPA in the presence of Ca2+ and Mg2+ ions at moderate temperatures 
(~100˚C) (Equation 2.2) [121, 122]. The lower temperature synthesis technique described in 
Equation 2.2 is much less studied although low temperature synthesis procedures typically form 
high surface area nanoparticles rather than micron sized particles offering the advantage to study 
the influence of the nanoscale surface with respect to in vitro cytocompatibility. 
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Equation 2.1 
Ca9(HPO4)(PO4)5(OH)       3Ca3(PO4)2 + H2O 
Equation 2.2 
2CaHPO4 + (1-x)Ca2+ + xMg2+      Ca3-xMgx(PO4)2 + 2H+ 
In previous work by Lee et al., rather than adding Ca2+ and Mg2+ ions during the hydrolysis of 
DCPA or DCPD (Equation 2.3), Mg2+ was introduced during the formation of DCPD prior to 
performing the hydrolysis reaction [81].  
Equation 2.3 
3Ca(1-x)MgxHPO4•2H2O      (Ca(1-x)Mgx)3(PO4)2 + H3PO4 + 2H2O 
For the single composition reported, it was concluded that β-TCMP was the only crystalline 
phase formed. However, the authors did not evaluate either the in vitro or in vivo 
biocompatibility of the β-TCMP prepared using this synthesis approach. This therefore formed 
the basis of the present work. 
Goals:   
- To synthesize β-TCMP using the approach described by Lee et al. [81] for a wide range 
of compositions and determine whether or not single phase β-TCMP was formed. 
- To study the role of β-TCMP composition on the in vitro proliferation and differentiation 
of osteoblast progenitor cells.   
Hypothesis: Mg2+ substitution in β-TCP will vary the physicochemical properties of β-TCP 
based scaffolds resulting in improved cytocompatibility in comparison to scaffolds prepared 
using commercially available β-TCP. The synthesis of β-TCMP with increased Mg2+ 
concentrations will result in the formation of multiple phases rather than single phase β-TCMP. 
The formation of multiple rather than single phase β-TCMP will vary the dissolution profile and 
surface properties of β-TCMP scaffolds. The release of bioactive Mg2+, Ca2+, and PO43- ions at 
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different rates will influence the osteogenic differentiation of osteoblast progenitor cells towards 
mature osteoblasts. The results obtained and subsequent discussion pertaining to this Specific 
Aim will be presented in Chapter 3 of this thesis. 
2.2 SPECIFIC AIM 2  
SYNTHESIS AND CHARACTERIZATION OF MAGNESIUM-STRONTIUM CO-
SUBSTITUTED Β-TRICALCIUM PHOSPHATE 
Background: The optimum scaffold composition determined in Specific Aim 1 which supports 
increased cell proliferation and differentiation will be compared with scaffolds prepared with 
both Mg2+ and Sr2+. Sr2+ concentrations between 0.01 and 0.1 mM in cell culture media have 
been found to promote the osteogenic differentiation of human mesenchymal stem cells through 
Wnt and MAPK signaling pathways by activating calcium sensing receptors (CaSRs) [123, 124]. 
Sr2+ containing supplements prepared using strontium ranelate are also currently prescribed to 
osteoporotic patients since they have been shown to increase bone density. However, excessive 
amounts of Sr2+ can also cause Rickets and renal failure [119]. Therefore, the incorporation of 
Sr2+ ions into bioactive glasses, biodegradable metals, and calcium phosphate scaffolds have been 
studied to provide a sustained release of Sr2+ locally at the defect site [76, 125]. In comparison to 
Mg2+, Sr2+ ions have an increased solubility in CaPs due to a similar ionic radius with Ca2+ ions 
[118]. While Mg2+ and Sr2+ co-substituted β-TCP has been prepared using the method described 
in Equation 2.1, the use of DCPD hydrolysis at moderate temperatures of ~100˚C to synthesize 
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Mg2+ and Sr2+ co-substituted β-TCP using the reaction mechanisms described in Equation 2.2 
and Equation 2.3 is yet to be reported. 
Goals: 
- To compare the influence of Mg2+ and Sr2+ doping on the cytocompatibility of β-TCP 
scaffolds. 
- To determine whether chemical cues, due to the dissolution of the scaffold, or physical 
cues, such as surface characteristics, influence the differentiation of osteoblast progenitor 
cells.  
- To study the role of cationic substitution on TGF-β and BMP signaling on β-TCP 
scaffolds. 
- To evaluate the roles of individual ions on supporting the osteogenic differentiation of 
osteoblast progenitor cells.  
Hypothesis: The co-substitution of β-TCP with Mg2+ and Sr2+ will result in increased cell 
proliferation in comparison to the scaffolds prepared using Mg2+ substituted β-TCP, described in 
Specific Aim 1, due to the release of Sr2+ ions in addition to Mg2+. The supplementation of 
culture media with either Mg2+ or Sr2+ has previously been shown to support differentiation 
[126]. However, work evaluating the cytocompatibility of nano-sized co-substituted β-TCP is yet 
to be reported. Therefore, it is hypothesized that both the chemical and the physical cues 
provided by the scaffold will support differentiation through TGF-β and BMP signaling. 
Chapters 4 and 5 of this thesis will focus on the results and discussion related to this Specific 
Aim. 
 34 
2.3 SPECIFIC AIM 3  
EVALUATION OF MAGNESIUM AND STRONTIUM SUBSTITUTED Β-
TRICALCIUM PHOSPHATES AS COATINGS ON BIODEGRADABLE MAGNESIUM 
ALLOYS 
Background: Degradable Mg based alloys have shown promise as an alternative to widely used 
non-degradable metallic biomaterials such as titanium and stainless steel [127]. Unfortunately, 
the majority of Mg alloys developed to date undergo rapid and uncontrolled corrosion under 
physiological conditions resulting in the accumulation of hydrogen gas, a corrosion product, near 
the implant site. In an attempt to improve bioactivity while also providing corrosion control for 
orthopedic and dental applications, CaP based coatings have been explored [108, 128]. CaPs 
have been deposited using a wide range of approaches. Some of the more widely used techniques 
include biomimetic approaches, sol-gels, pulsed laser deposition, and electrophoretic deposition 
[108, 129]. The limitations of many of the existing approaches are the need for heat treatment at 
elevated temperatures, the slow deposition process, and the inability to coat 3D porous scaffolds. 
The use of cationic substituted CaPs as coatings on biodegradable alloys is yet to be studied in 
detail [128]. The deposition of either strontium phosphates or Sr2+ doped CaPs on Mg alloys has 
only recently been reported [130, 131]. In addition to the improved cytocompatibility of cationic 
substituted CaPs in comparison to undoped CaPs, the variation in solubility in comparison to 
undoped CaPs may also lead to improved corrosion protection. 
Goals: 
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- To deposit Mg2+ and Sr2+ substituted β-TCP coatings, similar to the materials studied in 
Specific Aims 1 and 2, on a biodegradable magnesium alloy. 
- To study the influence of alloy pretreatment on CaP coating properties. 
- To evaluate the influence of CaP coating composition on corrosion protection. 
- To evaluate the influence of CaP coating composition on cytocompatibility. 
Hypothesis: CaP coatings with similar compositions to the powders synthesized in Specific 
Aims 1 and 2 will be deposited on a biodegradable Mg alloy. The incorporation of Sr2+ into CaP 
coatings through an aqueous approach can reduce coating solubility providing increased 
corrosion control and cytocompatibility in comparison to undoped CaP coatings. Chapter 6 of 
this thesis will focus on all of the details related to this Specific Aim. 
2.4 SPECIFIC AIM 4  
SYNTHESIS AND CHARACTERIZATION OF CATIONIC SUBSTITUTED SELF-
SETTING CALCIUM PHOSPHATE CEMENTS 
Background: HA self-setting cement formulations are widely used in craniofacial and 
orthopedic bone regeneration [101]. A few of the major disadvantages of HA forming cements 
include their poor in vivo resorption and limited radiopacity. The incorporation of Sr2+ into CaP 
scaffolds was previously found to enhance the solubility of HA in vitro and enhance the 
radiopacity of CaP cements [132]. Therefore, several approaches have been utilized to 
incorporate Sr2+ ions into HA forming cements. These reported methods have included the use of 
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highly soluble Sr2+ salts, such as SrCO3 and SrCl2•6H2O in addition to the precursors for HA 
forming cements described in Section 1.4.2.3 [124, 133]. However, the incorporation of Sr2+ ions 
into the CaP cements when using this approach is dependent upon the relative solubility of Sr2+ 
containing precursors in comparison to CaP precursors during the setting reaction. The use of 
cationic substituted CaP precursors rather than Sr2+ salts is much less studied although this may 
be a more efficient route to incorporate Sr2+ ions ensuring the sustained release of Sr2+ from these 
scaffolds once implanted. 
 Goals: 
- To synthesize and characterize Sr2+ substituted DCPD by precipitation in aqueous 
conditions using the approaches studied in Specific Aims 1 and 2. 
- To develop Sr2+ substituted HA forming self-setting cements which provide a sustained 
release of Sr2+ ions. 
- To study to the role of Sr2+ content on cement handling, setting, and mechanical 
properties. 
- To study the role of cement composition on cell proliferation, osteoblastic, and 
osteoclastic differentiation. 
Hypothesis: Sr2+ substitution can be used to improve the handling properties and solubility of 
HA forming cements while also improving cytocompatibility. The use of Sr2+ containing CaP 
precursors rather than Sr2+ containing salts will enhance the incorporation of Sr2+ into HA 
forming cements rather than using Sr2+ containing salts. The incorporation of increased amounts 
of Sr2+ into the final setting product will result in the sustained release of Sr2+ ions from these 
scaffolds. The resulting increased Sr2+ concentration will enhance the proliferation and 
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differentiation of both osteoblast and osteoclast progenitors. Chapter 7 of this thesis will focus on 
all of the details related to this Specific Aim. 
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3.0  SYNTHESIS AND CHARACTERIZATION OF MAGNESIUM SUBSTITUTED Β-
TRICALCIUM PHOSPHATE 
3.1 INTRODUCTION 
In order to improve the mechanical stability of β-TCP scaffolds, Mg2+ substitution has previously 
been explored since it is known to increase the temperature at which the β-TCP to α-TCP 
conversion occurs, enabling improved sintering and densification [120, 134]. Due to the 
instability of β-TCP under aqueous conditions, it can only be synthesized either by solid state 
methods or by the heat treatment of CDHA to temperatures of 800˚C or more [82]. In contrast, β-
TCMP has been synthesized under aqueous conditions by precipitation, hydrolysis, and 
hydrothermal techniques, in addition to the non-aqueous methods used to synthesize β-TCP [7, 
81, 135]. As a result, β-TCMP with a wide range of particle sizes and varying crystallinity, both 
of which are known to influence degradation, cell proliferation, and differentiation, can be 
synthesized, in comparison to β-TCP [36, 107].  
In addition to the capability of Mg2+ to stabilize β-TCP under aqueous conditions, Mg2+ 
deficiency has been shown to cause bone fragility and osteoporosis [136]. Mg2+ therapy has also 
been shown to increase bone mass in patients suffering from postmenopausal osteoporosis [137]. 
Despite this evidence to suggest that Mg2+ plays a critical role in bone metabolism, the exact role 
of Mg2+ in bone remodeling remains poorly understood. However, several studies have reported 
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a relationship between Mg2+ and parathyroid hormone levels [119, 138]. With respect to β-
TCMP, it has been shown that β-TCMP scaffolds are capable of supporting cell attachment and 
proliferation [139]. However, fewer studies have explored the role of Mg2+ substitution in β-TCP 
on osteogenic differentiation [140, 141]. The few in vivo studies performed to date with β-TCMP 
scaffolds have shown that in a murine dental alveolus model β-TCP was found to support 
increased bone regeneration in comparison to β-TCMP. However, β-TCMP based scaffolds have 
been shown to support bone regeneration in both rat and rabbit femur models [138, 142, 143]. As 
a result, further work is warranted to more accurately determine the role of Mg2+ substitution in 
β-TCP on both in vitro and in vivo biocompatibility.  
Previous work by Lee et al. using a novel low temperature aqueous synthesis approach 
has shown that upon refluxing Mg2+ substituted DCPD, synthesized with a 50% Mg/(Ca+Mg) 
molar ratio, β-TCMP with a relatively high surface area of approximately 200 m2 g-1 can be 
formed [81]. An elemental analysis of β-TCMP produced by this method indicated that the 
Mg/(Ca+Mg) molar ratio was close to 30 mol. %, although previous reports using Rietveld 
refinement have confirmed that the maximum possible Mg2+ substitution in the β-TCP structure 
is approximately 14 mol. % [122, 134].  To date, the structural refinement and in vitro 
cytocompatibility of β-TCMP synthesized using this method is yet to be reported. Therefore, this 
low temperature approach reported by Lee et al. was employed to generate β-TCMP with 
varying levels of substitution. Rietveld refinement was used to evaluate the actual level of ionic 
substitution in β-TCMP while varying the Mg/(Ca+Mg) ratio during synthesis. The effect of 
Mg2+ substitution on the physicochemical properties, cytocompatibility, and the capability to 
support the osteogenic differentiation of the MC3T3-E1 mouse preosteoblast cell line was 
studied in detail. 
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3.2 MATERIALS AND METHODS 
3.2.1 Synthesis of Magnesium Substituted β-Tricalcium Phosphate 
The detailed molar amounts used for the synthesis of β-TCMPs are illustrated in Table 3.1. 
Briefly, a 100 ml solution consisting of mixtures of CaCl2•2H2O (ACS Reagent≥99.0%, Acros 
Organics) and MgCl2•6H2O (ACS Reagent, ≥99.0%, Acros Organics) was added dropwise under 
constant stirring to 100 ml of a 0.5 M solution of disodium hydrogen phosphate (Na2HPO4, 
≥99.0% Sigma-Aldrich) at room temperature. The mixture was stirred for 15 minutes prior to 
centrifuging and washing the collected precipitate with deionized water. The reaction illustrated 
in Equation 3.1 is believed to proceed. In all cases, the (Ca+Mg)/P mole ratio was kept constant 
at a value of 1, corresponding to DCPD. The washed precipitate was then dispersed in 200 ml of 
deionized water and was refluxed for 2 hours following the previously published report which 
has shown that for a Mg/(Ca+Mg) ratio of 50%, refluxing for 2 hours resulted in the highest 
surface area [81]. While refluxing, the hydrolysis reaction illustrated in Equation 2.3 is believed 
to proceed resulting in the formation of β-TCMP. After refluxing, the powders were collected by 
centrifugation and were once again washed with deionized water prior to drying overnight at 
60˚C. 
Equation 3.1 
(1-x) Ca2+ + x Mg2+ + HPO42- + 2H2O         Ca1-xMgxHPO4•2H2O 
Where 0.35 ≤ x ≤ 0.50 
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Table 3.1 The molar amounts of calcium and magnesium chloride dissolved in 100 ml of DI water and 
used in the precipitation of DCPD by adding drop wise to 100 ml of 0.05 M Na2HPO4 at room temperature. 
 
3.2.2 X-Ray Diffraction and Rietveld Refinement 
Phase analysis was performed using X-ray diffraction (XRD). XRD was performed using a 
Philips X-Pert PRO diffractometer employing Cu Kα radiation (λ=1.5406 Å) with a Si-detector 
(X’celerator). The X-ray generator was operated at 45 kV and 40 mA at a 2θ range of 10-70˚ 
with a step size of 0.0167˚ and a time per step of 3s. Quantitative analysis of phase composition 
and Mg substitution was performed using Rietveld refinement. The structural model of ICSD 
card number 6191 [144] was used for the undoped β-TCP and is described in further detail in 
Table 3.2. ICSD card numbers 15326 and 22225 were used for Mg2P2O7 and Ca2P2O7, 
respectively. 
  
Table 3.2 Calcium site positions and occupancy factors for β-TCP from Dickens et. al. 
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X’Pert HighScore Plus version 3.0d was used to perform Rietveld refinements. The refined 
parameters were scale factor, zero displacement, background as Chebyshev polynomial of fifth 
grade and 1/x function, crystallite size, micro-strain, lattice parameters, and occupancy factors. 
Rietveld refinements were performed using the pseudo-Voigt peak shape model. Mg atoms were 
inserted into Ca(4) and Ca(5) lattice sites and a constraint that the sum of the occupancy factors 
for these sites be equal to 0.491 and 0.999, respectively, was applied [122]. 
3.2.3 Thermal Stability 
Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) were performed 
using a Netzsch STA 409 PC DTA/TGA instrument to analyze the weight loss and phase 
stability of the refluxed powders during heat treatment. The measurements were performed by 
heating samples in air up to 1000˚C at a heating rate of 10˚C min-1. The analysis of the ceramic 
powders was performed using a platinum crucible. 
3.2.4 Elemental Analysis 
An elemental analysis of the powders formed after precipitation and after refluxing was 
performed using inductively coupled plasma optical emission spectrometry (ICP-OES, iCAP duo 
6500, Thermo Scientific). The powders were first dissolved in diluted HNO3 solutions and the 
concentrations of Ca2+, Mg2+, and PO43- in solution was determined using known standards. A 
minimum of four batches were analyzed independently. The mean and standard deviation for 
each composition was reported. 
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3.2.5 Scaffold Preparation 
13 mm diameter β-TCMP pellets were formed by uniaxial compression (Carver, Wabash, IN). 
Briefly, 0.35 g of powder was compressed with an applied load of 2,500 psi. All β-TCMP pellets 
were heat treated to 600˚C for 4 hours prior to use in any further experiments. Commercially 
available β-TCP (HIMED, Old Bethpage, NY, ≥ 53 µm) was similarly uniaxially pressed and 
heat treated to 1000˚C for 4 hours to be used as a control. Heat treated pellets were used for all of 
the subsequent experiments described. 
3.2.6 Scaffold Pore Size Distribution and Protein Adsorption 
The pore size distribution and total pore volume of sintered β-TCMP and β-TCP pellets was 
analyzed using mercury porosimetry (Autopore IV 9500, Micromeritics). To study protein 
adsorption on β-TCMP and β-TCP pellets, pellets were first washed with PBS followed by 
incubation in fetal bovine serum (FBS, Atlanta Biologicals, Lawrenceville, GA) for 24 hours at 
37˚C. After incubation, the samples were washed twice with PBS and incubated for half an hour 
in a lysis buffer (CelLytic M Lysis Reagent, Sigma Aldrich) on a platform shaker at room 
temperature. The lysis buffer was collected and the concentration of the proteins adsorbed to the 
surface of the pellets was measured using the BCA assay (Peirce BCA Protein Assay Kit, 
Thermo Scientific). Further analysis of the adsorbed proteins was performed using SDS-
polyacrylamide gel electrophoresis and Coomassie Blue staining (ChemiDoc XRS Molecular 
Imager, Bio-Rad). 
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3.2.7 Cell Culture and Maintenance 
Murine preosteoblast cell line, MC3T3-E1, was obtained from ATCC (Manassas, VA). Cells 
were cultured under 37°C, 5% CO2, and 95% relative humidity in minimum essential medium 
alpha (α-MEM, Gibco, Grand Island, NY) containing 10% FBS and 1% penicillin streptomycin 
(P/S, Gibco, Grand Island, NY). Cells after third passage were used in experiments and were 
seeded at a density of 50,000 cells per pellet/scaffold. For differentiation studies, cells were 
cultured on samples, as previously described, for up to 7 days. After 7 days, growth media 
supplemented with 10 mM β-glycerophosphate, 50 µM ascorbic acid, and 100 nM 
dexamethasone was used to induce differentiation. 
3.2.8 Cell Viability 
Cell viability was assessed using live/dead staining (Invitrogen, Live/Dead Staining Kit) and the 
MTT assay (Vybrant MTT Cell Proliferation Assay Kit, Invitrogen, Carlsbad, CA). After 3 days 
of culture on heat treated pellets, samples were washed with phosphate buffered saline (PBS) and 
incubated for 40 minutes with the live/dead stain. After incubation, the samples were once again 
gently washed with PBS prior to imaging using fluorescence (Olympus CKX41). Cells were then 
fixed with 4% paraformaldehyde and were subjected to alcohol dehydration followed by sputter 
coating with palladium (Cressington sputter coater 108A) in order to observe cell morphology by 
scanning electron microscopy (Philips XL30 FEG ESEM).  
The MTT assay was used to quantitatively determine cell proliferation after 3 and 9 days. 
1 ml of culture media was added to each well along with 100 µL of a 12 mM MTT stock solution 
in PBS. Samples were incubated for 4 hours during which water soluble MTT is reduced to 
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insoluble formazan inside living cells. 100 µl of a 0.1 g/ml solution of sodium dodecyl sulfate in 
0.01 M hydrochloric acid was then added to each well to solubilize formazan and the samples 
were incubated for an additional 15 hours. 100 µl aliquots were removed from each well and 
added to a 96 well plate. Absorbance was then measured at a wavelength of 570 nm. 
3.2.9 Alkaline Phosphatase Activity 
Cells were lysed using the CelLytic M lysis buffer according to the manufacturer’s protocol. 30 
µL of cell lysate was added to 170 µL of 1 g L-1 p-nitrophenyl phosphate (pNPP) dissolved in 0.2 
M tris buffer (SIGMAFASTTM p-Nitrophenyl phosphate tablets, Sigma Aldrich). Samples were 
then incubated for 1 h at 37˚C prior to stopping the reaction with 20 µL of 0.3 N NaOH. The 
concentration of p-nitrophenyl (pNP) in solution after 1 h was determined by measuring the 
absorbance at a wavelength of 405 nm. pNP standards were prepared by diluting in 0.02 N 
NaOH. Alkaline phosphatase (ALP) activity was normalized with respect to DNA concentration 
which was measured using the Quant-iT PicoGreen Kit (Invitrogen, Carlsbad, CA) according to 
the manufacturer’s protocol. 
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Figure 3.1 Powder X-ray diffraction data collected from i) DCPD (JCPDS 09-0077) and DCPD 
precipitated ii) 35%, iii) 40%, iv) 45%, and v) 50% Mg. 
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Table 3.3 qRT-PCR genes and primer sequences used for MC3T3-E1 mouse preosteoblasts 
 
3.2.10 Osteogenic Gene Expression 
After 14 and 21 days of culture in osteogenic media, RNA extraction was performed using the 
NucleoSpin RNA II kit (Macherey Nagel, Bethlehem, Pa) according to the manufacturer’s 
protocol. RNA concentration was determined by measuring absorbance at 260 and 280 nm, 
respectively, using a BioRad SmartSpec spectrophotometer. Reverse transcription was then 
performed using the ImProm II Promega Reverse Transcription Kit according to the 
manufacturer’s protocol. Primers for GAPDH, osteocalcin, collagen-I, and runx2 were used in 
qRT-PCR experiments (Table 3.3) and each sample was measured in triplicate using Brilliant II 
SYBR Green Master Mix (Agilent Technologies). 
3.2.11 Statistical Analysis 
Five independent batches for each condition described in Table 3.1, were prepared. Unless 
otherwise mentioned, analyses were performed independently for each batch. Accordingly, the 
average and standard deviation were reported. Statistical significance was determined using a 
one way analysis of variance (ANOVA). The Tukey-Kramer test was used for all pairwise 
comparisons. A p value < 0.05 was considered significant. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Powder Characterization 
3.3.1.1 X-Ray Diffraction 
X-ray diffraction was performed to determine the crystallinity and phase composition of the 
powder samples formed both after precipitating and refluxing in the presence of various Mg2+ 
concentrations (Table 3.1). After precipitating DCPD in the presence of various Mg2+ 
concentrations and drying overnight at 60˚C, DCPD (JCPDS 09-0077) was the only crystalline 
phase formed when using up to 50% MgCl2•6H2O (Figure 3.1). The powders were then 
dispersed in deionized water and boiled with reflux for up to two hours. A similar analysis of the 
phase composition was performed. Specifically of interest was to determine whether or not 
samples prepared with 35-45% Mg were capable of stabilizing β-TCMP under aqueous 
conditions, as was previously observed for samples prepared with 50% Mg [81]. The XRD 
spectra of powder samples prepared with 35-50% Mg after refluxing and washing is illustrated in 
Figure 3.2. The peaks observed for all compositions closely resembled that of β-TCP (JCPDS 
09-0169) and no other crystalline phases were detected. A slight peak shift to increased 2θ values 
was also observed between β-TCP and the β-TCMPs. In comparing the XRD spectra collected 
for the various β-TCMPs, little or no peak shift was observed between conditions despite varying 
the Mg2+ concentration used during synthesis. 
The peak shift observed for the β-TCMPs in comparison to β-TCP is most likely due to a 
decrease in lattice size as a result of smaller 0.065 nm Mg2+ ions substituting for larger 0.099 nm 
Ca2+ ions in the β-TCP crystal structure [118]. Therefore, the similar peak positions observed for 
the β-TCMPs suggests that similar amounts of Mg2+ were retained in the β-TCMP formed after 
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refluxing despite varying Mg2+ concentration. Interestingly, upon increasing Mg2+ concentration, 
an increase in the full width half maxima (FWHM) was also observed. A similar increase in 
FWHM and loss of crystallinity was observed when synthesizing β-TCMP with increased Mg2+ 
concentrations using a hydrothermal technique [135]. As a result of the increased FWHM, it is 
difficult to confirm the presence of amorphous content for samples prepared with 50% Mg. 
However, little or no amorphous content was observed in the XRD spectra of samples prepared 
with 35%-45% Mg. Traditional β-TCMP synthesis methods, such as the heat treatment of CDHA 
and solid state synthesis, require heat treatment to at least 800˚C in order to form β-TCMP [121]. 
However, by refluxing Mg2+ substituted DCPD, precipitated with Mg/(Ca+Mg) molar ratios of 
35-50%, β-TCMP can be synthesized under aqueous conditions at temperatures near 100˚C, 
similar to previous reports using hydrothermal and hydrolysis techniques [135, 145]. 
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Figure 3.2 Powder X-ray diffraction data collected from i) β-TCP (JCPDS 09-0169) and β-TCMP after 
refluxing with ii) 35%, iii) 40%, iv) 45%, and v) 50% Mg. 
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3.3.1.2 Thermal Analysis 
Thermal analysis was performed in order to further characterize the phase purity of the refluxed 
powders since the presence of amorphous content could not be confirmed by XRD. The TGA 
and DSC curves collected from samples prepared with 35 and 50% Mg are illustrated in Figure 
3.3. For samples prepared with 35% Mg, an endothermic peak near 100˚C, due to the 
evaporation of moisture adsorbed to the surface of powder samples, was observed. Interestingly, 
near 750˚C a sharp exothermic peak was also observed. For samples prepared with 50% Mg, a 
similar peak between 100-150˚C, indicative of the evaporation of adsorbed moisture, was 
observed. However, it was of much greater intensity in comparison to the peak observed for 
samples prepared with 35% Mg. At increased temperatures, a sharp exothermic peak near 750˚C 
was also observed. Similar to the peak indicative of the evaporation of adsorbed moisture, the 
peak observed near 750˚C was also of much greater intensity in comparison to the peak observed 
at a similar temperature for samples prepared with 35% Mg. Similar patterns were also observed 
for samples prepared with 40 and 45% Mg. 
The exothermic peak at 750˚C observed for both samples could be due to the 
crystallization of an amorphous phase, which was not previously detected by XRD, the phase 
separation of β-TCMP, or the reconstitutive phase transformation of β-TCMP. Mg2+ substitution 
was previously found to increase the thermal stability of β-TCP since it increased the 
temperature at which β-TCP converts to α-TCP [134]. Therefore, it is highly unlikely that a 
phase separation or a phase transformation of β-TCMP is occurring, since for all compositions β-
TCMP was the only crystalline phase detected. Considering these aspects, it can be assumed that 
the exothermic peak arises due to the presence of an amorphous phase. The greater peak intensity 
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for samples prepared with 50% Mg suggests the formation of increased amorphous content upon 
increasing Mg2+ concentration. 
 
 
Figure 3.3 Thermogravimetric analysis and differential scanning calorimetry data collected from 
powder samples prepared with 35 and 50% Mg. 
 
In order to confirm the presence of amorphous phases, the refluxed powder samples were 
heat treated to 750˚C for 4 hours and analyzed using XRD and SEM (Figure 3.4). XRD results 
indicated that in addition to β-TCMP, Ca2P2O7 and Mg2P2O7, were formed after heat treatment to 
750˚C (Figure 3.4). SEM images of these heat treated samples illustrated the formation of 
sintered particles for samples prepared with 35% Mg (Figure 3.5 a)). However, for samples 
prepared with 50% Mg, two distinct morphologies were observed (Figure 3.5 b)). Similar 
sintered particles, as were observed for samples prepared with 35% Mg, along with much smaller 
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evenly distributed particles, believed to be due to the formation of increased amounts of 
Mg2P2O7, were also observed. 
 
 
Figure 3.4 Powder X-ray diffraction data collected from samples prepared using i) 35, ii) 40, iii) 45, and 
iv) 50% Mg after heat treatment to 750˚C (Ca2P2O7 JCPDS 03-0421 and Mg2P2O7 JCPDS 05-0582). 
 
Heat treatment to 600˚C was also performed (Figure 3.6). Similar to the XRD spectra 
collected after refluxing, a peak shift to greater 2θ values was observed and β-TCP was the only 
crystalline phase detected. A slight increase in FWHM could also still be observed after heat 
treatment to 600˚C for samples prepared with 50% Mg in comparison to powder samples 
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prepared with 35-45% Mg. The BET surface area after precipitating, refluxing, and heat 
treatment to 600˚C was also determined (Table 3.4). Surface area increased after refluxing upon 
increasing Mg2+ concentration for all conditions and a maximum surface area of 200 m2*g-1 was 
measured, similar to previous studies [81].  
 
 
Figure 3.5 SEM images of powder samples prepared with a) 35% and b) 50% Mg after heat treatment 
to temperatures greater than 750˚C. 
 
After heat treatment to 600˚C, both surface area and true density decreased with increasing Mg2+ 
concentration. These results confirmed that β-TCMPs synthesized using this method can be 
processed and subsequently heat treated at temperatures of up to 600˚C retaining β-TCMP as the 
only crystalline phase.  
In summary, thermal analysis and heat treatment confirmed the formation of amorphous 
phases after refluxing. However, the level of Mg2+ substitution and weight % of the crystalline 
and amorphous phases formed after refluxing remains unknown. The amorphous phase appears 
to form Mg2P2O7 and Ca2P2O7 upon heat treatment to 750˚C, maintaining a (Ca+Mg)/P ratio of 
1, which was kept constant during synthesis prior to refluxing. Therefore, it appears that Mg2+ 
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doped DCPD first forms an amorphous intermediate phase which converts into β-TCMP during 
refluxing. In previous work where β-TCMP was synthesized by the hydrolysis of DCPD or 
dicalcium phosphate (DCP), Ca2+ and Mg2+ containing solutions were added to solutions 
containing dissolved DCPD or DCP while refluxing ensuring that a (Ca+Mg)/P stoichiometric 
ratio of 1.5, that of β-TCP, was maintained [145]. In the current work, additional Ca2+ and Mg2+ 
ions were not added while refluxing Mg2+ doped DCPD, resulting in the formation of H3PO4 as a 
by-product. pH measurements after refluxing and prior to washing ranged between 3.7-5.8. More 
basic pH values were obtained for samples prepared with increased Mg2+ concentrations, 
suggesting a lower conversion. As a result of the poor conversion for samples prepared with 
increased Mg2+ concentrations, it is likely that increased amorphous content was also formed. 
3.3.1.3 Rietveld Refinement 
For CaPs, Rietveld refinement has typically been used to study biphasic substituted mixtures of 
HA and β-TCP and more recently even co-substituted β-TCP [82, 146, 147]. In the current work, 
five batches for each condition were prepared and were analyzed independently by Rietveld 
refinement to observe variations in lattice parameters, to determine the amount of Mg2+ retained 
in the β-TCP crystal structure, and to estimate the weight % of amorphous content formed. The 
occupancies of Ca(4) and Ca(5) sites were included in the refined parameters since it is known 
that Mg2+ ions preferentially occupy these two sites within the β-TCP crystal structure [144, 
148]. Ca(5), which is coordinated with six oxygen atoms, is initially occupied by Mg2+ followed 
by Ca(4), which is coordinated with three oxygen atoms [149]. 
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Figure 3.6 Powder X-ray diffraction data collected from i) β-TCP (JCPDS 09-0169) and β-TCMP after 
refluxing and heat treatment to 600˚C with ii) 35%, iii) 40%, iv) 45%, and v) 50% Mg.  
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Table 3.4 BET surface areas and true density of β-TCMP powders after precipitating, refluxing for 
two hours, and heat treatment to 600˚C.  
 
 
Refinement results indicated a decrease in lattice size compared to undoped β-TCP for all 
conditions studied (Figure 3.7). A steady decrease in lattice parameter a was observed upon 
increasing the Mg2+ concentration used during synthesis. A similar trend was observed for lattice 
parameter c, although it was observed to increase for samples prepared with 50% Mg. Previous 
work by Enderle et. al. has found that the lattice parameter a constantly decreases up to 14 mol. 
% Mg2+ substitution whereas the lattice parameter c decreases up to 10 mol. % Mg2+ substitution 
and then increases until it approaches 14% substitution [134]. Similar to Enderle et al a slight 
increase in the lattice parameter c was also observed in the current study and is believed to be 
due to Mg2+ preferably occupying the Ca(5) site and not occupying the Ca(4) site until the Ca(5) 
site is near full occupancy. This result indicates an increased Mg2+ substitution for samples 
prepared with 50% Mg in comparison to those prepared with 35-45% Mg. However, the 
substitution level appears to be similar for all conditions based on the limited range of variation 
of lattice parameters in comparison to that observed in other studies analyzing β-TCMP 
synthesized via high temperature approaches [121, 122]. 
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Figure 3.7 The effect of varying the Mg2+ concentration in β-TCMP synthesis on lattice parameters a 
and c. 
 
Mg2+ substitution was calculated based on the refined occupancy factors using Rietveld 
refinement and was compared with the mol. % of Mg determined by elemental analysis (Figure 
3.8). As the Mg2+ concentration in synthesis was increased, there was a greater deviation 
between the Mg/(Ca+Mg) molar ratio determined by Rietveld refinement in comparison to that 
determined using elemental analysis. Samples prepared with 50% Mg had the maximum Mg2+ 
substitution of roughly 13 mol. %, which was lower than the maximum possible Mg2+ 
substitution of 14% in β-TCP [122]. However, the total mol. % of Mg2+ for samples prepared 
with 50% Mg, measured by elemental analysis, was almost twice that which was determined by 
Rietveld refinement. Interestingly, β-TCMP synthesized with 35% Mg had a fairly similar result 
for Mg/(Ca+Mg) ratio from both the elemental analysis and computational methods.  
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Figure 3.8 A comparison of the mol. % of Mg2+ calculated from Rietveld refinement and measured 
using elemental analysis.   
 
This discrepancy between elemental analysis and Rietveld refinement results suggests 
that the excess Mg2+ is retained in the amorphous phase. Assuming that an amorphous phase has 
formed for samples prepared with 35% Mg due to the exothermic peak observed in thermal 
analysis, the similarity in Mg/(Ca+Mg) ratio determined by experimental and computational 
methods suggests that the amorphous content for this condition is either relatively small or has a 
similar composition to the crystalline content. As previously mentioned, upon heat treatment the 
amorphous phase appears to crystallize and form Ca2P2O7 and Mg2P2O7 (Figure 3.4). In order to 
estimate the amorphous content, Rietveld refinement was used to quantitatively determine the 
composition of the mixture after heat treatment to 750˚C and indirectly ascertain the amorphous 
phase content. Surprisingly, for samples prepared with 35% Mg, as much as 15% by weight 
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consisted of Ca2P2O7 with traces of Mg2P2O7 whereas for samples prepared with 50% Mg, 20% 
by weight consisted of Mg2P2O7 with traces of Ca2P2O7. This result indicates the variation in 
composition of the amorphous phase upon varying the Mg2+ concentration in synthesis, and 
confirms the formation of increased amorphous content. 
Using this low temperature aqueous method, high surface area β-TCMP, with 11-13% 
Mg substitution along with amorphous calcium magnesium phosphate was synthesized. Similar 
to β-TCP, amorphous calcium phosphate (ACP) has also been shown to be a relevant material for 
a wide range of applications in hard tissue regeneration [150, 151]. ACP exists in vivo and is 
believed to be a precursor for the nucleation and growth of HA crystals which are formed during 
mineralization, along with DCPD and octacalcium phosphate (OCP) [152]. Previous work has 
shown that Mg2+ substitution reduces the solubility of β-TCP thereby restricting the release of 
bioactive Ca2+, Mg2+, and PO43- ions [137]. Therefore, the formation of a highly soluble 
amorphous calcium magnesium phosphate phase in addition to β-TCMP may positively 
influence cytocompatibily in comparison to traditionally synthesized single phase β-TCMP. As a 
result, further study is warranted to determine the influence of the amorphous content formed on 
the proliferation and differentiation of osteoblast progenitor cells in the presence of β-TCMP. 
3.3.2 Scaffold Characterization 
3.3.2.1 Pore Size Distribution and Total Pore Volume 
Refluxed β-TCMP powders were uniaxially pressed to form 13 mm diameter pellets and were 
heat treated to 600˚C for 4 hours prior to use in any further experiments. Commercially available 
β-TCP was similarly processed and used as a control. Heat treatment to 600˚C was performed to 
provide sufficient mechanical stability during handling and under aqueous conditions while 
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avoiding the formation of multiple crystalline phases, observed after heat treatment to 750˚C. 
The pore size distribution and total pore volume of the scaffolds formed after uniaxial 
compression and heat treatment was determined to compare the surface area exposed in scaffolds 
formed using various β-TCMPs and β-TCP  powders. 
 
 
Figure 3.9 The pore size distribution of scaffolds prepared using commercially available β-TCP, 35% β-
TCMP, and 50% β-TCMP measured using Hg porosimetry. 
 
  In Figure 3.9, the pore size distribution of pellets prepared with β-TCP, 35%, and 50% 
β-TCMP is illustrated. For scaffolds prepared with commercially available β-TCP, the mean pore 
size is approximately 1 μm. For those prepared with 35 % β-TCMP, a mean pore size of 100 nm 
was obtained while a value of 40 nm was measured for scaffolds prepared with 50% β-TCMP. 
Despite the decreased mean pore size, the total intrusion volume for pellets prepared with 50% β-
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TCMP was 0.25 ml g-1 and that for samples prepared with β-TCP was 0.15 ml g-1, suggesting a 
greater total pore volume for scaffolds prepared with 50% β-TCMP. 
The increased mean pore size for pellets prepared using commercially available β-TCP is 
due to the larger particle size of high temperature synthesized β-TCP in comparison to the β-
TCMPs prepared in the study. An increased BET surface area was measured for β-TCMP 
prepared with 50% Mg in comparison to 35% Mg (Table 3.4), suggesting a decrease in particle 
size. As a result of the decreased particle size, a smaller mean pore size was obtained for pellets 
prepared using 50% Mg powders when using the same applied load. The near two-fold increase 
in intrusion volume for samples prepared with 50% Mg in comparison to β-TCP suggests that 
increased volumes of cell culture media and physiological fluids may interact with pellets 
prepared using 50% Mg, potentially leading to increased protein adsorption and cell attachment. 
3.3.2.2 Protein Adsorption 
 
 
Figure 3.10 The total protein measured from scaffolds after incubation in FBS. 
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Protein adsorption is known to influence cell attachment and proliferation as well as the 
activation and inhibition of the nucleation and growth of mineral phases [153]. Material 
properties such as phase purity, crystallinity, composition, microstructure, surface morphology, 
particle size, shape, and texture have all been shown to have a strong influence on protein 
adsorption [154]. Heat treated scaffolds were incubated overnight in FBS and rinsed with PBS 
prior to immersing in a lysis buffer to collect the adsorbed proteins. The concentration of total 
protein in the solutions collected is illustrated in Figure 3.10. Interestingly, despite a reduced 
total pore volume in comparison to β-TCMP scaffolds, increased protein concentrations were 
measured from commercially available β-TCP. In comparing the β-TCMPs, increased protein 
concentrations were measured from those prepared with increased Mg2+ concentrations (45-
50%). Similar trends observed in protein concentration were also observed using Coomassie 
Blue staining (Figure 3.11). While the variation of physical properties, such as porosity and total 
pore volume, may influence protein adsorption, it appears that the chemical properties of bulk β-
TCP scaffolds facilitate increased protein adsorption, despite the near 50% lower total pore 
volume in comparison to 50% β-TCMP. 
 
 
Figure 3.11 Coomassie blue staining illustrating the size distribution of proteins adsorped to scaffold 
surfaces. 
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3.3.2.3 Cell Viability 
Uniaxially pressed and heat treated β-TCMP and β-TCP pellets were sterilized by rinsing in 
ethanol and allowed to dry while exposed to UV. Once sterile, they were soaked overnight in 
culture media prior to seeding MC3T3-E1 mouse preosteoblast cells. Cell viability on these 
scaffolds was initially assessed using live/dead staining after 3 days of culture (Figure 3.12 a) i)-
iii)). A relatively high live cell density was observed on pellets prepared with commercially 
available β-TCP after 3 days of culture while much fewer dead cells were detected (Figure 3.12 
a) i)). In comparison to β-TCP, much fewer live cells were observed on pellets prepared with 
35% Mg (Figure 3.12 a) ii)). However, similar to scaffolds prepared using β-TCP, a relatively 
high live cell density was observed on scaffolds prepared with 50% Mg and much fewer dead 
cells were detected. Cell morphology after 3 days was observed using SEM (Figure 3.12 b) (i)-
iii)). Cells seeded on β-TCP exhibited a broad morphology whereas those on scaffolds prepared 
with 35% Mg appeared rather elongated (Figure 3.12 b) i)-ii)). A similar broad morphology was 
observed on scaffolds prepared using 50% Mg in comparison to commercially available β-TCP, 
despite the formation of increased amorphous content (Figure 3.12 b) iii)).  
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Figure 3.12 MC3T3-E1 a) live/dead staining and b) SEM images on scaffolds prepared using i) 
commercially available β-TCP, ii) 35% β-TCMP, and iii) 50% β-TCMP. 
 
The MTT assay was used to quantitatively analyze cell proliferation after live dead 
staining confirmed that cells could indeed attach and proliferation on β-TCMPs (Figure 3.13). 
Initially, cells cultured on β-TCP were most proliferative. However, after 9 days those cultured 
on substrates prepared with 50% Mg exhibited an increased proliferation in comparison to β-
TCP and all other β-TCMPs. Previous studies have found that increased concentrations of Mg2+ 
ions in cell culture media can adversely influence the MTT assay [155]. In order to compensate 
for any interference, substrates without cells were used as controls in this experiment. The 
potential increased Mg2+ concentrations were not observed to influence the MTT assay. 
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Figure 3.13 MC3T3-E1 proliferation on β-TCMP scaffolds determined using the MTT assay after 3 and 
9 days of culture. A p value of < 0.05 was considered significant. 
 
Previous studies have reported that Mg2+ ions act as a mitogenic factor, supporting 
enhancing cellular proliferation, in vitro [135]. Therefore, the increased proliferation observed on 
scaffolds prepared using β-TCMP synthesized with 50% Mg may be due to the release of 
increased Mg2+ ions into the surrounding culture media. Since a similar level of Mg2+ substitution 
in the β-TCP structure was determined by Rietveld refinement, if there is indeed an increased 
Mg2+ concentration in culture media it is most likely due to the dissolution of increased Mg2+ 
rich amorphous content. It has also previously been reported that Mg2+ substitution reduces the 
solubility of β-TCP, confirming that increased Mg2+ concentrations in culture media would be 
due to the dissolution of amorphous rather than crystalline phases [137]. 
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3.3.2.4 Ionic Concentrations in Culture Media 
The pH and ionic concentrations of cell culture media were analyzed throughout the 9 day 
culture period in the presence of MC3T3-E1 cells to confirm the release of increased Mg2+ and 
PO43- ions into culture media. The pH measurements generally varied from 7.8-8.4 and were 
similar among most groups (Figure 3.14 a)). A more noticeable difference was observed for Ca2+ 
concentration (Figure 3.14 b)). For samples prepared with β-TCP, there was a near two-fold 
increase in Ca2+ concentration at earlier time points in comparison to media collected from β-
TCMP based scaffolds. The Ca2+ concentration in media collected from β-TCMP pellets steadily 
increased throughout the experiment. After 7 days, similar Ca2+ concentrations were measured 
for both β-TCMP and β-TCP based scaffolds. Mg2+ and PO43- measurements (Figure 3.14 c) and 
d)) exhibited quite similar trends throughout the 9 day period. In general, increased Mg2+ and 
PO43- concentrations were measured in the media collected from samples prepared with 50% Mg 
throughout the 9 day experiment. 
The similar trend in Mg2+ and PO43- concentrations for samples prepared with elevated 
Mg2+ concentrations is likely due to the dissolution of larger amounts of Mg2+ rich amorphous 
phosphate phases, as previously described. The basal concentrations of Ca2+, Mg2+, and PO43- in 
culture media were roughly 1.8, 0.8, and 1 mM, respectively. The sharp decrease in Ca2+ 
concentration from basal levels for β-TCMPs is most likely due to the biomimetic precipitation 
of CaPs from the culture media under slightly basic conditions. The gradual increase in Ca2+ 
concentration suggests that less surface modification is occurring at later time points. Therefore, 
it is likely that the reduced proliferation observed at earlier time points on β-TCMPs in 
comparison to β-TCP is due to the significant surface modification occurring and increased 
proliferation was observed once scaffold surfaces stabilized (Figure 3.13). 
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Figure 3.14 The a) pH and b) Ca2+, c) Mg2+, and d) PO4
3- concentrations in cell culture media during the 
MC3T3-E1 proliferation experiments. 
3.3.2.5  Alkaline Phosphatase Activity 
β-TCMP scaffolds prepared with 35-50% Mg were all shown to support at least similar levels of 
MC3T3-E1 proliferation in comparison to commercially available β-TCP. However, their 
capability to support the differentiation of MC3T3-E1 cells towards mature osteoblasts is yet to 
be determined. ALP is an enzyme secreted by cells during differentiation which hydrolyzes 
pyrophosphates, resulting in increased local PO43- concentrations, thus promoting mineralization 
[95]. ALP is expressed at early stages of mineralization and can be observed both on the cell 
surface and matrix vesicles [156]. ALP activity was determined after 7, 14, and 21 days of 
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culture in osteogenic media for all conditions (Figure 3.15). After 7 days, significantly increased 
ALP activity was measured from cells cultured on scaffolds prepared with 50% Mg in 
comparison to all other groups. After 14 days, ALP activity increased for all conditions and cells 
cultured on samples prepared with 50% Mg once again had an elevated ALP activity. After 21 
days, a slight reduction in ALP activity was observed in comparison to 14 days. However, cells 
cultured on scaffolds prepared with 50% Mg once again had an elevated ALP activity and a 
significant increase in comparison to β-TCP was observed. 
 
 
Figure 3.15 Alkaline phosphatase activity measured after 7, 14, and 21 days in osteogenic media 
normalized with respect to DNA concentration. A p value of < 0.05 was considered significant.  
 
As a result of the elevated ALP activity, it appears that cells cultured on samples prepared 
with 50% Mg are more mature and prone to mineralize in comparison to those cultured on other 
β-TCMP and β-TCP substrates. However, in some cases it has been reported that Mg2+ ions are 
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capable of enhancing ALP activity and several mechanisms by which Mg2+ may influence ALP 
activity have been proposed [119]. In the current study, Mg2+ concentration continuously 
decreased throughout the culture period (Figure 3.14 c)). Therefore, if the ALP assay was indeed 
influenced by Mg2+ concentration, it was most likely to occur at earlier rather than later time 
points for samples prepared with 50% Mg during the dissolution of Mg2+ rich amorphous phases. 
Nonetheless, ALP activity alone cannot be used to conclude that increased osteogenic 
differentiation has occurred on β-TCMPs prepared with 50% in comparison to all other groups 
and further experiments are required. 
3.3.2.6 Osteogenic Gene Expression 
qRT-PCR was used to further assess the effect of Mg2+ substitution, phase composition, and 
physicochemical properties on the osteogenic differentiation of mouse preosteoblast cells. 
Collagen type 1 (Col-1), osteocalcin (OCN), and Runt related transcription factor 2 (Runx2) 
were chosen as osteoblast differentiation markers. Differentiating osteoblasts have been shown to 
produce Col-1 during bone formation and OCN is a mature osteoblast marker typically expressed 
at the end of matrix maturation [7, 18]. In contrast, Runx2 is an earlier marker for osteogenic 
differentiation which is down regulated during the latter stages of differentiation to support 
mature bone growth [141]. 
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Figure 3.16 qRT-PCR gene expression of a) collagen 1, b) osteocalcin, and c) runx2 for MC3T3-E1 cells 
cultured on commercially available β-TCP and β-TCMP scaffolds after 14 and 21 days in osteogenic media. 
All conditions were normalized to undifferentiated cells. A p value of < 0.05 was considered significant. 
 
After 14 days, cells cultured on scaffolds prepared with increased Mg2+ concentrations 
had a slightly increased expression of Col-1, OCN, and Runx2 in comparison to other groups 
(Figure 3.16 a)-c)). After 21 days, an up regulation of all of the selected markers was observed. 
Similar to the observations made after 14 days, cells cultured on samples prepared with increased 
Mg2+ concentrations also had an increased expression of Col-1, OCN, and Runx2 in comparison 
to the other β-TCMPs. In comparison to β-TCP, cells cultured on scaffolds prepared with 35-
40% Mg had a decreased expression of osteogenic genes while those cultured on scaffolds 
prepared with 45-50% Mg had as much as a tenfold greater expression of all three genes of 
interest. Based on the results obtained from qRT-PCR and the ALP assay, it can be concluded 
that increased osteogenic differentiation was observed for cells cultured on β-TCMP scaffolds 
prepared with 50% Mg in comparison to all other groups, including commercially available β-
TCP.  
The capability of these scaffolds prepared with increased Mg2+ concentrations to support 
the enhanced differentiation may be due to either the increased ionic concentrations in culture 
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media or the interaction of MC3T3-E1 cells with the scaffold surface. Differentiation was 
induced after 7 days using growth media supplemented with β-glycerophosphate, ascorbic acid, 
and dexamethasone. Although the release of Mg2+ and PO43- ions constantly decreased up to 9 
days, a near two fold increase in  Mg2+ and PO43- concentration was measured after 9 days from 
scaffolds prepared with 50% Mg in comparison to all other groups (Figure 3.14 c) and d)). High 
Mg2+ concentrations have previously been reported to inhibit human osteoblast differentiation in 
vitro while increased PO43- concentrations have been reported to reduce human mesenchymal 
stem cell differentiation [68, 90]. However, conflicting reports on the role of Mg2+ on 
differentiation have been reported [157]. The previously mentioned variations in ionic 
concentrations did not seem to influence cell proliferation since increased proliferation was 
observed on samples prepared with 50% Mg prior to inducing differentiation (Figure 3.13). 
Therefore it appears that the further reduction of Mg2+ and PO43- concentrations, below 1.5 mM, 
for samples prepared with 50% Mg after 9 days did not inhibit differentiation. 
In a previous study where cationic substituted β-TCP was synthesized using a solid state 
approach and no amorphous content was formed, undoped β-TCP was observed to support 
increased Runx2 expression in comparison to β-TCMP for human osteoblasts cultured directly 
on scaffolds [141]. However, the opposite trend was observed in the current study. The observed 
differences in the current study are most likely due to the presence of amorphous phases which 
may influence both the ionic concentrations in culture media and the biomimetic precipitation of 
mineral on scaffold surfaces. In another study where MC3T3-E1 differentiation in the presence 
of the extracts of β-TCMP was compared to β-TCP and a biphasic mixture of β-TCMP and HA, 
cells cultured in β-TCP extracts were observed to express increased ALP, OCN, and TGF-β1 in 
comparison to β-TCMP [86]. Although the ionic concentrations in the extracts were not reported, 
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the absence of amorphous content in this study suggests that Mg2+ and PO43- concentrations were 
most likely lower than the values obtained in the current study due to the capability of Mg2+ to 
reduce the solubility of β-TCP [137]. In addition, the absence of physical contact between cells 
and the scaffold may also influence differentiation and further study is warranted to identify the 
underlying mechanisms driving osteoblast differentiation when cultured on biphasic β-TCMP 
scaffolds. 
3.4 CONCLUSIONS 
Biphasic mixtures of β-TCMP with 11-13% Mg2+ substitution in β-TCP and a secondary 
amorphous calcium magnesium phosphate phase were synthesized. Protein adsorption, cell 
attachment, and cell spreading on scaffolds prepared with β-TCMP were observed to increase on 
samples prepared with increased Mg2+ concentrations and were at least comparable to 
commercially available β-TCP. Osteogenic differentiation studies indicated that the expression 
of both early and mature osteogenic markers were as much as ten-fold up-regulated on scaffolds 
prepared with increased Mg2+ concentrations in comparison to scaffolds prepared using 
commercially available β-TCP. These results suggest that low temperature synthesis methods can 
be a useful technique to prepare Mg2+ substituted β-TCP which may more closely mimic the 
native structure of mineralized tissues resulting in enhanced osteogenic differentiation. However, 
further work is required to more accurately determine whether the chemical cues, such as the 
release of bioactive Mg2+, Ca2+, and PO43- ions, or the physical cues, such as the ceramic 
microstructure, provided by the scaffolds prepared using these materials support the enhanced 
osteogenic differentiation observed. In addition, little is known on the signaling pathways 
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involved in regulating osteogenic differentiation upon exposure to β-TCP scaffolds prepared 
with increased Mg2+ concentrations. As a result, further work to understand the cellular 
mechanisms involved in regulating this process is required. 
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4.0  SYNTHESIS AND CHARACTERIZATION OF MAGNESIUM-STRONTIUM CO-
SUBSTITUTED Β-TRICALCIUM PHOSPHATE 
4.1 INTRODUCTION 
In the results presented in Chapter 3, it was observed that β-TCP prepared with 50% Mg 
supported enhanced differentiation in comparison to scaffolds prepared using commercially 
available β-TCP. In addition to Mg2+, Sr2+ substituted CaPs have also gained significant interest, 
as discussed in earlier Chapters, due to the capability of Sr2+ to support osteoblastic 
differentiation while simultaneously inhibiting osteoclastogenesis [158]. Work by Yang et al. 
showed that enhanced in-vitro osteogenic differentiation was observed in human mesenchymal 
stem cells (hMSCs) cultured in the presence of increased Sr2+ concentrations through Wnt/β-
catenin signaling. Sr2+ substituted HA-collagen composites were also implanted into rat calvarial 
defects and Sr2+ substituted HA was shown to significantly enhance in-vivo bone regeneration in 
comparison to HA [159]. However, the release of increased amounts of Sr2+ may lead to rickets 
and renal failure [119]. Mg2+-Sr2+ co-substituted CaPs have also been explored to further mimic 
native mineralized tissues [82]. Nevertheless, the majority of studies performed to date have 
focused only on the synthesis and characterization of these materials rather than evaluating either 
their in-vitro or in-vivo biocompatibility. 
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Although cationic substituted CaPs have been demonstrated to support osteogenic 
differentiation, little is known on the signaling pathways involved in regulating this process 
(Figure 4.1), particularly with respect to hMSCs, which are capable of differentiating to form 
myoblasts, adipocytes, fibroblasts, and chondrocytes, in addition to osteoblasts [160]. In order to 
study the role of individual ions on cell proliferation and osteogenic differentiation while 
avoiding the influence of scaffold surface or physical properties, several studies have been 
performed using culture media supplemented with various concentrations of Ca2+, Mg2+, Sr2+, 
and PO43- [124, 126, 161]. In Chapter 3, the scaffolds which supported increased differentiation 
also released increased concentrations of Mg2+ and PO43- into the surrounding culture media. 
However, it is yet to be determined whether either the physical or the chemical cues provided by 
the scaffold supported enhanced differentiation.  
 
 
Figure 4.1 The signaling pathways involved in regulating MSC differentiation on natural 
hydroxyapatite scaffolds [160].  
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In the current Chapter, the co-substitution of Mg2+ and Sr2+ in β-TCP was studied using 
the simple low temperature chemical synthesis approach applied in Chapter 3 to synthesize β-
TCMP of varying levels of divalent cation substitution. It was previously observed that upon 
increasing the Mg2+ concentration, increased amounts of amorphous content were formed in 
addition to β-TCMP. The β-TCMP prepared with a 50% Mg/(Ca+Mg) ratio using this low 
temperature approach also supported significantly increased levels of osteogenic differentiation 
in a mouse preosteoblast cell line in comparison to scaffolds prepared using commercially 
available β-TCP. However, the roles of the chemical and physical cues provided by the scaffold 
were not determined and the mechanisms through which these scaffolds supported differentiation 
were also not studied. Therefore, in the current Chapter the influence of Mg2+ and Mg2+-Sr2+ co-
substitution on the phase composition, physicochemical properties, proliferation, and 
mechanisms through which these scaffolds support hMSC osteogenic differentiation are 
reported. The influence of varying scaffold composition on TGF-β and BMP signaling was also 
investigated. 
4.2 MATERIALS AND METHODS 
4.2.1 Synthesis of Mg and Mg-Sr Co-Substituted β-Tricalcium Phosphate 
CaCl2•2H2O (ACS Reagent≥99.0%, Acros Organics), MgCl2•6H2O (ACS Reagent, ≥99.0%, 
Acros Organics), and SrCl2•6H2O (ACS Reagent, ≥99.0%, Sigma Aldrich) were dissolved in 100 
ml of deionized water (Table 4.1). This solution was then slowly added under constant stirring to 
100 ml of 0.5 M of disodium hydrogen phosphate (Na2HPO4, ≥99.0% Sigma-Aldrich) at room 
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temperature, during which the reaction illustrated in Equation 4.1 is believed to proceed. The 
mixture was stirred for 15 minutes prior to centrifuging and washing the precipitate formed with 
deionized water. In all cases, the (Ca+Mg+Sr)/P mole ratio was kept constant at a value of 1. The 
washed precipitate was then dispersed in 200 ml of deionized water and was refluxed for 2 
hours. After refluxing, the powders were once again collected by centrifugation and washed with 
deionized water prior to drying overnight at 60˚C. 
Equation 4.1 
(1-x-z) Ca2+ + x Mg2+ + z Sr2+ + HPO42- + 2H2O          Ca1-x-zMgxSrzHPO4•2H2O 
Where 0.35 ≤ x ≤ 0.50 and 0 ≤ z ≤ 0.15 
 
Table 4.1 Amounts of Ca2+, Mg2+, and Sr2+ containing precursors used in the precipitation of Mg and 
Mg-Sr doped CaHPO4•2H2O. 
 
4.2.2 Powder Characterization 
X-ray diffraction (XRD) was performed using a Philips X-Pert PRO diffractometer employing 
Cu Kα radiation (λ=1.5406 Aͦ) with a Si-detector (X’celerator). The X-ray generator was 
operated at 45 kV and 40 mA at a 2θ range of 10-70˚ with a step size of 0.0167˚ and a time per 
step of 3s. Specific surface area was determined using multi point Brunauer Emmett Teller 
(BET, ASAP 2020, Micromeritics). True density was measured using helium pycnometry 
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(Accupyc II 1340, Micromeritics). Thermogravimetric and differential thermal analyses were 
performed using a Netzsch STA 409 PC DTA/TGA. Measurements were performed by heating 
samples in air to 1000˚C at a rate of 10˚C min-1. Heat treatments of the as synthesized powder 
and pressed pellets were performed using a Lindberg box furnace (Lindberg/blue, Riverside MI). 
Elemental analysis was performed using inductively coupled plasma optical emission 
spectrometry (ICP-OES, iCAP duo 6500, Thermo Scientific). Scanning electron microscopy 
(SEM, Philips, XL30) and high resolution transmission electron microscopy (HRTEM, JEOL 
JEM-2100F with Gatan GIF-Tridiem) were used to observe particle morphology and 
crystallinity. 
4.2.3 Scaffold Preparation 
13 mm diameter β-TCMP pellets were formed by uniaxially pressing (Carver, Wabash, IN) 0.35 
g of powder with an applied load of 2,500 psi. All β-TCMP pellets were heat treated to 600˚C for 
4 hours prior to use in any further experiments. Commercially available β-TCP (HIMED, Old 
Bethpage, NY, ≥ 53 µm) was similarly uniaxially pressed and heat treated to 1000˚C for 4 hours 
to be used as a control. Heat treated pellets were used for all of the subsequent experiments 
described. 
4.2.4 Cell Culture and Maintenance  
Human mesenchymal stem cells (hMSCs) obtained from the normal human bone marrow were 
purchased from Lonza (Lonza, Allendale, NJ) and were cultured under 37 ˚C, 5% CO2, and 95% 
relative humidity. Cells after the third passage were used in all experiments and were cultured in 
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growth media containing minimum essential media α (MEMα) supplemented with 20% FBS and 
1% P/S. Osteogenic differentiation was induced after 7 days of culture in growth media 
supplemented with 100 nM dexamethasone, 50 µM ascorbic acid, and 10 mM β-
glycerophosphate.  
4.2.5 Cell Proliferation 
Cell viability was assessed using the MTT assay (Vybrant MTT Cell Proliferation Assay Kit, 
Invitrogen, Carlsbad, CA) and live/dead staining (Invitrogen, Carlsbad, CA). Water soluble MTT 
is reduced to insoluble formazan crystals in living cells. Formazan is then solubilized and its 
concentration can be determined by measuring optical density at 570 nm. Growth media 
containing 12 mM MTT was added to each well and incubated for 4 hours. A 0.1 g/ml solution 
of sodium dodecyl sulfate in 0.01 M hydrochloric acid was then added and the samples were 
incubated for an additional 15 hours. Absorbance was then measured at 570 nm. For live/dead 
staining, at the time points of interest samples were washed with PBS and were then incubated 
for 30 minutes with calcein and ethidium homodimer-1 diluted in PBS. After incubation, 
samples were once again gently washed with PBS prior to imaging using fluorescence (Olympus 
CKX41). 
4.2.6 Live/dead Staining  
At the time points of interest samples were washed with PBS and were then incubated for 30 
minutes with calcein AM and ethidium homodimer-1 diluted in PBS (Invitrogen, Live/dead 
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Staining Kit) at room temperature. After incubation, samples were once again gently washed 
with PBS prior to imaging using fluorescence (Olympus CKX41). 
4.2.7 Chemical Analysis of Culture Media 
The concentration of Ca2+, Sr2+, Mg2+, and PO43- in the culture media during the viability 
experiment was determined using ICP-OES. Culture media samples were collected every other 
day and diluted in pH 7.4 tris buffer for analysis using ICP-OES using known standards. 
4.2.8 Alkaline Phosphatase Activity 
hMSCs were lysed using a lysis buffer following the manufacturer’s protocol (CelLytic M, 
Sigma Aldrich). 170 µL of 1 g L-1 p-nitrophenyl phosphate (pNPP) dissolved in 0.2 M tris buffer 
(SIGMAFASTTM p-Nitrophenyl phosphate tablets, Sigma Aldrich) was then added to 30 µL of 
lysate. Samples were then incubated at 37˚C for one hour. The reaction was terminated by the 
addition of 20 µL of 0.3 N NaOH. The concentration of p-nitrophenyl (pNP) in solution after 
incubation was determined by measuring the absorbance at 405 nm. pNP standards were 
prepared by diluting pNP in 0.02 N NaOH. Alkaline phosphatase (ALP) activity was normalized 
with respect to total protein concentration. 
4.2.9 Indirect Cell Culture 
hMSCs were cultured in the presence of Mg2+ and Sr2+ substituted β-TCP pellet extracts using 
transwell membrane inserts. The membranes used in the study had a pore size of 0.4 µm and a 
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nominal pore density of 4,000,000 pores cm-2 (Transwell PET, Corning). Sintered dense pellets 
were placed on transwell inserts and hMSCs were cultured below on tissue culture plastic. The 
influence of extracts containing various Ca2+, Mg2+, Sr2+, and PO43- concentrations on the 
proliferation and osteogenic differentiation of hMSCs in the absence of physical contact with 
dense cationic substituted β-TCP pellets was also studied. 
4.2.10 Osteogenic Protein Expression 
Osteogenic protein expression was quantified using a MAGPIX instrument (Luminex, Austin, 
TX).  A Human Bone Magnetic Bead Panel kit (EMD Millipore, Billerica, Ma) was used 
according to the manufacturer’s protocols. Cell lysates were incubated overnight at 4˚C with 
antibody conjugated magnetic beads. After incubation, the well contents were washed prior to 
measuring protein concentration using known standards. The intracellular expression of 
osteprotegrin (OPG) and osteopontin (OPN) were determined. Measurements were conducted in 
triplicate for each sample and were normalized with respect to total protein concentration. 
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Figure 4.2 X-ray diffraction data collected from as prepared i) DCPD (JCPDS 09-0077), ii) 35-15%, iii) 
40-10%, iv) 45-5%, and 50% Mg and Mg-Sr doped DCPD.   
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4.2.11 Transforming Growth Factor-β Signaling PCR Array 
After 21 days of culture in osteogenic media directly on scaffolds prepared with varying Mg2+ 
and Sr2+ content, RNA was collected using a NucleoSpin RNA II kit (Macherey Nagel, 
Bethlehem, Pa) according to the manufacturer’s protocol. RNA concentration was determined by 
measuring absorbance at 260 and 280 nm, respectively, using a BioRad SmartSpec 
spectrophotometer. Reverse transcription was performed using the RT2 First Strand Kit (Qiagen, 
Germantown, MD). cDNA was then combined with SYBR Green (RT2 SYBR Green qPCR 
Mastermix, Qiagen) and added to 96 well plates preloaded with primers relevant to TGF-β and 
BMP signaling (TGF-β/BMP Signaling Pathway PCR Array, Qiagen). The markers with cycle 
threshold (Ct) values of less than 30 were reported. The data collected was analyzed using 
software provided by the PCR Array manufacturer. 
4.2.12 Statistical Analysis 
All experiments were performed with a minimum of three repeats for each condition. The mean 
and standard error were reported. One way analysis of variance (ANOVA) was used to 
determine statistical significance. The Tukey-Kramer test was used for all pairwise comparisons. 
A p value < 0.05 was considered significant. 
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Figure 4.3 X-ray diffraction data collected from as prepared i) β-TCP (JCPDS 09-0169), ii) 35-15%, iii) 
40-10%, iv) 45-5%, and 50% Mg and Mg-Sr doped β-TCP. 
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4.3 RESULTS AND DISCUSSION 
4.3.1 Powder Characterization 
4.3.1.1 Phase Composition 
X-ray diffraction was used to determine the crystallinity and phase composition of the powders 
precipitated with varying Mg2+ and Sr2+ concentrations both after precipitating and after 
refluxing. After precipitating, the data collected for all of the conditions described in Table 4.1 
closely resembled that of DCPD (JCPDS 09-0077) and no other crystalline phases were detected 
(Figure 4.2). After refluxing (Figure 4.3), the patterns observed for all compositions closely 
resembled that of β-TCP (JCPDS 09-0169). A slight peak shift to lower 2θ values was observed 
for samples prepared with increased Sr2+ concentrations in comparison to β-TCP (Figure 4.3 i) 
and ii)). The observed peak shift is likely due to an increase in lattice parameter as a result of the 
ionic substitution of Ca2+ by larger Sr2+ ions [82]. An increase in full width half maxima 
(FWHM) was also observed upon increasing Mg2+ concentration and reducing Sr2+ 
concentration.  
Previous work has shown that the maximum amount of Mg2+ that can be substituted into 
the β-TCP crystal structure is roughly 14 mol. % [122, 134]. This is primarily due to the large 
difference in ionic radii between Mg2+ and Ca2+ ions [118, 162]. In contrast, although larger than 
Ca2+, Sr2+ is known to have an increased solubility in β-TCP due to less of a discrepancy in ionic 
radii with Ca2+. Previous reports have found that up to 80 atomic % Sr2+ can be substituted for 
Ca2+ in the β-TCP structure thereby resulting in a linear enlargement of the unit cell [163, 164]. 
As a result of the increase in FWHM, the presence of amorphous phases could not be confirmed 
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for compositions prepared with increased Mg2+ concentrations. However, for all conditions β-
TCP was the only crystalline phase detected. 
4.3.1.2 Elemental Composition 
Elemental analysis was performed on the refluxed powders using ICP to determine the mol. % of 
Mg2+ and Sr2+ retained after precipitating, refluxing, and washing steps (Table 4.2). For all of the 
conditions synthesized with Sr2+, the mol. % of Sr2+ measured after refluxing was similar to the 
mol. % of Sr2+ used in the initial precipitation step. However, the mol. % of Mg2+ measured 
using ICP was much lower than the mol. % of Mg2+ used during synthesis for all conditions. 
Interestingly, although β-TCP was the only crystalline phase detected using X-ray diffraction 
(Figure 4.3), the mol. % of Mg2+ measured in some cases exceeded the maximum amount of 
Mg2+ that can be substituted for Ca2+ in the β-TCP crystal structure [122, 134]. In addition, the 
(Ca+Mg+Sr)/P ratio measured using ICP was much lower than 1.5, that of β-TCP, for all 
conditions. 
 
Table 4.2 Elemental analysis of as prepared Mg and Mg-Sr doped β-TCP. 
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4.3.1.3  Thermal Stability 
The presence of excess Mg2+ and the lower than expected (Ca+Mg+Sr)/P ratio suggests that in 
addition to cationic substituted β-TCP, amorphous phases may also be formed. Therefore, 
thermal analysis was performed on the refluxed powders to further study the phase composition 
and thermal stability (Figure 4.4). A weight loss was observed for samples prepared with 50% 
Mg and 35-15% Mg-Sr while heating to 1000˚C in air. A greater than 10% weight loss was 
observed for samples prepared with 50% Mg while those prepared with 35-15% Mg-Sr 
experienced a near 5% weight loss. In both cases, an endothermic peak near 150˚C was also 
observed. Similar to the observed weight loss, samples prepared with 50% Mg had a more 
intense endothermic peak in comparison to those prepared with 35-15% Mg-Sr. The endothermic 
peak near 150˚C is believed to correspond to the evaporation of moisture adsorbed to the surface 
of powder samples. The observed change in weight is also believed to be due to the evaporation 
of adsorbed moisture since the majority of weight loss occurred at temperatures below 200˚C for 
both of the compositions shown.  
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Figure 4.4 DTA-TGA data collected from samples prepared with 50% Mg and 35-15% Mg-Sr doped β-
TCP while heating in air at a rate of 10˚C min-1 up to 1000˚C. 
 
At elevated temperatures, a sharp exothermic peak was observed between 700-750˚C in 
the DSC curves collected from samples prepared with 50% Mg and 35-15% Mg-Sr. Similar to 
the trends observed in weight loss and the intensity of the endothermic peak due to the 
evaporation of moisture, the intensity of the exothermic peak observed was much greater for 
samples prepared with 50% Mg. This exothermic peak is believed to correspond to the 
crystallization of an amorphous phase which was not previously detected using X-ray diffraction. 
The increased peak intensity for samples prepared with 50% Mg also suggests that increased 
amorphous content may be formed in comparison to samples prepared with 35-15% Mg-Sr. 
Further analysis using X-ray diffraction confirmed the formation of pyrophosphates after heat 
treating refluxed powders to temperatures greater than 750˚C. Unconverted DCPD is known to 
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form calcium pyrophosphate upon heat treatment to elevated temperatures [143, 145]. However, 
after heat treatment to 600˚C, β-TCP remained the only crystalline phase detected (Figure 4.5). 
4.3.1.4 Particle Size and Density 
Thermal analysis confirmed that in addition to poorly crystalline cationic substituted β-
TCP, a secondary amorphous phase was formed for all of the conditions described in Table 4.1. 
Therefore, the presence of Sr2+ in addition to Mg2+ did not result in the formation for single 
phase cationic substituted β-TCP. High resolution transmission electron microscopy (HRTEM) 
was used to further study the crystallinity and to observe the particle size after heat treatment to 
600˚C (Figure 4.6). The representative low magnification image shown in Figure 4.6 a) of 
samples prepared using 35-15% Mg-Sr illustrates the formation of 40-50 nm particles after heat 
treatment. A higher magnification image with a Fast Fourier Transform Diffraction Pattern 
(FFT-DP) inset collected from the region marked ‘X’ indicates the formation of primarily 
crystalline material (Figure 4.6 b)). Figure 4.6 c) illustrates a similar representative low 
magnification image of samples prepared with 50% Mg. A slight increase in particle size after 
heat treatment in comparison to samples prepared with 35-15% Mg-Sr was observed. In contrast 
to samples prepared with 35-15% Mg-Sr, high magnification images of samples prepared using 
50% Mg indicated the formation of both crystalline and amorphous material, indicated using the 
symbols ‘X’ and ‘A’, respectively (Figure 4.6 d)). This data confirms the formation of increased 
amorphous content for samples prepared with 50% Mg and suggests that these samples may have 
been sintered to a higher degree after heat treatment to 600˚C. 
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Figure 4.5 X-ray diffraction data collected from i) β-TCP (JCPDS 09-0169), ii)35-15%, iii) 40-10%, iv) 
45-5%, and v) 50% Mg and Mg-Sr β-TCP heat treated to 600˚C.  
 
BET and helium pycnometry were used to further study the influence of composition on 
particle size and density after precipitating, refluxing, and heat treatment (Table 4.3). After 
precipitating, samples prepared with increased Sr2+ concentrations had increased surface area. 
Upon refluxing, surface area further increased at least five-fold for all conditions. Samples 
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prepared with 50% Mg had the largest surface area after refluxing. As expected, surface area 
decreased after heat treatment to 600˚C due to an increase in particle size. Similar to HRTEM 
images, BET results also indicate an increased particle size for samples prepared with 50% Mg 
in comparison to 35-15% Mg-Sr after sintering. The true density after heat treatment to 600˚C 
was also measured. Increasing Sr2+ concentration resulted in an increase in true density while the 
opposite trend was observed upon increasing Mg2+ concentration. The reduced density observed 
upon increasing Mg2+ concentration may be due to a reduction in mass and lattice parameters as 
a result of smaller Mg2+ ions substituting for larger Ca2+ ions in the β-TCP crystal structure or 
the formation of increased amounts of an amorphous phase, previously confirmed using DSC 
and HRTEM (Figure 4.4 and Figure 4.6). 
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Figure 4.6 TEM images of 35-15% Mg-Sr doped β-TCP after heat treatment to 600˚C at a 
magnification a) 6,000X and b) 40,000X and 50% Mg doped β-TCP after heat treatment to 600˚C at a 
magnification of c) 6,000X and d) 40,000X. The crystalline and amorphous regions observed in the areas from 
which the Fast Fourier Transform Diffraction Patterns (FFT-DPs) were collected are illustrated using the 
symbols ‘X’ and ‘A’, respectively. 
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Table 4.3 Surface area and true density of Mg and Mg-Sr doped β-TCP after precipitating, refluxing, 
and heat treatment to 600˚C. 
 
 
From this experimental data it can be concluded that biphasic mixtures of cationic 
substituted β-TCP and amorphous calcium phosphates were formed for all conditions. The 
majority of the Sr2+ added during synthesis was retained in the product formed after refluxing 
while large amounts of Mg2+ were lost. X-ray diffraction indicated that β-TCP remained the only 
crystalline phase formed after heat treatment at temperatures of up to 600˚C. The differences in 
composition were also observed to vary the particle size and the degree of sintering. Due to the 
varying crystallinity and particle size, the surface properties and rate at which Ca2+, Mg2+, Sr2+, 
and PO43- ions are released due to dissolution from cationic substituted β-TCP  will vary upon 
exposure to physiological solutions [64, 75]. Interestingly both surface properties and ionic 
concentrations are known to influence cell proliferation and differentiation [124, 165]. Therefore, 
by varying the composition used in synthesis, β-TCP with tailored properties for improved 
cytocompatibility can be synthesized. 
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4.3.2 In-Vitro Cytocompatibility 
4.3.2.1 Cell Proliferation 
To evaluate the cytocompatibility of cationic substituted β-TCP, the powders formed after heat 
refluxing were uniaxially pressed and heat treated to 600˚C in air forming dense pellets of 
crystalline cationic substituted β-TCP and amorphous cationic substituted calcium phosphate. 
The heat treated scaffolds were rinsed with ethanol and dried under ultraviolet light prior to 
seeding human mesenchymal stem cells (hMSCs) cells directly on their surface. hMSC 
proliferation on Mg2+ and Sr2+ containing scaffolds in comparison to commercially available β-
TCP was assessed after 3 and 9 days using the MTT assay (Figure 4.7). After 3 days of culture, 
the scaffolds prepared with 35-15% Mg-Sr supported increased hMSC proliferation in 
comparison to other cationic substituted β-TCPs. In addition, a similar level of proliferation was 
observed in comparison to commercially available β-TCP. However, after 9 days similar levels 
of proliferation were obtained for all conditions in comparison to β-TCP.  
Live/dead staining and SEM were used to observe cell morphology after 3 days of culture 
in growth media (Figure 4.8). hMSCs cultured on pellets prepared with 35-15% Mg-Sr had a 
similar live cell density in comparison to hMSCs cultured on commercially available β-TCP 
(Figure 4.8 a) and b)). However, a slightly increased number of dead cells were also observed on 
scaffolds prepared using 35-15% Mg-Sr in comparison to those cultured on β-TCP. The samples 
were then fixed using 2.5% glutaraldehyde and were subjected to alcohol dehydration prior to 
imaging using SEM (Figure 4.8 c) and d)). In both cases, hMSC morphology was broad rather 
than elongated and the cells were evenly dispersed throughout the surface of the substrate.  
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Figure 4.7 Cell viability was assessed after 3 and 9 days in growth media using the MTT assay. The 
data collected for all conditions was normalized to that of commercially available β-TCP. 
 
The results obtained suggest that at earlier time points the increased Sr2+ and reduced 
Mg2+ content in samples prepared with 35-15% Mg-Sr β-TCP supports increased proliferation in 
comparison to all other conditions. In previous work studying Sr2+ substituted CaP cements, a 
similar level of hMSC proliferation was observed for cells cultured in growth media without 
osteogenic supplementation containing no Sr2+ and media containing up to 1 mM Sr2+  [124]. 
With respect to Mg2+, the addition of up to 10 mM MgSO4 resulted in a similar level of human 
bone marrow stromal cell (hBMSC) proliferation in both growth media and osteogenic media 
[126]. Therefore, hMSCs are capable of tolerating much greater Mg2+ rather than Sr2+ 
concentrations. However, the concentration of these ions in culture media is yet to be 
determined. Nonetheless, after longer periods of culture, the scaffolds prepared with both 
increased Mg2+ and Sr2+ concentrations were at least equally capable of supporting hMSC 
proliferation in comparison to commercially available β-TCP. 
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Figure 4.8 Live/dead staining of hMSCs seeded on scaffolds prepared with a) 35-15% Mg-Sr β-TCP 
and b) β-TCP after 3 days and SEM images of hMSCs after 3 days on samples prepared using c) 35-15% Mg-
Sr β-TCP and d) β-TCP. 
4.3.2.2 Chemical Analysis of Culture Media 
To evaluate the role of ionic concentrations on cell proliferation, the concentrations of Sr2+, 
Mg2+, Ca2+, and PO43- in culture media were measured throughout the experiment using ICP 
(Figure 4.9). The culture media was collected on the days it was changed and diluted in a pH 7.4 
tris-HCl buffer solution. Known standards were similarly diluted and used to generate a standard 
curve. The Ca2+ concentration measured from β-TCP scaffolds was initially increased in 
comparison to all other groups and remained relatively constant at approximately 1.2 mM 
throughout the 9 day period (Figure 4.9 a)). The Ca2+ concentration for all other groups gradually 
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increased throughout the proliferation experiment and was comparable to that of β-TCP after 
approximately 7 days. The measured basal concentration of Ca2+ in the culture media was 1.7 
mM. This data suggests that a greater amount of mineral from the media was therefore deposited 
on cationic substituted β-TCP scaffolds at earlier time points in comparison to β-TCP. The 
increased surface modification at earlier time points may explain the reduced proliferation 
observed for most of the cationic substituted β-TCP conditions (Figure 4.7). 
 
 
Figure 4.9 The ionic concentrations of a) Ca2+, b) Sr2+, c) Mg2+, and d) PO4
3- in culture media 
throughout the experiment. 
 
  Sr2+ concentration was observed to constantly decrease throughout the experiment 
(Figure 4.9 b)). Scaffolds prepared with increased amounts of Sr2+ also released increased 
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amounts of Sr2+ into the surrounding culture media. Based on previous reports, it can be 
concluded that the amount of Sr2+ released into the culture is non-toxic to hMSCs [124]. Similar 
trends in the ionic concentrations of both Mg2+ and PO43- were observed throughout the 
experiment (Figure 4.9 c) and d)). The basal concentrations of Mg2+ and PO43- in culture media 
were measured to be 0.8 and 0.9 mM, respectively. Increased Mg2+ and PO43- concentrations 
were measured for samples prepared with increased Mg2+ concentrations. This is most likely due 
to the formation of increased amounts of a highly soluble Mg2+ rich amorphous calcium 
phosphate phase upon increasing the Mg2+ concentration during synthesis, previously confirmed 
using thermal analysis (Figure 4.4).  
It can be concluded that the concentrations of the ions released into the culture media are 
non-toxic to hMSCs. However, their role of supporting the differentiation of hMSCs towards 
mature osteoblasts, or bone forming cells, is yet to be determined. In previous work, Sr2+ 
concentrations between 0.01 and 0.1 mM were found to support increased hMSC alkaline 
phosphatase expression [124]. Concentrations of Mg2+ between 5 and 10 mM were found 
support the increased formation of mineral in comparison to hMSCs cultured in basal 
concentrations of Mg2+ [126]. In addition to the increased Sr2+ and Mg2+ concentrations 
compared to β-TCP, increased PO43- concentrations were also detected. Recent work studying 
the role of PO43- ions on osteogenic differentiation found that growth media containing 5 mM 
PO43- and no osteogenic supplementation was able to support comparable levels of OCN, a 
mature osteoblast marker, expression in comparison to hMSCs cultured in growth media 
containing osteogenic supplementation [161]. Therefore, it can be concluded that based on the 
reported literature the amounts of these ions released into the culture media are within the range 
required to support enhanced osteogenic differentiation. 
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4.3.2.3 Osteogenic Protein Expression  
After demonstrating that CaP scaffolds prepared with varying concentrations of Mg2+ and Sr2+ 
were capable of supporting hMSC proliferation and showed minimal cytotoxicity in comparison 
to commercially available β-TCP, their capability to also support the differentiation of hMSCs 
towards an osteogenic lineage was studied. hMSCs were cultured for up to 7 days in growth 
media, allowing them to become near fully confluent. Osteogenic differentiation was then 
induced by culturing in media supplemented with glycerophosphate, ascorbic acid, and 
dexamethasone for up to 21 days. Alkaline phosphatase (ALP) activity and the intracellular 
expression of osteogenic proteins, such as osteopontin (OPN) and osteoprotegrin (OPG) were 
used to study hMSC differentiation towards mature osteoblasts. 
 
 
Figure 4.10 Alkaline phosphatase (ALP) activity measured from hMSCs after culturing for 14 and 21 
days in osteogenic media on β-TCP prepared with various amounts of Mg and Mg-Sr. A p value of < 0.05 was 
considered significant. 
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ALP is an enzyme secreted during osteogenic differentiation which cleaves PO43- from 
surrounding molecules providing the increased PO43- concentrations necessary for osteoblast 
progenitor cells to mineralize their extracellular matrix [166]. ALP activity was determined after 
14 and 21 days of culture in osteogenic media and was normalized with respect to total protein 
concentration (Figure 4.10). At both time points, hMSCs cultured on scaffolds prepared with 
50% Mg and no Sr2+ expressed increased ALP activity in comparison to cells cultured on all Mg-
Sr containing compositions. Between time points, a slight decrease in ALP activity was observed 
for most conditions. Interestingly, a near three-fold increase in ALP activity was observed for 
hMSCs cultured on samples prepared with 50% Mg in comparison to those cultured on 
commercially available β-TCP at both time points.  
The intracellular expression of two osteogenic proteins, OPN and OPG, were also 
analyzed after 21 days of culture in osteogenic media using a magnetic bead kit. OPN is a 
secreted protein which regulates attachment to extracellular matrix thus modulating the 
resorption of mineralized tissues [167]. OPN is considered to be a potent inhibitor of 
mineralization and is expressed at the initial stages of differentiation [18]. In addition to its role 
in bone remodeling, elevated OPN levels have been observed during wound healing and 
inflammation [168]. OPG is a RANKL antagonist secreted by osteoblasts and other cell types 
which has been shown to inhibit the formation of osteoclasts through the RANK-RANKL-OPG 
signaling pathway [169]. OPG deficient knockout mice have been shown to develop osteoporosis 
due an increased number of osteoclasts [170]. The expression of OPN and OPG in hMSCs 
cultured on scaffolds prepared using β-TCP and the two conditions synthesized with the 
maximum concentrations of Mg2+ and Sr2+ were reported  (Figure 4.11 a)). 
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Figure 4.11 The intracellular expression of osteopontin (OPN) and osteoprotegrin (OPG) of hMSCs 
cultured for 21 days in osteogenic media a) directly and b) indirectly on β-TCP prepared with various 
amounts of Mg and Mg-Sr. A p value of < 0.05 was considered significant. 
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After 21 days, similar to ALP activity, the OPN and OPG expression of hMSCs cultured 
on samples prepared with 50% Mg was elevated in comparison to all other groups (Figure 4.11 
a)). In summary, samples prepared with 50% Mg and no Sr supported increased levels of 
osteogenic markers in comparison to all other Mg and Mg-Sr containing compositions as well as 
commercially available β-TCP. Interestingly, although increased Sr2+ concentrations have been 
shown to enhance osteogenic differentiation, in the current study the incorporation of Sr2+ did 
not facilitate increased hMSC differentiation in comparison to samples prepared with 50% Mg. It 
has been previously shown that increasing the Mg2+ concentration in synthesis results in the 
formation of increased amorphous content [171]. While amorphous CaP phases are generally 
considered to be more reactive and more soluble than their crystalline counterparts, the influence 
of the amorphous phase on the physical and chemical cues provided by the scaffold to support 
osteogenic differentiation remains largely unknown. 
4.3.2.4 Indirect Cell Culture 
In order to study the role of the physical and chemical cues provided by cationic substituted β-
TCP scaffolds prepared with varying Mg2+ and Sr2+ concentrations on supporting hMSC 
osteogenic differentiation independently, transwell membrane inserts were used. hMSCs were 
cultured on tissue culture plastic for the duration of the experiment while cationic substituted β-
TCP scaffolds were suspended on permeable membranes supports. The use of transwell 
membranes enabled hMSCs to be exposed to Ca2+, Mg2+, Sr2+, and PO43- concentration profiles 
identical to the previous experiments while eliminating the physical contact with sintered dense 
CaP substrates. The intracellular expression of OPG and OPN were once again used to study 
hMSC differentiation after 21 days (Figure 4.11 b)). In the absence of physical contact with 
scaffold surfaces, similar tends in the expression of OPN and OPG were observed. Therefore, 
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this data suggests that the release of Mg2+, Sr2+, and PO43- ions from these scaffolds plays a more 
influential role in providing the signaling necessary to support differentiation rather than the 
exposure of hMSCs to the scaffold surface. 
4.3.2.5 Transforming Growth Factor-β Signaling PCR Array 
In the data reported, scaffolds prepared with Mg2+ and no Sr2+ supported increased 
differentiation in comparison to all other conditions, including commercially available β-TCP. 
The capability of these scaffolds to support increased differentiation in comparison to β-TCP was 
determined to be due to the release of sufficient amounts of Mg2+ and PO43- ions resulting in 
concentrations within the desired range for both ions previously reported to stimulate hMSC 
differentiation. To study the influence of Mg2+ and PO43- on the mechanisms involved in 
regulating osteogenic differentiation, a TGF-β and BMP signaling PCR array was used. All three 
forms of TGF-β are found in bone tissue and both osteoblasts and osteoclasts are capable of 
synthesizing TGF-β [172]. In contrast to TGF-βs, BMPs are capable of stimulating ectopic bone 
formation and are expressed in multiple mineralized tissues at various stages throughout 
development [173]. Through the activation of TGF-β and BMP receptors, the regulatory SMADs 
are phosphorylated and together with SMAD4, a co-SMAD, the complex formed then 
translocates to the nucleus [174]. SMAD4 serves to stabilize the SMAD complex and interacts 
with several critical transcription factors. In addition to SMAD dependent TGF-β and BMP 
signaling, TGF-β and BMP proteins can also enhance differentiation through SMAD 
independent signaling using the mitogen activated protein kinase (MAPK) pathway [175, 176]. 
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Figure 4.12 The gene expression of a) BMP and its receptors b) TGF-β and its receptors, c) SMAD 
proteins, and d) the ECM components and transcription factors either up or downregulated by more than 
50% cultured on 50% Mg β-TCP in comparison to commercially available β-TCP. The markers with Ct 
values of less than 30 were reported.  
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RNA was collected from hMSCs cultured directly on scaffolds prepared with β-TCP and 
50% Mg β-TCP after 21 days in osteogenic media. The gene expression of cells cultured on 
scaffolds prepared with 50% Mg β-TCP was normalized with respect to those cultured on 
scaffolds prepared with β-TCP. Therefore, the data was reported as fold change with respect to 
β-TCP. The markers with Ct values of less than 30 for both β-TCP and 50% Mg β-TCP were 
reported. In Figure 4.12 a) the gene expression of several BMPs and BMP receptors is illustrated. 
The gene expression of two of the three BMP proteins was upregulated by greater than 1.5 fold 
in comparison to hMSCs cultured on β-TCP while all three of the BMP receptors illustrated were 
upregulated by greater than 1.5 fold. The gene expression of TGF-β and its receptors is reported 
in Figure 4.12 b). None of the TGF-β family proteins had a gene expression greater than 1.5 fold 
in comparison to β-TCP while the gene expression for two of the three receptors exceeded a 1.5 
fold increase. The gene expression of the SMAD proteins is illustrated in Figure 4.12 c). 
SMAD4, the co-SMAD, which is critical for SMAD dependent TGF-β and BMP signaling, was 
upregulated by greater than 1.5 fold. In Figure 4.12 d) the gene expression of the ECM 
components and transcription factors included in the PCR array with Ct values of less than 30 
and either up or downregulated by greater than 50% are illustrated. The upregulation of several 
key ECM components, such as COL1A1 and OCN, once again suggests that hMSCs cultured on 
scaffolds prepared with 50% Mg β-TCP undergo increased levels of differentiation in 
comparison to those cultured on β-TCP.   
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Figure 4.13 The interaction of genes in the Cellular Development network analyzed using Ingenuity 
Pathway Analysis. The red filled shapes correspond to the up-regulated genes while the blank ones were not 
found in the input list. The genes with a fold change greater than or equal to 2 in comparison to β-TCP were 
included in the analysis. 
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The greater than 50% increase in the gene expression of both TGF-β and BMP receptors 
and near two fold upregulation of SMAD4 suggests that hMSCs cultured on scaffolds prepared 
with 50% Mg β-TCP undergo osteogenic differentiation through SMAD dependent TGF-β and 
BMP signaling. Commercially available β-TCP, which is known for its excellent 
biocompatibility and has been demonstrated to possess osteoinductive properties, was used as a 
control [29]. Therefore, very few markers were greater than two fold upregulated in comparison 
to β-TCP.  
A further analysis of the interaction network between the markers which were 
upregulated by greater than two fold in comparison to β-TCP was performed using Ingenuity 
Pathway Analysis (Figure 4.13). From the data illustrated, several interactions were observed 
between the markers upregulated by greater than two fold in comparison to β-TCP and both 
CREB and ERK1/2. Interestingly, in previous work studying the differentiation of human 
adipose derived stem cells in the presence of the extracts of a Ca, Mg, and Si containing ceramic, 
it was observed that ERK signaling could facilitate the enhanced differentiation observed [177]. 
Similar to the current work, this effect was also observed to be concentration dependent. In the 
current study, the increased Mg2+ and PO43- ion concentrations stimulated increased levels of 
osteogenic differentiation. With respect to PO43- ions, the mechanisms by which the cellular 
uptake of PO43- ions are regulated and their roles in supporting osteogenic differentiation have 
only recently been reported [161]. However, the role of Mg2+ in regulating this process in the 
presence of PO43- ions is yet to be determined. Therefore, further work is required to evaluate the 
role of the individual ions released in the current system on supporting osteogenic differentiation 
and to determine which of the two is more influential. 
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4.4 CONCLUSIONS 
Biphasic mixtures of Mg2+ and Mg2+-Sr2+ co-substituted β-TCP and an amorphous phase were 
formed using a low temperature synthesis approach for all of the conditions synthesized. All of 
the compositions prepared supported similar levels of hMSC proliferation in comparison to 
commercially available β-TCP. A significantly increased expression of osteogenic proteins, such 
as ALP, OPN, and OPG, was measured from hMSCs cultured directly on samples prepared with 
50% Mg and no Sr2+ in comparison to all other groups, including those prepared with increased 
Sr2+ concentrations. In the absence of physical contact with scaffold surfaces while maintaining 
similar ionic concentrations to direct cell culture experiments, similar trends in the expression of 
osteogenic markers were also observed. Therefore, it was concluded that the release of increased 
amounts of Mg2+ and PO43- ions from scaffolds prepared with 50% β-TCMP supported increased 
hMSC osteogenic differentiation rather than physical contact between hMSCs and the scaffold 
surface due to the material microstructure and grain boundary effects. The influence of these 
scaffolds, capable of releasing increased Mg2+ and PO43- ions, on hMSC TGF-β and BMP 
signaling was evaluated using a TGF-β and BMP signaling qRT-PCR array kit. From the data 
collected, it was concluded that scaffolds prepared with 50% β-TCMP supported increased 
differentiation in comparison to commercially available β-TCP through the SMAD dependent 
TGF-β and BMP signaling. Further work is required to determine whether either Mg2+ or PO43- 
ions independently or together to provide the chemical cues necessary to support enhanced 
differentiation and to determine whether or not the stimulation provided by these ions is a 
synergistic effect. In addition, the blocking of SMAD signaling may be a useful approach to 
determine whether or not other pathways, such as MAPK, are involved in the signaling which 
regulates the enhanced differentiation observed with hMSCs cultured on 50% β-TCMP.  
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5.0  SYNTHESIS AND CHARACTERIZATION OF AMORPHOUS CALCIUM 
MAGNESIUM PHOSPHATES 
5.1 INTRODUCTION 
The ideal concentration ranges of both Mg2+ and PO43- ions to support the osteogenic 
differentiation of hMSCs and osteoblast progenitor cells under in vitro conditions have 
previously been determined [90, 126, 161]. In Chapter 4, it was concluded that 50% β-TCMP 
containing scaffolds supported increased hMSC differentiation through the release of increased 
amounts of bioactive ions rather than their surface characteristics. In comparing the 
concentration profiles obtained for the various ions of interest, increased Mg2+ and PO43- ion 
concentrations in the culture media were observed for samples prepared using 50% β-TCMP. 
These increased ionic concentrations were likely due to the formation of increased amounts of a 
highly soluble magnesium rich amorphous calcium phosphate phase that was formed upon 
increasing the Mg2+ concentration used during the synthesis of Mg substituted β-TCP. As 
outlined in Chapters 3 and 4, it is clear that a large amount of amorphous content is generated 
when the nominal concentration of Mg is 50%. However, it was difficult to examine the amount 
of amorphous content present. Therefore, an attempt was made to isolate the amorphous phase 
formed in the biphasic system. 
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Amorphous calcium phosphates (ACPs) have been synthesized using a wide range of 
techniques in the presence of several ions, including Mg2+ [150]. ACPs have also been prepared 
with a wide range of Ca/P ratios, ranging from 1.2-2.2, under both acidic and basic conditions 
[104, 178]. This variation in the stoichiometric composition of ACPs also results in a wide range 
of solubility for the metastable phase formed. Ionic substitutions for Ca2+ and PO43- ions, such as 
Mg2+, F-, CO32-, and P2O74-, have also been shown to stabilize the ACP phase which readily 
converts to poorly crystalline HA over extended periods of time even while stored under dry 
conditions [179, 180]. During the aqueous synthesis of ACP, the careful control of the solution 
pH is often required to stabilize the amorphous phase [171]. However, simplified chemical 
precipitation approaches which do not require pH control have also been explored. For example, 
work by Lee et al. demonstrated the synthesis of ACP using multiple (Ca+Mg)/P ratios at room 
temperature and under a physiological pH without the need for the external control of the pH 
[151]. In the absence of pH control, relatively high Mg/(Ca+Mg) ratios of 20% and 30% for 
(Mg+Ca)/P ratios of 1.5 and 1.67, respectively, were required to stabilize the disordered 
amorphous phase. The biological response of the Mg substituted ACP formed was however not 
explored.  
In the current Chapter, the synthesis of either fully amorphous or fully crystalline β-
TCMP using a similar synthesis approach to that which was studied in Chapters 3 and 4 was 
utilized. The formation of fully amorphous 50% β-TCMP, rather than a biphasic mixture of 
crystalline β-TCMP and amorphous content, is hypothesized to result in an increased release rate 
of Mg2+ and PO43- ions into the surrounding culture media upon exposure to aqueous 
environments. The influence of the modified release profile of these bioactive ions on the 
proliferation and differentiation of hMSCs towards mature osteoblasts cultured with and without 
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osteogenic supplementation was systematically characterized. Additionally, although previous 
studies have explored the capability of Mg2+ and PO43- ions to support hMSC osteogenic 
differentiation separately, their roles when delivered simultaneously is yet to be reported. 
Understanding the role of Mg2+ and PO43- ions when delivered simultaneously to hMSCs is of 
particular importance in determining the mechanisms through which magnesium and phosphate 
containing ceramics, bioactive glasses, and magnesium based alloys support cell proliferation 
and differentiation. Therefore, in the current Chapter the goal was to study the influence of the 
supplementation of cell culture media with a combination of Mg2+ and PO43- ions particularly on 
hMSC cell proliferation and osteogenic differentiation was also studied.  
5.2 MATERIALS AND METHODS 
5.2.1 Synthesis of pH Modified β-TCMP 
DCPD was precipitated with 50% Mg, as described in Chapters 3 and 4 and Equation 3.1. After 
precipitating and washing 50% Mg DCPD, the powders collected were dispersed in 200 ml of 
deionized water and boiled with reflux. While refluxing, the pH of the solution was continuously 
monitored throughout the two hour period using a pH meter (Beckman Coulter, Φ350). 
Throughout the refluxing process, the pH was adjusted to either 4 or 8 every 15 minutes using 
solutions of either 1 M HCl or 1 M NaOH, as required. At the end of the two hour period, the 
powders formed were collected by centrifugation and washed with deionized water. After 
washing, they were dried overnight at 60˚C prior to further use.   
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5.2.2 Characterization of Amorphous β-TCMP Powder 
The phase composition of the powders formed after refluxing was characterized by X-ray 
diffraction using a Philips X-Pert PRO diffractometer employing Cu Kα radiation (λ=1.5406 Aͦ) 
with a Si-detector (X’celerator). The parameters used were similar to those described in section 
4.2.2. Fourier transform infrared spectroscopy (FT-IR, Nicolet 6700 Thermo Fisher) was used to 
study the chemical structure of the powders formed. An average of 32 scans was reported using a 
spectral resolution of 4 cm-1. The elemental composition of the powders formed was analyzed 
using inductively coupled plasma optical emission spectroscopy (ICP-OES, iCAP duo 6500 
Thermo Fisher). The powder samples were dissolved in a 3% HNO3 solution and the 
concentrations of Ca2+, Mg2+, and PO43- ions in solution were determined using known standards 
(Sigma-Aldrich, St. Louis MO) for the ions of interest.  
5.2.3 The Formation of β-TCP and β-TCMP Scaffolds 
13 mm diameter pellets of amorphous β-TCMP were formed by uniaxial compression using an 
applied load of 2,500 psi, as previously described. The constructs formed were sintered at the 
appropriate temperatures for 4 h, rinsed in ethanol, and dried under UV prior to seeding cells 
directly on their surfaces. 
5.2.4 Human Mesenchymal Stem Cell Culture and Maintenance 
hMSCs isolated from human bone marrow were used in all experiments (Lonza, Allendale NJ). 
The cells collected after passaging twice were used. They were cultured under 37˚C in 5% CO2 
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and 97% humidity. The culture media consisted of MEMα containing 20% FBS and 1% P/S. For 
differentiation experiments, the growth media was supplemented with 100 nM dexamethasone, 
50 μM ascorbic acid, and 10 mM β-glycerophosphate. The cells were seeded directly on 
scaffolds using a seeding density of 30,000 cells per well.  
5.2.5 Cell Proliferation 
Cell proliferation was assessed using the alamarblue assay (Life Technologies, Grand Island 
NY). At the time points of interest, the cells were incubated in 500 μL of the alamarblue reagent 
diluted in growth media, according to the manufacturer’s protocol. Growth media was used to 
ensure that the assay was not influenced by the presence of increased Mg2+ and PO43- ions or the 
osteogenic supplements used. After 4 hours, 100 µL aliquots of media were removed from each 
well and fluorescence was measured at an excitation wavelength of 540 nm and an emission 
wavelength of 590 nm using a microplate reader (Synergy 2 Multi-Mode Microplate Reader, 
Biotek). Four repeats were performed for each condition at each time point. 
5.2.6 Alkaline Phosphatase Activity 
hMSC osteogenic differentiation was assessed using the ALP assay. Cell lysates were collected 
after 14, and 21 days in either growth media or osteogenic media. The samples were first rinsed 
in PBS prior to incubation on a platform shaker using the CelLytic M lysis buffer (Sigma 
Aldrich, St. Louis MO) at room temperature, according to the manufacturer’s protocol. ALP 
activity was determined using the protocol described previously. Briefly, 30 μL of cell lysate was 
added to 170 μL a tris buffered solution containing pNPP. The concentration of pNP in solution 
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after 1 hour of incubation at 37˚C was determined. The data collected was normalized with 
respect to the total protein concentration in the cell lysate solution, determined using the BCA 
assay. 
5.2.7 qRT-PCR 
RNA isolation was performed using a Nucleospin RNA Extraction Kit (Macherey Nagel, 
Bethlehem PA) according to the manufacturer’s protocol at the time points of interest. RNA 
concentration was measured using a spectrophotometer (BioRad, SmartSpec) by measuring the 
absorbance at wavelengths of 260 and 280 nm. Reverse transcription was performed using the 
Improm-II Reverse Transcription Kit (Promega, Madison WI). Approximately 100 ng of RNA 
was loaded for each reaction. The PCR reactions were then performed using the primer 
sequences described in Table 5.1. A SYBR green mastermix (Brilliant II, Agilent) was also used 
in the PCR reactions. The data collected was presented as the fold change with respect to the 
cells cultured on commercially available β-TCP under the same conditions. 
 
Table 5.1 The qRT-PCR primer sequences used to determine the gene expression of GAPDH, RUNX2, 
collagen-1, and osteocalcin. 
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5.2.8 Media Supplementation with Mg2+ and PO43- Ions 
hMSC growth media was supplemented with 5 mM Mg2+, 5 mM PO43-, or a combination of 5 
mM Mg2+ and 5 mM PO43-. The cells were cultured in media containing increased ionic 
concentrations of Mg2+ and PO43- to determine the role of these ions on hMSC proliferation and 
osteogenic differentiation. In these experiments, the cells were seeded on tissue culture plastic. 
MgCl2•6H2O was used to supplement culture media with additional Mg2+ ions. A combination of 
Na2HPO4 and NaH2PO4 was used to supplement cell culture media with additional inorganic 
PO43- ions. These salts were combined using a 4:1 ratio of Na2HPO4: NaH2PO4 by weight to 
ensure the maintenance of a physiological pH. Growth media and differentiation media without 
additional ionic supplementation were used as controls during this experiment. 
5.2.9 MTT Assay 
The MTT assay (Vybrant MTT Cell Proliferation Assay Kit, Invitrogen, Carlsbad, CA) was used 
to analyze cell proliferation in media supplemented with various amounts of Mg2+ and PO43- 
ions. A protocol similar to that described in Sections 3.2.8 and 4.2.5 was followed. Briefly, at the 
time points of interest, a 12 mM MTT solution in PBS was diluted in growth media. 110 μl of 
this solution was added to each well and incubated for 4 hours. After 4 hours, 100 μl of 0.1 g ml-
1 SDS dissolved in 0.01 M HCl was added to each well. The samples were incubated overnight 
and absorbance was measured using a microplate reader at a wavelength of 570 nm. 
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5.2.10 Osteoimage Mineralization Assay 
The Osteoimage Mineralization Assay (Lonza, Allendale NJ) was used to stain and quantify the 
amount of mineral formed by the hMSCs seeded on tissue culture plastic in the presence of 
various concentrations of Mg2+ and PO43- ions. The cells cultured in differentiation, or 
osteogenic, media were used as a positive control and those cultured in growth media were used 
as a negative control. At the time points of interest, the cells were fixed by incubation for 10 
minutes in a solution of 95% ethanol and 5% acetic acid. They were then washed with PBS and 
incubated in the Osteoimage staining solution for 30 minutes at room temperature, according to 
the manufacturer’s protocol, while protected from light. After removing the staining solution and 
washing several times using the reagents provided, the samples were imaged using fluorescence 
to detect the hydroxyapatite mineral formed due to osteogenic differentiation. The amount of 
hydroxyapatite formed was quantified by measuring the intensity of the fluorescent signal using 
a microplate reader. The data was collected at an excitation wavelength of 490 nm and an 
emission wavelength of 520 nm.   
5.2.11 Statistical Analysis 
All experiments were performed with a minimum of three repeats for each condition. The mean 
and standard error were reported. One way analysis of variance (ANOVA) was used to 
determine statistical significance. The Tukey-Kramer test was used for all pairwise comparisons. 
A p value < 0.05 was considered significant. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Characterization of Amorphous β-TCMP 
Based on the reaction illustrated in Equation 2.3, resulting in the formation of β-TCP through the 
moderate temperature induced hydrolysis of DCPD without providing additional Ca2+ ions, 
H3PO4 is formed as a by-product. Therefore, as the reaction proceeds a reduction in pH is 
expected. In Figure 5.1, the pH as a function of time while refluxing is illustrated for samples 
prepared with 35 and 50% Mg. In both cases, as expected, a reduction in pH is observed over the 
two hour period. However, a substantially greater reduction in pH was observed for samples 
prepared with 35% Mg. This result confirms the limited conversion of Mg2+ containing DCPD to 
β-TCMP as the Mg2+ concentration used in the synthesis of DCPD is increased from 35% to 50% 
thereby resulting in the formation of increased amounts of an amorphous phase. 
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Figure 5.1 The pH with respect to time while refluxing DCPD precipitated with 35 and 50% Mg. 
 
In an attempt to form fully amorphous or fully crystalline β-TCMP, rather than biphasic 
mixtures, the pH while refluxing 50% Mg DCPD was adjusted. It was hypothesized that the 
consumption of the H3PO4, formed as an undesired by-product, would result in the formation of 
increased amounts of crystalline β-TCMP rather than mixtures of β-TCMP and an amorphous 
phase. The X-ray diffraction spectra collected from 50% Mg DCPD refluxed under both acidic 
and basic conditions are illustrated in Figure 5.2. The reference X-ray diffraction reference 
spectra for β-TCP (JCPDS 09-0169) is illustrated in Figure 5.2 i). In Figure 5.2 ii), the X-ray 
diffraction data collected after refluxing DCPD prepared with 50% Mg at a pH of 4 is illustrated. 
In comparison to the data collected without pH modification (Figure 5.2 iii)), a reduction in 
FWHM is observed upon reducing the pH while refluxing. Upon maintaining the pH at a value 
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of 8 while refluxing, the crystalline peaks indicative of the formation of β-TCP were no longer 
detected and a fully amorphous material was formed (Figure 5.2 iv)).  
The reduction in FWHM upon reducing the pH while refluxing suggests that more 
crystalline β-TCP has been formed in comparison to when the pH is not modified or when a 
basic pH is maintained. Due to the capability of Mg2+ ions to reduce the crystallinity of calcium 
phosphates, this data may also suggest that less Mg2+ is retained in the β-TCP crystals formed 
under acidic conditions [181, 182]. Interestingly, upon increasing the pH to a value of 8 a fully 
amorphous product is formed. This data suggests that, although the excess H3PO4 formed as a 
result of the hydrolysis of DCPD was consumed by the NaOH added to maintain the pH, such 
basic conditions may also disrupt the stability of the crystalline β-TCMP formed [137]. In 
addition, increased amounts of Mg2+ ions may be retained in the structure while refluxing at a 
basic pH resulting in the stabilization of the amorphous phase. 
ICP-OES was used to analyze the influence of pH modification on the elemental 
composition of the powders formed before and after refluxing (Table 5.2). Despite synthesizing 
DCPD with a 50% Mg/(Ca+Mg) ratio, a substantial loss of Mg2+ ions was observed as a value of 
approximately 34% was measured. In addition, the (Ca+Mg)/P ratio used during synthesis was 
maintained at a value of 1, corresponding to that of pure DCPD. However, a value of 1.23 was 
measured. The increased (Ca+Mg)/P ratio suggests that in addition to the crystalline DCPD 
formed during precipitation with 50% Mg, illustrated in Figure 3.1 and Figure 4.2, HPO42- ions 
are lost and an amorphous phase is also formed. The increased (Ca+Mg)/P ratio in comparison to 
that expected for DCPD also suggests that the amorphous phase is composed of PO43- ions rather 
than HPO42- ions. 
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Figure 5.2 X-ray diffraction data collected from i) β-TCP (JCPDS 09-0169), 50% Mg DCPD refluxed at 
ii) a pH of 4, iii) with no pH modification, and iv) a pH of 8. 
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Table 5.2 The elemental composition of 50% Mg DCPD and the powders collected after refluxing 50% 
Mg DCPD at a pH of 4, without pH modification, and at a pH of 8. 
 
 
Upon refluxing the Mg2+ containing amorphous-crystalline DCPD mixture and increasing 
the solution pH, the mol. % of Ca steadily decreased while that of Mg increased. Despite the 
variations in cationic composition, the mol. % of P and the (Ca+Mg)/P ratio remained relatively 
constant for all three conditions after refluxing with or without pH modification. These results 
suggest that the amorphous PO43- phase formed prior to refluxing is Mg2+ rich and is lost due to 
dissolution upon reducing the solution pH while refluxing. Upon increasing the solution pH, this 
magnesium rich amorphous phase is retained in the powders formed and provides the increased 
Mg2+ concentration necessary to stabilize a fully amorphous product under basic conditions. 
FT-IR was performed to analyze the chemical composition of the biphasic mixtures of 
crystalline and Mg2+ rich amorphous content, determined using ICP, formed after refluxing since 
X-ray diffraction could not be used to characterize the amorphous phase. The spectra collected 
for commercially available β-TCP and 50% Mg DCPD refluxed either without pH modification 
or at a pH of 8 are illustrated in Figure 5.3. In general, the spectra collected for 50% β-TCMP, 
prepared either without pH modification or under basic conditions, closely resembled that of 
commercially available β-TCP. The characteristic PO43- vibrational modes at approximately 500 
and 1000 cm-1 were observed for all samples [81, 151]. However, in comparison to commercially 
available β-TCP, these peaks were relatively diffuse. The reduced resolution of these peaks is 
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most likely due to the distortion of the Ca2+ and PO43- vibrations upon increasing the Mg2+ 
content, previously confirmed using ICP.  
In addition to the similar peaks observed in comparison to β-TCP, several additional 
peaks were also detected. For both 50% β-TCMP conditions, a broad peak between 3500-3000 
cm-1 was observed. This peak is due to the presence of H2O, either bound to the surface of the 
powder particles or incorporated into the structure of the phosphate phases formed after refluxing 
[183]. Additional peaks near 850 and 1700 cm-1 were also observed for both 50% β-TCMP 
conditions and were not detected for commercially available β-TCP. These peaks are 
characteristic of the presence of HPO42- in addition to PO43- groups [184, 185]. Based on the 
(Ca+Mg)/P ratios measured after refluxing, it is not surprising that HPO42- was detected in 
addition to PO43-. Despite the quite different X-ray diffraction spectra obtained for samples 
refluxed with no pH modification and those refluxed at a pH of 8, similar FT-IR patterns were 
observed for both of these conditions. Therefore, it can be concluded that the amorphous phase 
formed after refluxing 50% Mg DCPD at a pH of 8 closely resembles the structure of β-TCP 
rather than DCPD. 
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Figure 5.3 FT-IR spectra collected from commercially available i) DCPD, ii) β-TCP, iii) 50% β-TCMP, 
and iv) 50% β-TCMP refluxed at a pH of 8. 
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The incorporation of increased amounts of Mg2+, determined using ICP-OES, resulted in 
the formation of increased amorphous content. In Chapters 3 and 4, the amorphous content 
formed along with crystalline Mg and Mg-Sr containing β-TCP was observed to crystallize at 
temperatures of approximately 750˚C forming pyrophosphates. Thus the scaffolds were prepared 
by sintering at temperatures of 600˚C thereby avoiding the crystallization of the amorphous 
content. The thermal stability of the amorphous β-TCMP formed after refluxing at a pH of 8 was 
assessed to determine the temperature at which the amorphous powders could be processed 
without inducing their crystallization. In Figure 5.4, the phase composition of the amorphous 
powders refluxed at a pH of 8 after heat treatment to various temperatures is illustrated. The β-
TCP reference spectra (JCPDS 09-0169) and the data collected after refluxing are illustrated in 
Figure 5.4 i) and ii), respectively. After heat treatment to both 200 and 400˚C, the amorphous 
phase was retained and either very little or no crystalline content was detected (Figure 5.4 iii) 
and iv)). However, after heat treatment to 600˚C several crystalline peaks, which closely 
matched that of β-TCP, were observed. This data confirms that the amorphous β-TCMP formed 
while refluxing at a pH of 8 crystallizes at a temperature between 400 and 600˚C and suggests 
that this material can be processed at temperatures of up to 400˚C while maintaining the 
amorphous state. 
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Figure 5.4 Powder X-ray diffraction of i) β-TCP (JCPDS 09-0169), ii) as prepared amorphous β-
TCMP, amorphous β-TCMP heat treated to iii) 200˚C, iv) 400˚C, and v) 600˚C. 
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5.3.2 Cell Proliferation on Amorphous β-TCMP 
Dense 13 mm diameter scaffolds were prepared using commercially available β-TCP, 50% β-
TCMP, prepared without pH modification, and fully amorphous 50% β-TCMP prepared using a 
pH of 8. The fully amorphous 50% β-TCMP scaffolds were sintered at 400˚C to maintain the 
amorphous state while those prepared with 50% β-TCMP and commercially available β-TCP 
were sintered at temperatures of 600 and 1000˚C, respectively. After sterilization and overnight 
immersion in cell culture media, hMSCs were seeded directly on these scaffolds, as previously 
described. The alamarblue assay was used to evaluate cell proliferation on these dense scaffolds 
after 4 and 7 days of culture in hMSC growth media. Substrates without cells were used as 
negative controls to ensure that subtle variations in both the ionic concentration and pH of the 
culture media during incubation with the alamarblue reagent did not influence the measurement. 
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Figure 5.5 hMSC proliferation on scaffolds prepared using commercially available β-TCP, 50% β-
TCMP, and fully amorphous 50% β-TCMP refluxed at a pH of 8. 
 
After 4 days, increased proliferation was observed on scaffolds prepared with fully 
amorphous β-TCMP in comparison to both 50% β-TCMP and commercially available β-TCP 
(Figure 5.6). After 7 days, an increase in proliferation was observed for cells cultured on samples 
prepared with both 50% β-TCMP and commercially available β-TCP while a comparable value 
was obtained for cells cultured on fully amorphous 50% β-TCMP at both time points. The 
increased alamarblue fluorescence value obtained at earlier time points on fully amorphous 50% 
β-TCMP suggests that the cells cultured on these substrates proliferate more rapidly in 
comparison to those cultured on both 50% β-TCMP and commercially available β-TCP. The 
similar value obtained at the later time point suggests that the cells have become confluent by 4 
days while the increase observed for the other two conditions between the two time points 
indicates that the cells seeded on these samples become confluent between 4 and 7 days. From 
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this data, it can be concluded that the expected increase in the release of Mg2+ and PO43- ions 
from fully amorphous 50% β-TCMP in comparison to 50% β-TCMP does not inhibit cell 
proliferation. In contrast, the release of increased amounts of Mg2+ and PO43- ions may actually 
support the enhanced proliferation of hMSCs. This is not surprising since Mg2+ was previously 
demonstrated to be a mitogenic factor capable of supporting proliferation [141]. It can also be 
concluded that the amount of ions released from the fully amorphous scaffolds does not result in 
a concentration of Mg2+ and PO43- ions which is toxic and incompatible with hMSCs. 
5.3.3 Ionic Concentrations in Culture Media 
Similar to the data collected in Chapters 3 and 4, the media was once again collected on the days 
it was changed and the concentrations of the ions of interest were measured using ICP-OES for 
the duration of the experiment to correlate these values with that observed for cell proliferation. 
As previously observed, the concentration of Ca2+ for all conditions gradually increased (Figure 
5.6 a)). Initially, an increased Ca2+ concentration was observed in the media collected from 
commercially available β-TCP. However, after approximately 13 days in growth media, similar 
Ca2+ concentrations were measured for all groups.  
Increased Mg2+ and PO43- concentrations in comparison to β-TCP were once again 
observed (Figure 5.6 b) and c)). Interestingly, although fully amorphous, only a slight increase in 
Mg2+ concentration was observed at earlier time points in comparison to β-TCMP (Figure 5.6 
b)). At later time points, a steeper reduction in Mg2+ concentration was observed for β-TCMP 
while a sustained release of Mg2+ was observed for the amorphous β-TCMP and a value slightly 
greater than 4 mM was measured after 21 days. In contrast to the Mg2+ release profile, a sharp 
increase in PO43- concentration was observed for amorphous β-TCMP in comparison to β-TCMP 
 130 
(Figure 5.6 c)). Despite the sharper reduction in PO43- concentration throughout the 21 day 
period, for amorphous β-TCMP, as expected, an increased release of PO43- in comparison to β-
TCMP was observed. Similar to Mg2+ concentration, after 21 days a value of approximately 4 
mM was measured. 
The reduced Ca2+ concentration at earlier time points is due to increased formation of 
mineral on the surface of both β-TCMP and amorphous β-TCMP in comparison to commercially 
available β-TCP [153]. However, it appears that the deposition of mineral nears completion on 
both β-TCMP conditions prior to β-TCP due to the sharper increase in Ca2+ concentration as it 
approaches the basal value of 1.8 mM. Based on previously published work, values of 
approximately 5-10 mM Mg2+ and 5 mM PO43- were both found to support enhanced 
differentiation [126, 161]. Despite the formation of a fully amorphous scaffold, the bulk 
concentration in the media collected after 21 days was approximately 4 mM for both of these 
ions of interest. Therefore, it is possible that the amorphous scaffold may provide a more ideal 
microenvironment to support differentiation in comparison to the other two conditions. 
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Figure 5.6 The ionic concentrations of a) Ca2+, b) Mg2+, and c) PO4
3- in culture media after up to 21 
days in growth media released from β-TCP, β-TCMP, and Aβ-TCMP scaffolds. 
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5.3.4 Osteogenic Differentiation on Amorphous β-TCMP 
In previous work studying hMSC proliferation and differentiation on 50% β-TCMP containing 
scaffolds, similar levels of proliferation were observed on 50% β-TCMP in comparison to 
commercially available β-TCP while the increased expression of osteogenic markers, such as 
ALP, OPG, and OPN, was observed on 50% β-TCMP. However, the capability of fully 
amorphous 50% β-TCMP containing scaffolds to support hMSC osteogenic differentiation is yet 
to be determined, which is the basis of the work conducted in the current Chapter. ALP activity 
was once again used to evaluate osteogenic differentiation on 50% β-TCMP scaffolds prepared 
with and without pH modification in comparison to commercially available β-TCP (Figure 5.7). 
The capability of the material to support osteogenic differentiation in the absence of osteogenic 
supplements was also determined. 
After 14 days, a comparable level of ALP activity was observed for cells cultured in 
growth media in comparison to those cultured on β-TCP in differentiation media. However, for 
both β-TCMP and amorphous β-TCMP, an increase in ALP activity was observed on samples 
cultured in differentiation, or osteogenic, media in comparison to the other conditions. A 
statistically significant increase was observed for the cells cultured on amorphous β-TCMP in 
comparison to all other conditions. After 21 days, a similar trend was observed. A slight 
reduction in ALP activity was observed on scaffolds prepared with fully amorphous 50% β-
TCMP between 14 and 21 days. However, the value obtained was once again greater than that 
measured for β-TCMP and β-TCP. Based on this data it can also be concluded that osteogenic 
supplementation is required to support osteogenic differentiation on these materials.  
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Figure 5.7 The alkaline phosphatase activity of hMSCs cultured directly on β-TCP, β-TCMP, and Aβ-
TCMP containing scaffolds with growth media (GM) and differentiation media (DM) after 14 and 21 days. 
 
qRT-PCR was performed to further analyze the expression of additional osteogenic 
markers to determine the capability of amorphous β-TCMP to support enhanced osteogenic 
differentiation (Figure 5.8). The data presented for β-TCMP and amorphous β-TCMP are 
normalized with respect to cells cultured on β-TCP. The samples cultured for 14 days in 
osteogenic media were analyzed. A similar expression of RUNX2, a marker expressed relatively 
early in the osteogenic differentiation process, was observed for all three systems of β-TCP, β-
TCMP, and amorphous β-TCMP [18, 141]. The expression of two mature osteoblast markers, 
COL-1, the most abundant organic component of native mineralized tissues, and OCN, a protein 
produced solely by mature osteoblasts, were also analyzed [18, 44]. In comparison to β-TCP, a 
two to three fold increase in the expression of both mature osteoblast markers were observed for 
β-TCMP and amorphous β-TCMP. In contrast to the results observed from the ALP assay where  
 
 134 
 
Figure 5.8 qRT-PCR results collected from hMSCs cultured on β-TCMP and amorphous β-TCMP 
constructs after 14 days in osteogenic media. The data presented is normalized to that determined for hMSCs 
cultured on scaffolds prepared using commercially available β-TCP. 
 
a statistically significant increase in ALP activity was observed for amorphous β-TCMP in 
comparison to β-TCMP, a comparable gene expression of COL-1 and OCN were observed for 
both the amorphous and biphasic β-TCMP conditions. 
The increased ALP activity observed suggests that the cells cultured on fully amorphous 
β-TCMP undergo enhanced differentiation in comparison all other conditions. However, the 
similar OCN and COL-1 expression for both amorphous β-TCMP and biphasic β-TCMP in 
comparison to β-TCP after 14 days suggests that the formation of a fully amorphous scaffold 
does not enhance the differentiation of hMSCs in comparison to the biphasic mixture. 
Nonetheless, a substantial increase in the expression of osteogenic markers for both experiments 
was observed in comparison to β-TCP. However, although the concentrations of Mg2+ and PO43- 
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released into the culture media are near the desired range after extended periods of culture, it 
remains to be confirmed which of these ions released are more influential in supporting 
differentiation. 
 
 
Figure 5.9 MTT cell viability data collected from hMSCs cultured in growth media (GM) supplemented 
with 5 mM Mg, 5 mM PO4, 5 mM Mg and 5 mM PO4, and differentiation, or osteogenic, media (DM). The 
data presented is normalized with respect to that collected for the cells cultured in growth media after 1 day. 
hMSCs cultured in GM with 10% DMSO was used as a negative control.  
5.3.5 Influence of Mg2+ and PO43- Concentration on Proliferation 
To assess the roles of Mg2+ and PO43- ions both individually and when delivered simultaneously 
on hMSC proliferation, growth media was supplemented with 5 mM Mg2+, 5 mM PO43-, and a 
combination of the two. The MTT assay was used to evaluate proliferation after up to one week 
of culture (Figure 5.9). After one day, a similar level of proliferation was observed for all 
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conditions, including the cells cultured in hMSC growth media containing osteogenic 
supplements. After 3 days, an increase in proliferation was observed for all conditions in 
comparison to day 1. A slight increase in comparison to the other conditions was observed for 
the cells cultured in media prepared with 5 mM PO43- and the combination of 5 mM Mg2+ and 5 
mM PO43-. However, no statistically significant differences were observed. After 7 days, a slight 
increase in comparison to the data collected after 3 days was observed. Once again, no 
statistically significant differences were detected between groups. In summary, this data 
confirms that the supplementation of hMSC growth media with these concentrations of Mg2+ and 
PO43- ions is non-toxic to cells. However, the role of culturing hMSCs in the presence of these 
ions on their capability to differentiate towards an osteoblastic lineage is yet to be determined. 
 
 
Figure 5.10 A proposed scheme for the stages of osteogenic differentiation. Active proliferation typically 
occurs for up to one week. The first regulatory transition during the differentiation process result in matrix 
formation which the second concludes with matrix maturation and mineralization [18]. 
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5.3.6 Influence of Mg2+ and PO43- Concentration on Mineralization 
After confirming that cell proliferation was not influenced by ionic supplementation, the 
influence of these ions on osteogenic differentiation was studied. In Figure 5.10, the stages of 
osteogenic differentiation are illustrated. At the end of the proliferative stage, differentiation 
begins resulting in the formation of the extracellular matrix. As this process progresses, the 
matrix formed is eventually mineralized. The amount of mineral formed at various stages 
throughout this process is often measured to assess the stage of differentiation. In the current 
study, the mineral formed at various time points was stained and imaged using fluorescence. The 
amount of mineral formed was also quantified using a microplate reader. 
 The staining of the mineral formed after culturing for 14 days in media supplemented 
with additional Mg2+ and PO43- ions is illustrated in Figure 5.11. Very little or no mineral was 
detected while culturing in media containing 5 mM Mg2+ while the formation of mineral was 
observed for hMSCs cultured in media supplemented with 5 mM PO43- (Figure 5.11 a) and b)). 
Interestingly, mineral was not observed with cells cultured the combination of 5 mM Mg2+ and 5 
mM PO43- (Figure 5.11 c)). Mineral staining was performed once again after 21 days. A similar 
trend in mineral formation was observed in comparison to the data collected after 14 days 
(Figure 5.12). The cells cultured in PO43- containing media underwent a similar amount of 
mineral formation in comparison to the cells cultured in differentiation media while either very 
little or no mineral was detected by the cells cultured in media containing Mg2+ and a 
combination of Mg2+ and PO43-. 
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Figure 5.11 The staining of the mineral formed by hMSCs cultured in media supplemented with a) 5 
mM Mg, b) 5 mM PO4, c) 5 mM Mg and 5 mM PO4, and d) osteogenic or differentiation media after 14 days.  
 
The amount of mineral formed was also quantified using a microplate reader after 14 and 
21 days (Figure 5.13). After 14 days, only a slight increase in mineral formation was observed in 
the cells cultured in 5 mM PO43- in comparison to the cells cultured in 5 mM Mg2+ and a 
combination of PO43- and Mg2+. However, after 21 days the amount of mineral formed in 5 mM 
PO43- was similar to that which was measured in differentiation media. From this data, it can be 
concluded that PO43- ions support mineralization and the addition of Mg2+ ions appears to inhibit 
the mineralization of hMSCs which was induced by PO43- ions. 
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Figure 5.12 The staining of the mineral formed by hMSCs cultured in media supplemented with a) 5 
mM Mg, b) 5 mM PO4, c) 5 mM Mg and 5 mM PO4, and d) osteogenic or differentiation media after 21 days. 
 
Interestingly, the scaffolds prepared using β-TCMP which released increased amounts of 
both PO43- and Mg2+ ions in comparison to β-TCP supported increased osteogenic differentiation. 
This result contradicts that observed in the experiments where media was supplemented with 
PO43- and Mg2+ ions. Based on this observation, it appears that either the interaction between 
Mg2+ ions and the other components of osteogenic media, such as dexamethasone and ascorbic 
acid, may reduce the inhibition of mineralization by Mg2+ ions or the increased Ca2+ 
concentration at later time points may enhance differentiation. Further work is required to 
determine which of these mechanisms acts to support osteogenic differentiation in the presence 
of β-TCMP scaffolds. 
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Figure 5.13 The quantification of the mineral formed in the presence of growth media supplemented 
with various amounts of Mg and PO4 ions. The data collected was normalized with respect to that collected 
for cells cultured in growth media after 14 days. 
5.4 CONCLUSIONS 
The maintenance of basic conditions while refluxing was observed to result in the formation of a 
fully amorphous calcium magnesium phosphate phase. Upon increasing the solution pH, an 
increased retention of Mg2+ was observed in the amorphous powders formed. The increased 
Mg2+ content is believed to result in a reduction in crystallinity. Scaffolds prepared using these 
fully amorphous β-TCMPs were observed to support the enhanced proliferation of hMSCs in 
comparison to both commercially available β-TCP and 50% β-TCMP, composed of a biphasic 
mixture of crystalline β-TCMP and an amorphous phase. These amorphous scaffolds also 
supported increased ALP activity, a marker for early stage osteogenic differentiation. However, a 
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similar level of osteogenic gene expression was observed between amorphous β-TCMP and β-
TCMP based on the expression of two mature osteoblast markers, OCN and COL-1.  
The influence of Mg2+ and PO43- ion concentration on hMSC proliferation and 
differentiation was also studied. Similar to previously reported work, the addition of Mg, either 
on its own or in combination with PO43- was observed to support cell proliferation. The 
supplementation of growth media with 5 mM PO43- was found to support a similar level of 
mineralization in comparison to the cells cultured in differentiation, or osteogenic, media. 
However, the addition of 5 mM Mg2+ to the media containing 5 mM PO43- was observed to 
completely suppress mineral formation. Therefore, the enhanced concentration of Ca2+ at the 
later stages of cell culture with both β-TCMP and amorphous β-TCMP is most likely also 
playing a role in supporting enhanced differentiation. 
Cationic substitutions have been demonstrated in Chapters 3-5 to be a useful tool to 
enhance the properties of β-TCP. However, thus far they have been studied in the form of 
granules or a preformed scaffold. Based on the discussion provided on the clinically relevant 
forms of calcium phosphate in Chapter 1, there are many other more useful forms of these 
materials that can be potentially used for clinical application. Therefore, in Chapters 6 and 7 
cationic substitutions in β-TCP and HA will be explored in alternative forms, namely bioactive 
coatings and injectable self-setting calcium phosphate based cements to observe whether or not a 
similar improvement in cytocompatibility can be achieved through ionic substitutions for Ca2+ 
using Mg2+ and Sr2+. 
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6.0  CATIONIC SUBSTITUTED CALCIUM PHOSPHATE COATINGS ON 
BIODEGRADABLE MAGNESIUM ALLOYS  
6.1 INTRODUCTION 
Biodegradable Mg based alloys have become widely studied in the development of degradable 
implants, particularly cardiovascular stents and both orthopedic and craniofacial bone fixation 
devices [109]. The human body is known to contain as much as 30g of Mg, the majority of 
which is found in mineralized tissues [127]. As a result, Mg is believed to play a critical role in 
bone biology. Previous studies have demonstrated the influence of Mg on both osteoblast and 
osteoclast differentiation, rendering Mg based alloys an attractive material for bone tissue 
engineering applications [118]. Nonetheless, the exact role of Mg2+ in the regeneration of 
mineralized tissues remains poorly understood, warranting further research. 
While degradable metallic implants hold great promise, the uncontrolled non-uniform 
corrosion, typical of the majority of Mg alloys developed to date, remains a primary concern 
[186]. In order to control the corrosion of Mg alloys, coatings have been widely studied. 
Unfortunately, the relatively low melting points of Mg alloys preclude the use of high 
temperature coating processes which are routinely employed for refractory metals, such as 
titanium and stainless steel. Alternative approaches to control corrosion behavior, including 
alloying with rare earths and the development of Mg based bulk metallic glasses, have also been 
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explored to date [187, 188]. Unfortunately, the unknown long term toxicity of the varying 
alloying elements, reduced mechanical stability, and the challenges of large scale production of 
these metallic systems with reproducible microstructural, mechanical, and corrosion properties 
limit the wider acceptance of these approaches [189, 190].  
As a result, coating strategies remain one of the more promising approaches to tailor the 
corrosion of Mg alloys. For bone tissue engineering applications in particular, CaP coatings are 
of interest since CaPs are a major component of native mineralized tissues [7]. Several CaP 
phases have therefore been studied as coatings on Mg alloys and have been shown to provide 
corrosion control while also enhancing bioactivity [108]. Low temperature processes such as 
electrodeposition and various aqueous immersion techniques, including biomimetic approaches, 
are a few of the more commonly studied techniques. Immersion techniques are also of 
considerable interest since they are relatively simple, cost effective, and can be used to coat a 
variety of complex porous structures in a controlled manner.  
To date, the CaP coatings formed on Mg alloys by immersion techniques are typically 
non-uniform and porous, limiting their ability to provide corrosion control [108]. Pretreatment is 
thus a critical step with immersion techniques in order to form a passivation layer on which CaP 
coatings are subsequently grown or deposited. Both acidic and alkaline conditions have been 
studied to form pretreatment layers [191, 192]. Surprisingly, very few reports have explored the 
influence of pretreatment conditions on the coating performance, although the microstructure and 
mechanical stability of CaP coatings are highly dependent upon the properties of the underlying 
pretreated layer [112].  
Ionic substitutions to stabilize the phase composition are an alternative approach to 
optimize the physicochemical properties of CaP coatings. In this regard, the doping of CaP 
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coatings with Sr2+ is of much interest since it is known to cause an imbalance in bone turnover, 
favoring the formation rather than the resorption of bone [193]. For example, previous work by 
Bracci et al. has explored the use of a biomimetic approach to deposit Sr2+ doped CaP coatings 
on Ti and their results concluded that doped coatings promoted osteogenic differentiation due to 
an upregulation of collagen type 1 [162]. Interestingly, to the best of our knowledge Sr2+ doped 
CaP coatings deposited on Mg alloys using immersion approaches are yet to be studied leaving 
much to be explored in the coating space for these systems. However, strontium phosphate 
coatings have only recently been explored [194]. 
In the current work, the influence of pretreatment conditions and the role of Sr2+ doping 
into the CaP structure on providing corrosion protection and cytocompatibility were explored. 
Substrates were accordingly pretreated by immersion in Na2HPO4 followed by heat treatment to 
various temperatures. The effect of substrate pretreatment on CaP coating structure was also 
studied. It was hypothesized that Sr2+ doped CaP coatings could improve the ability of CaP 
coatings to support the osteogenic differentiation of a mouse preosteoblast cell line and human 
mesenchymal stem cells (hMSCs) in comparison to undoped CaPs. 
6.2 MATERIALS AND METHODS 
6.2.1 Substrate Preparation, Pretreatment, and Coating Formation 
A 0.81 mm thick sheet of AZ31 was acquired from Alfa Aesar (Ward Hill, MA) and was 
subjected to acid etching followed by polishing with SiC paper, as previously described [128]. 
Cleaned substrates were then immersed in an 80 g l-1 Na2HPO4 solution at 40˚C for 3 h before 
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rinsing in DI water and drying in air. Na2HPO4 treated substrates were heat treated in argon to 
either 350 or 400˚C for 10 h. After heat treatment, the substrates were immersed in solutions 
prepared with 0, 5, and 10% Sr/(Ca+Sr) ratios and a fixed (Ca+Sr)/P ratio, illustrated in Table 
6.1, at 70˚C for 48 h. Upon completion of the coating process, substrates were once again rinsed 
in DI water and dried at 60˚C prior to further experiments. Throughout the manuscript, the 
substrates subjected to the above pretreatments will be represented as wherein the numbers 
following Sr refer to % Sr/(Ca+Sr) and the numbers following the hyphen refer to the 
pretreatment temperature (Sr0-350, Sr0-400, Sr5-350, Sr5-400, Sr10-350, and Sr10-400). 
 
Table 6.1 The molar concentrations of the salts used to prepare coating solutions. A (Ca+Sr)/P of 1.67 
was maintained for all conditions and the Sr/(Ca+Sr) ratio was varied between 0, 5, and 10%. 
 
6.2.2 Coating Characterization 
X-ray diffraction (X-Pert PRO Cu Kα λ=1.5418Å, with X’celerator detector, Philips) was 
performed to determine the phase composition and crystallinity of CaP coated substrates. 
Diffraction patterns were collected between 2θ values of 10-90˚ with the X-ray generator 
operated at 45 kV and 40 mA. Further analysis of the phase composition of pretreated and coated 
substrates was performed using the attenuated total reflectance Fourier transform infra-red 
spectroscopy (ATR-FTIR, Nicolet 6700, Thermo Scientific). A spectral resolution of 2 cm-1 
 146 
between 400-4000 cm-1 was used and the average of 64 scans was recorded. Coating 
microstructure and elemental composition were then analyzed using scanning electron 
microscopy (Philips, XL30 FEG ESEM) and inductively coupled plasma optical emission 
spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher). 
6.2.3 Corrosion Experiments 
6.2.3.1 Hydrogen Evolution 
Three samples for each condition were placed in individual sample holders made of a non-
degradable polymer mesh, ensuring that the complete surface area of each sample was fully 
exposed. The samples were then suspended in a 9.7 g/l Hank’s balanced salt solution (HBSS, 
Sigma Aldrich, Catalog # H1387) supplemented with 0.35 g/l sodium bicarbonate (NaHCO3, 
Sigma Aldrich), maintaining an initial pH of 7.4. The ratio of substrate surface area to HBSS 
volume was kept constant at 10 cm2 l-1 to ensure that sufficient hydrogen would be generated for 
both coated and bare substrates. Additionally, the temperature was maintained at 37˚C 
throughout the experiment. The hydrogen generated was collected in an inverted burette and 
measurements of the volume of HBSS displaced were correspondingly recorded during a one 
week period. 
6.2.3.2 Immersion Test 
Coated and bare substrates were immersed in 2 ml of Dulbecco’s modification of eagle medium 
(DMEM, Mediatech Inc., Manassas, VA) supplemented with 10% fetal bovine serum (FBS, 
Atlanta Biologicals, Lawrenceville, GA) and 1% P/S (penicillin streptomycin, Gibco, Grand 
Island, NY). The samples were stored in an incubator at 37˚C and 5% CO2 for up to 3 weeks. 
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The media was refreshed every 48 h and collected for further analysis by measuring the pH (Ф 
350 pH meter, Beckman Coulter) and elemental composition using ICP. 
6.2.3.3 Electrochemical Corrosion Testing 
Electrochemical corrosion experiments were performed at 37˚C in DMEM supplemented with 
10% FBS and 1% P/S using a CH604a electrochemical workstation (CH Instruments, Austin 
TX). A three electrode cell comprised of platinum as a counter electrode and a Ag/AgCl 
reference electrode was used. Open circuit potential (OCP) was first established for all the 
samples after at least 1 h of stabilization in 125 ml of DMEM. Potentiodynamic polarization tests 
were then performed at a scan rate of 1 mV s-1. The corrosion current and potential were 
determined using a Tafel extrapolation added into the OriginPro 8 data analysis and graphing 
software. 
6.2.4 In-Vitro Cytocompatibility 
6.2.4.1 Cell Culture and Maintenance 
MC3T3-E1 cell line (ATCC, Manassas, VA) was cultured in minimum essential medium α 
(MEMα, Gibco) containing 10% FBS and 1% P/S under 37 ˚C, 5% CO2, and 95% relative 
humidity. Cells after fourth passage were used in all experiments at a seeding density of 50,000 
cells ml-1. For osteogenic differentiation studies, MC3T3-E1 growth media was accordingly 
supplemented with 100 nM dexamethasone, 50 µM ascorbic acid, and 10 mM β-
glycerophosphate. The cells were cultured on samples for 7 days prior to inducing 
differentiation. 
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The hMSCs obtained from the normal human bone marrow were purchased from Lonza (Lonza, 
Allendale, NJ) and were cultured under 37 ˚C, 5% CO2, and 95% relative humidity. Cells after 
the third passage were used in all experiments and were cultured in MEMα containing 20% FBS 
and 1% P/S. Similar to MC3T3-E1 cells, for osteogenic differentiation studies, hMSC growth 
media was accordingly supplemented with 100 nM dexamethasone, 50 µM ascorbic acid, and 10 
mM β-glycerophosphate.  
6.2.4.2 Cell Proliferation 
Live/dead staining (Invitrogen, Live/Dead staining kit) was used to observe live cell attachment 
on coated and bare substrates after 3 and 7 days of culture. Samples were rinsed with PBS 
followed by incubation for 40 minutes with the live/dead stain diluted in PBS. Imaging was 
performed using a fluorescent microscope (Olympus, CKX41) prior to fixing samples with 2.5% 
glutaraldehyde. Once fixed, samples were dehydrated by washing with ethanol and were 
subsequently sputter coated with palladium before imaging using SEM. 
The DNA concentration on coated and bare substrates was assessed using the Quant-iT 
PicoGreen dsDNA Kit (Invitrogen, Carlsbad, Ca). Culture media was removed and samples were 
rinsed with PBS. The cells were then lysed (CelLytic M Cell Lysis Reagent, Sigma Aldrich) and 
the supernatants were collected after centrifuging. DNA concentration in the supernatant was 
determined by measuring the fluorescence at an excitation wavelength of 480 nm and an 
emission wavelength of 520 nm (Synergy 2 Multi-Mode Microplate Reader, Biotek). 
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Table 6.2 The qRT-PCR primer sequences used for mouse preosteoblast cell line MC3T3-E1. 
 
 
Table 6.3 The qRT-PCR primer sequences used for human mesenchymal stem cells. 
 
6.2.4.3 Osteogenic Gene Expression 
After culturing in osteogenic media, RNA extraction was performed using the NucleoSpin RNA 
II kit (Macherey Nagel, Bethlehem, Pa) according to the manufacturer’s protocol. The RNA 
concentration and purity was determined by measuring the absorbance at 260 and 280 nm using 
a microplate reader. Reverse transcription was then performed using the ImProm II Promega 
reverse transcription kit (Promega, Madison, WI) according to the manufacturer’s protocol. 
Primers for mouse and human GAPDH, osteocalcin, and osteopontin were used in the qRT-PCR 
experiments (Table 6.2 and Table 6.3). Measurements were then conducted in triplicate for each 
sample.  
6.2.4.4 Osteogenic Protein Expression 
Protein expression was quantified using a MAGPIX instrument (Luminex, Austin, TX).  A 
Human Bone Magnetic Bead Panel kit (EMD Millipore, Billerica, Ma) was purchased and used 
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according to the manufacturer’s protocols. The expression of osteocalcin (OCN) was studied 
after 18 days of culture in osteogenic media.  
6.2.4.5 Statistical Analysis 
All of the experiments were performed also with a minimum of three repeats for each condition. 
Measurements for each repeat were performed in triplicate. The mean and standard error were 
accordingly reported. Unless otherwise mentioned, analyses were performed independently. Two 
way analysis of variance (ANOVA) was used to determine the statistical significance. The 
Tukey-Kramer test was used for all pairwise comparisons. A p value < 0.05 was considered 
significant for the data collected. 
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6.3 RESULTS AND DISCUSSION 
6.3.1 Pretreatment Characterization 
 
Figure 6.1 a) Optical images of AZ31 after immersion in Na2HPO4 and heat treatments as well as SEM 
images of the substrate surface after b) immersion in Na2HPO4, c) heat treatment to 350˚C, and d) heat 
treatment to 400˚C (Scale bars are 2 µm). 
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All substrates were pretreated by immersion in Na2HPO4 forming a passivation layer on the 
substrate surface prior to depositing the CaP coating. Basic phosphate solutions were used for 
pretreatment to enhance the local PO43- concentration during the precipitation of CaP coatings 
and to reduce the formation of more soluble acidic CaP phases, such as dicalcium phosphate 
dihydrate. After immersion in Na2HPO4, the AZ31 substrates were heat treated to either 350 or 
400˚C in argon for 10 h. Heat treatment to either temperature resulted in the formation of a dull 
yellow film. Samples heat treated to 400˚C formed a film with a more intense yellow color in 
comparison to those heat treated to 350˚C (Figure 6.1 a)). The microstructure of the layer formed 
as a result of Na2HPO4 treatment was highly porous and comprised of lamellar shaped plate-like 
particles approximately 2 µm wide (Figure 6.1 b)), determined using SEM. After heat treatment 
to 350˚C (Figure 6.1 c)), minimal change in microstructure was observed by SEM. After heat 
treatment to 400˚C (Figure 6.1 d)), an estimated two to three fold increase in the width of the 
lamellar plates formed after immersion in Na2HPO4 and heat treatment to 350˚C was observed. 
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Figure 6.2 ATR-FTIR spectra collected from samples after a) Na2HPO4 treatment, b) heat treatment to 
350˚C, and c) heat treatment to 400˚C. 
 
FT-IR was used to characterize variations in the chemical structure of the coatings 
formed prior to and after heat treatment. The FT-IR spectra collected after Na2HPO4 treatment 
(Figure 6.2 a)) closely resembled that of HPO42- with characteristic bands observed at 1069,  804, 
595, and 555 cm-1 [195]. After heat treatment to 350˚C, the FTIR spectra collected contained 
relatively broad peaks in comparison to the spectra collected prior to heat treatment (Figure 6.2 
b)). The FT-IR spectra of samples heat treated to 400˚C (Figure 6.2 c)) closely resembled that of 
samples heat treated to 350˚C. After both heat treatments similar characteristic peaks of HPO42- 
were observed at 1039 and 569 cm-1 while the peaks observed prior to heat treatment near 853 
and 804 cm-1 were no longer detected. It is believed that the peak broadening after heat treatment 
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may be due to the distortion of bond vibrations as a result of the incorporation of the alloying 
elements, Mg, Al, and Zn, into the pretreated layer. 
XRD was used to further characterize the Na2HPO4 pretreated layer before and after heat 
treatments. Prior to heat treatment, the predominant crystalline phase detected was Na2HPO4 
despite thorough washing after removing the substrates from the Na2HPO4 solutions (Figure 6.3 
i)). In addition, peaks from the AZ31 substrate, Mg3(PO4)2•8H2O, and an amorphous background 
were also observed. Previous work studying magnesium phosphate cements has shown that after 
reacting MgO with Na2HPO4 an amorphous material is formed while the reaction of MgO with 
(NH4)2HPO4 results in the formation of crystalline MgNH4PO4•6H2O [196]. 
In addition, the immersion of AZ31 in (NH4)2HPO4 followed by steam curing was 
previously observed to result in the formation NH4MgPO4•6H2O at elevated (NH4)2HPO4 
concentrations, confirmed using XRD [197, 198]. Therefore, it appears that an amorphous 
magnesium sodium phosphate phase may also be formed after immersion in Na2HPO4. 
Interestingly, the XRD spectra of pretreated samples after heat treatment to 350˚C showed 
mostly AZ31 peaks while after heat treatment to 400˚C only MgO could be detected (Figure 6.3 
ii) and iii)). Thus, it appears that after heat treatment to 350˚C an amorphous magnesium sodium 
phosphate phase and poorly crystalline MgO is formed while the heat treatment to 400˚C 
enhances the crystallization of MgO. 
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Figure 6.3 XRD collected from coatings formed on AZ31 after i) Na2HPO4 treatment, ii) heat treatment 
to 350˚C, and iii) heat treatment to 400˚C. (Na2HPO4 (JCPDS 01-0997), Mg3PO4•8H2O (JCPDS 33-0877), and 
MgO (JCPDS 04-0829)). 
 
Elemental analysis was performed using ICP in order to confirm the diffusion of alloying 
elements, Mg, Al, and Zn, into the Na2HPO4 pretreated layer after heat treatments (Table 6.4). 
The coatings formed after pretreatments were collected, after carefully removing from the 
surface of the substrate, and dissolved in dilute HNO3 solutions prior to determining their 
elemental composition using ICP. After immersion in Na2HPO4, relatively large amounts of Na 
and P were detected despite thorough washing of the substrates after Na2HPO4 treatment, similar 
to XRD observations. After heat treatment to 350˚C, the mol. % of Na and P sharply decreased 
while that of Mg and Zn expectedly increased. Upon heat treatment to 400˚C, Na and P content 
further decreased, while Mg and Zn content once again was observed to increase. The increase in 
Zn content after heat treatment is most likely due to either the relatively low melting point of Zn 
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in comparison to Mg and Al or the formation of an intermetallic. The increasing Mg content after 
heat treatment is due to the formation of greater amounts of MgO with increasing temperature, 
also confirmed by XRD. 
 
Table 6.4 ICP elemental analysis of pretreated coatings formed after immersion in Na2HPO4. Coatings 
from 9 samples were collected and analyzed. 
 
6.3.2 Coating Structural Characterization 
To develop coatings of undoped CaP and Sr doped CaPs, pretreated substrates were then 
immersed in solutions containing Ca2+, Sr2+, and HPO4- ions kept at 70˚C with a fixed (Ca+Sr)/P 
ratio and varying Sr/(Ca+Sr) ratios (Table 6.1). XRD was used to determine the crystallinity and 
phase composition of CaP coatings formed in the presence of varying Sr2+ concentrations (Figure 
6.4). Biphasic mixtures of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP) were 
observed to form on substrates pretreated to 350˚C (Figure 6.4 a)). Similar to the CaP coatings 
formed on substrates pretreated to 350˚C, the CaP films deposited on substrates pretreated to 
400˚C also consisted of biphasic mixtures of HA and β-TCP (Figure 6.4 b)). β-TCP is known to 
be unstable under aqueous conditions, however, increased Mg2+ concentrations have been 
reported to stabilize β-TCP [81]. Moreover, the formation of increased amounts of MgO after 
heat treatment to 400˚C, previously confirmed using ICP and XRD, may lead to increased local 
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Mg2+ concentrations during the precipitation of CaP coatings thus promoting the formation of β-
TCP rather than HA. 
The elemental composition of CaP coatings was evaluated using ICP (Table 6.5). Once 
again, coatings were gently removed from the substrate and solubilized in dilute HNO3 solutions. 
Despite the use of different pretreatment temperatures, the amount of Sr2+ incorporated into CaP 
coatings was similar between both groups. Similar to the elemental analysis of pretreated layers, 
increased amounts of Mg were also detected in CaP coatings formed on substrates pretreated to 
400˚C. This suggests that increased levels of ionic substitution of Ca2+ by Mg2+ occurred in the 
CaP coatings formed on substrates pretreated to 400˚C, since neither magnesium phosphate nor 
excess MgO were detected using XRD. The (Ca+Mg+Sr)/P ratio of CaP coatings formed on 
substrates pretreated to 400˚C was also slightly increased. However, the Ca/P ratios were similar 
between both groups. 
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Figure 6.4 XRD collected from CaP coatings formed on pretreated AZ31 after heat treatment to a) 
350˚C and b) 400˚C and immersion in solutions prepared with i) 0, ii) 5, and iii) 10% Sr/(Ca+Sr) ratios (β-
TCP (JCPDS 09-0169)  and HA (JCPDS 09-0432)). 
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Table 6.5 ICP elemental analysis of CaP coatings formed after immersion in solutions containing 
various amounts of Ca2+, Sr2+, and PO4
3-. Coatings from 9 samples were collected and analyzed. 
 
 
The influence of pretreatment and Sr2+ concentration on as deposited coating 
microstructure was observed using SEM (Figure 6.5). Coatings formed on substrates pretreated 
to 350˚C without Sr2+ consisted mostly of rod shaped particles. In addition, fiber like structures 
and rosette shaped particles were also observed (Figure 6.5 a)). Upon increasing Sr2+ 
concentration, fewer rod shaped particles were detected and primarily rosette and fiber like 
particles were observed (Figure 6.5 b)). In contrast, CaP coatings formed on substrates pretreated 
to 400˚C without Sr2+ consisted of mostly round 10 μm or greater particles (Figure 6.5 c)). Upon 
increasing Sr2+ concentration, particle size greatly decreased (Figure 6.5 d)). Coating thickness 
on substrates pretreated to either temperature without Sr2+ was also determined using SEM 
(Figure 6.6). Despite the formation of increased MgO after heat treatment to 400˚C, coating 
thickness was similar for both conditions prepared without Sr2+. Similar trends in coating 
thickness were observed for coatings prepared with 5 and 10% Sr. 
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Figure 6.5 The morphology of CaP coatings formed on substrates pretreated to 350˚C prepared with a) 
no Sr and b) 10% Sr; substrates pretreated at 400˚C with c) no Sr and d) 10% Sr. 
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Figure 6.6 The thickness of CaP coatings formed on substrates pretreated to a) 350 and b) 400˚C with 
no Sr. 
6.3.3 Corrosion Protection 
6.3.3.1 Hydrogen Evolution and Immersion Test 
Upon exposure to aqueous environments, Mg alloys are known to corrode rapidly forming 
Mg(OH)2 and releasing H2 gas as corrosion products. As a result, the rate at which H2 is released 
and the total amount of H2 generated are commonly used to study the corrosion behavior of Mg 
alloys [199]. HBSS without serum proteins was used for H2 evolution experiments in order to 
study coated samples in an environment where corrosion occurs rapidly. A relatively large 
volume of HBSS to substrate surface area of 0.1 l cm-2 was used in order to minimize the risk of 
saturation of Mg2+. In comparison to bare AZ31, all coated samples generated much less 
hydrogen over a one week period (Table 6.6). Unfortunately, the difference in the amount of H2 
generated between coated samples varied by less than 0.2 ml, despite the use of HBSS without 
serum proteins. As a result, based on the amount of H2 generated alone, the role of either 
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pretreatment or Sr2+ doping on the capability of CaP coatings to act as a protective layer cannot 
be determined. However, it can be concluded that CaP coated samples corroded much less than 
bare AZ31 substrates. 
  
Table 6.6 Corrosion data collected from hydrogen evolution experiments and potentiodynamic 
polarization tests. Three repeats for each condition were performed for electrochemical corrosion 
experiments. 
 
 
The amount of Mg2+ released and the pH for both coated and bare substrates were 
measured after immersion in DMEM containing serum proteins. Media was collected and 
refreshed every 48 h. As mentioned previously, Mg alloys are known to form a Mg(OH)2 
passivation layer as a result of Mg2+ ions reacting with H2O during corrosion. The subsequent 
dissolution of Mg(OH)2 results in an increase in pH. For both coated and bare substrates, pH was 
initially high and decreased throughout the 21 day immersion period (Figure 6.7 a)). After 4 
days, the pH of media collected from coated samples stabilized at a pH of 8 while that of AZ31 
remained slightly elevated. Similar to H2 evolution experiments, the difference in pH between 
CaP coated groups remained relatively small. This may be due to the buffering capacity of 
culture media and the frequent changing of media. Further analysis of the collected culture media 
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by ICP showed that throughout the 21 day incubation period Mg2+ concentration from bare AZ31 
substrates was much greater than that of coated samples (Figure 6.7 b)). Similar to pH 
measurements, the amount of Mg2+ measured decreased throughout the experiment. 
The Mg2+ released into solution and measured by elemental analysis is due to the 
dissolution of the Mg(OH)2 passivation layer formed in the presence of chloride containing 
solutions. Therefore, the measurement of Mg2+ in solution does not directly correlate with 
corrosion since the rate at which the passivation layer dissolves is much slower than the rate at 
which it is formed and is dependent upon the chemical stability of the resulting hydroxide. As a 
result, a decrease in Mg2+ concentration for coated samples in comparison to the bare substrate is 
observed for all conditions throughout the incubation period. Nonetheless, the concentration of 
Mg2+ in media is critical in determining the cytotoxicity of coated and bare substrates. The high 
initial Mg2+ concentration measured for CaP coated samples is most likely due to the exposure of 
the underlying bare AZ31 substrate to the surrounding culture media due to the porosity of CaP 
coatings and the underlying pretreated layer.   
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Figure 6.7 a) pH measurements and b) elemental analysis of culture media after incubation with coated 
and uncoated samples for up to 21 days. 
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6.3.3.2 Electrochemical Corrosion Testing 
The H2 evolution experiments and immersion tests both fail to provide definitive conclusions 
relating to the role of various pretreatments or the film composition on corrosion protection. 
Therefore, potentiodynamic polarization (PDP) tests were also performed in order to further 
assess the effect of Sr2+ doping and pretreatment conditions on the corrosion control. After at 
least 1h of stabilization in order to establish the open circuit potential (OCP), substrates were 
subjected to PDP testing over a range of 200 mV lower than OCP and 500 mV greater than OCP 
at a scan rate of 1 mV s-1. It can be seen that similar to non-polarized current and voltage induced 
corrosion experiments, such as H2 evolution and immersion tests, coated samples were 
determined to be more stable than bare AZ31 samples due to a higher anodic corrosion potential 
(Ecorr) and lower corrosion current densities (Icorr), determined by Tafel extrapolation (Table 6.6).  
Interestingly, between the various Sr doped CaP coated AZ31 substrates pretreated to 350˚C, 
corrosion resistance increased upon increasing Sr2+ concentration. The observed increase in 
corrosion protection may be due to variations in phase composition of CaP coatings upon 
varying Sr2+ concentration or the increased doping of Sr2+ resulting in decreased coating 
solubility (Table 6.5). In contrast, the corrosion resistance of CaP coated substrates deposited on 
AZ31 pretreated at 400˚C decreased with increasing Sr2+ concentration. Elemental analysis by 
ICP (Table 6.5) indicated that the mol. % of Mg in CaP coatings formed on substrates pretreated 
to 400˚C increased upon increasing Sr2+ content, while it was much lower and remained 
relatively constant on substrates pretreated to 350˚C. Therefore, it appears that pretreatment has a 
greater influence on coating stability for substrates pretreated to higher temperatures. 
Nonetheless, in comparing the two groups, the optimum Ecorr and Icorr values achieved were 
similar for Sr10-350 and Sr0-400. 
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6.3.4 In-Vitro Cytocompatibility 
6.3.4.1 Live/Dead Staining 
CaP coatings with similar levels of Sr2+ doping were prepared, despite varying pretreatment 
conditions. The CaP coatings formed on substrates pretreated at increased temperatures consisted 
of increased amounts of Mg and Zn as a result of the diffusion of alloying elements into the 
pretreated layer at elevated temperatures. Both pretreatment conditions and Sr2+ concentration 
were observed to influence the capability of CaP coatings to protect against corrosion of the 
underlying substrate in culture media containing serum proteins. To study the capability of CaP 
coatings to support the proliferation of MC3T3-E1 cells, live/dead staining after 3 and 7 days on 
both coated and uncoated substrates was performed (Figure 6.8).  
Initial cell attachment and spreading on coated substrates was relatively low in 
comparison to MC3T3-E1 cells seeded on tissue culture plastic (Figure 6.8 a)-d)). A slightly 
increased number of live cells were observed on samples prepared with increased Sr2+ 
concentrations. After 7 days, a substantial increase in the number of live cells was observed for 
all conditions (Figure 6.8 e)-h)). Interestingly, slightly fewer cells were observed on samples 
prepared with increased Sr2+ concentrations. Cell morphology was observed on coated samples 
using SEM (Figure 6.9). The cells observed appeared broad rather than elongated and were 
evenly spread throughout the surface of the coated substrate after 7 days. 
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Figure 6.8 Live/dead staining on culture plastic, Sr0-350, Sr5-350, and Sr10-350 after 3 (a-d) and 7 (e-h) 
days of culture with MC3T3-E1 cells. 
 
The initial low live cell attachment on coated samples, in comparison to tissue culture 
plastic, suggests that many of the seeded cells did not attach. For bare AZ31 this is expected due 
to the rapid corrosion resulting in increased Mg2+ concentration and the release of hydrogen upon 
initial contact with cell culture media prior to passivation. For coated samples, initial attachment 
also remained low despite the fact that a passivation and coating layer had been formed prior to 
exposure to cell culture media. Nonetheless, cells which attached to coated substrates 
proliferated rapidly between 3 and 7 days. 
6.3.4.2 DNA Concentration 
To further study the capability of CaP and Sr2+ doped CaP coatings to support the proliferation of 
osteoblast-like cells in comparison to bare substrates, MC3T3-E1 mouse preosteoblasts were 
cultured on coated and bare substrates for 3 and 7 days prior to measuring DNA concentration 
(Figure 6.10 a)). After 3 days of culture, coatings prepared with no Sr2+ on substrates pretreated 
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to 350˚C supported significantly enhanced cell proliferation in comparison to uncoated AZ31 
and coatings prepared with 5 and 10% Sr on substrates pretreated to 400˚C.  After 7 days, a 
substantial increase in DNA concentration was observed for all conditions. Once again, elevated 
DNA concentrations were measured on CaP coated substrates prepared without Sr2+ and 
significant increases in DNA concentration in comparison to uncoated AZ31 were observed for 
CaP coated substrates. 
 
 
Figure 6.9 An SEM image of MC3T3-E1 cells after 3 days of culture on Sr10-350. 
 
hMSCs were also were cultured on CaP coated and bare AZ31 substrates for 3 and 7 days 
prior to measuring DNA concentration (Figure 6.10 b)). Similar trends in comparison to MC3T3-
E1 cells after 3 days were observed. Once again, cells cultured on coatings prepared with less 
Sr2+ had elevated DNA concentrations which were near double that of bare AZ31. After 7 days 
of culture, DNA concentration once again substantially increased and elevated DNA 
concentrations were again observed on Sr0-350 coatings. In summary, minimal toxicity was 
observed for both cell types on CaP coated AZ31 substrates. At both time points for both cell 
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types, coatings prepared with reduced Sr2+ concentrations supported increased proliferation. 
Although statistically significant differences were not observed between groups pretreated to 350 
and 400˚C, cell proliferation on Sr0-350 coatings was increased in comparison to all other 
groups for all time points of interest. 
6.3.4.3 Osteogenic Gene and Protein Expression 
CaP and Sr doped CaP coatings are both capable of supporting MC3T3-E1 cell and hMSC 
proliferation with minimal toxicity. In order to study the capability of CaP and Sr doped CaP 
coatings to facilitate the differentiation of MC3T3-E1 cells to mature osteoblasts, the expression 
of osteogenic genes, osteocalcin (OCN) and osteopontin (OPN), were studied on coated and bare 
AZ31 substrates. OPN is a non-collagenous protein known to influence wound healing, 
tumorigenesis, and the mineralization of bones and teeth [168]. With respect to its role in 
mineralization, OPN has also been shown to regulate cell attachment to extracellular matrix 
including the growth of hydroxyapatite crystals within the interfibrillar spaces of the bone matrix 
[167]. As a result, OPN is considered a relatively early marker for osteogenic differentiation 
since lower levels of OPN are required for matrix mineralization to occur [18]. In contrast, OCN 
is a late stage marker for osteogenic differentiation and is the most abundant non-collagenous 
protein found in bone [200]. 
qRT-PCR was performed with MC3T3-E1 cells after 18 days of culture in osteogenic 
media (Figure 6.11 a)). Gene expression was normalized to that of cells cultured on AZ31. 
Among coated samples, greater levels of OPN were expressed on CaP coatings deposited on 
substrates pretreated to 350˚C. For CaP coatings on substrates pretreated to either temperature, a 
slight increase in OPN expression was observed upon increasing Sr2+ concentration.  
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Figure 6.10 DNA concentration measured from a) MC3T3-E1 preosteoblast cells and b) hMSCs after 3 
and 7 days of culture in growth media on AZ31 coated and uncoated substrates. 
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OPN expression on CaP coatings deposited on substrates pretreated to 400˚C was similar to that 
of bare AZ31. 
Similar to OPN, OCN expression was also slightly increased for both pretreatment 
conditions upon increasing Sr2+ concentration. Interestingly, a near tenfold greater expression of 
OCN was observed for samples prepared on Sr10-400 coated substrates in comparison to bare 
AZ31. The combination of the decreased expression of OPN, an early differentiation marker, and 
the elevated expression of OCN, a mature osteoblast marker, on samples prepared with 10% Sr 
pretreated to 400˚C suggests that MC3T3-E1 cells cultured on these coatings are more mature 
osteoblasts in comparison to other conditions. 
Osteogenic gene expression was also studied on AZ31 coated substrates using hMSCs to 
further analyze the capability of coatings deposited on substrates pretreated to 400˚C to support 
enhanced differentiation (Figure 6.11 b)). In contrast to the trends observed with MC3T3-E1 
cells, elevated OPN expression was observed for cells cultured on coatings prepared on 
substrates pretreated to 400˚C rather than 350˚C. A comparable OPN expression was measured 
for hMSCs cultured on Sr10-350 coatings in comparison to those formed on substrates pretreated 
to 400˚C while much lower values were obtained on Sr0-350 and Sr5-350. In addition, no 
distinct trend upon increasing Sr2+ concentration was observed for OPN expression. However, a 
subtle increase in hMSC OCN expression was observed upon increasing Sr2+ concentration for 
both pretreatment conditions. In general, similar levels of OCN expression were measured for 
both groups. 
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Figure 6.11 qRT-PCR gene expression data showing the expression of osteopontin (OPN) and osteocalcin 
(OCN) of a) MC3T3-E1 cells and b) hMSCs cultured on coated samples normalized with respect to cells 
cultured on bare AZ31. 
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The relatively low expression of OCN, a mature osteoblast marker, for hMSCs cultured 
on CaP coated AZ31 substrates in comparison to bare AZ31 suggests that hMSCs cultured on 
these coated samples have not differentiated into mature osteoblast and are yet to mineralize their 
extracellular matrix [18]. Therefore, the enhanced expression of OPN, an earlier marker for 
osteoblastic differentiation, on coatings deposited on substrates pretreated to 400˚C suggests that 
these coatings may promote the osteogenic differentiation of hMSCs rather than those prepared 
with similar Sr2+ concentrations on substrates pretreated to 350˚C. While this was more obvious 
for hMSCs cultured on samples prepared with 0 and 5% Sr, similar OPN and OCN values were 
obtained for both pretreatment conditions for hMSCs cultured on coatings prepared with 10% Sr.  
The intracellular concentration of OCN in hMSCs cultured on coated samples after 18 
days in osteogenic media was determined using a Luminex instrument (Figure 6.12). Similar to 
the trends observed in hMSC gene expression, comparable levels of OCN were measured for 
most conditions. Interestingly, a distinct trend with increasing OCN expression upon increasing 
Sr2+ concentration was also observed regardless of the pretreatment temperature and a 
statistically significant increase in OCN concentration was observed between hMSCs cultured on 
Sr0-400 and Sr10-400 coatings. 
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Figure 6.12 Osteocalcin (OCN) concentration measured from lysed hMSCs after 18 days of culture in 
osteogenic media. 
 
Coatings prepared with reduced Sr2+ concentrations were observed to support increased 
cell proliferation for both cell types. In contrast, increased Sr2+ concentrations supported the 
increased expression of osteogenic markers for both cell types. MC3T3-E1 cells and hMSCs are 
both known to possess Ca2+ sensing receptors (CaSRs) and recent publications have shown that 
Sr2+ is capable of increasing the expression of bone morphogenic protein 2 (BMP-2) and OCN 
through Wnt and MAPK signaling pathways by activating CaSRs [123, 159, 201]. Although 
coatings deposited on substrates pretreated to both temperatures retained similar amounts of Sr2+ 
(Table 6.5), increased levels of differentiation were observed for MC3T3-E1 cells cultured on 
coatings deposited on substrates pretreated to 400˚C rather than 350˚C. A similar trend was also 
observed for hMSCs, except for samples prepared with 10% Sr. Therefore, this data suggests 
that, in addition to Sr2+ doping, pretreatment conditions of AZ31 substrates also influence 
osteogenic differentiation. As a result, further work is needed to optimize pretreatment 
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conditions prior to depositing CaP coatings to enhance not only coating stability and corrosion 
protection, but also cytocompatibility. 
6.4 CONCLUSIONS 
In the current Chapter, CaP coatings with various levels of Sr2+ doping were formed on Na2HPO4 
pretreated AZ31 heat treated to either 350˚C or 400˚C. Heat treatment to 400˚C resulted in the 
formation of greater amounts of MgO and increased diffusion of Zn into the pretreated layers 
prior to the deposition of CaP coatings. The CaP coatings formed consisted of biphasic mixtures 
of HA and β-TCP with increased HA formed upon increasing Sr2+ concentration. The corrosion 
protection offered by CaP coatings was influenced by both the Sr2+ concentration and the 
pretreatment conditions.  
Sr2+ doping was observed to reduce the proliferation of both MC3T3-E1 cells and hMSCs 
on coated substrates but increased the level of osteogenic differentiation due to the upregulation 
of OCN gene and protein expression in MC3T3-E1 cells and hMSCs, respectively. The coatings 
formed on substrates pretreated to 400˚C also supported increased differentiation in comparison 
to those formed on substrates pretreated to 350˚C. As a result, it can be concluded that both Sr2+ 
doping and pretreatment conditions influence the capability of CaP coatings to provide corrosion 
protection and further to also support osteogenic differentiation on biodegradable Mg alloys. It 
can also be concluded that Mg2+ ions did not influence the variation in osteogenic differentiation, 
in contrast to the trends observed in Chapters 3, 4, and 5 since similar amounts of Mg2+ were 
measured in the culture media surrounding the coated substrates. The favorable response of 
osteoblast progenitor cells to CaP coatings prepared with Sr2+ on AZ31 substrates suggests that 
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Sr2+ substitution may also be useful in various other clinically relevant forms of calcium 
phosphate for bone used for tissue regeneration. As previously discussed, CaP systems have been 
explored in various forms for clinical application in addition to bulk scaffolds and coatings. 
Therefore, the capability of Sr2+ to enhance the properties of a HA forming self-setting cement 
will be discussed in detail in Chapter 7. 
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7.0  MURINE OSTEOBLASTIC AND OSTEOCLASTIC DIFFERENTIATION ON 
STRONTIUM RELEASING HYDROXYAPATITE FORMING BONE CEMENTS 
7.1 INTRODUCTION 
Sr2+ substituted CaPs have shown promise in the development of synthetic bone graft substitutes 
[159, 202]. This is primarily due to the capability of Sr2+ ions to stimulate the differentiation of 
osteoblast progenitor cells, limit osteoclastic resorption, and enhance the radiopacity of CaPs 
[119]. To improve the clinical application of Sr2+ substituted CaP based scaffolds, self-setting 
Sr2+ substituted HA and DCPD forming cements have been developed [203]. HA forming CaP 
cements are traditionally of greater interest due to their less acidic setting reaction and improved 
mechanical properties in comparison to DCPD forming cements. HA forming cements have also 
been prepared using a wide range of CaP precursors. However, they are most commonly 
prepared either by the hydrolysis of α-TCP or by an acid-base reaction between TTCP and either 
DCPA or DCPD [72, 101]. 
To date, the majority of work reported on Sr2+ substituted HA forming cements has been 
with formulations prepared using α-TCP rather than TTCP and either DCPA or DCPD. 
Schumacher et. al prepared Sr2+ releasing HA forming cements using α-TCP and DCPA with 
mixtures of CaCO3 and SrCO3 forming either Sr2+ substituted HA or clusters of SrCO3 within a 
HA matrix [124, 133]. The capability of these cements to support the proliferation and 
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differentiation of human mesenchymal stem cells was also demonstrated. SrCl2•6H2O has also 
been used to introduce Sr2+ ions to HA forming cements prepared using α-TCP [204, 205]. In 
both cases, the incorporation of Sr2+ into the HA crystal structure, which is necessary for the 
sustained release of Sr2+ ions, is dependent upon the relative solubility of Sr2+ containing 
precursors with respect to α-TCP and the participation of Sr2+ in the reprecipitation process 
occurring during cement formation. Therefore, the use of Sr2+ directly substituted into CaP 
precursors, which are directly involved in the cements setting reaction, may be a more efficient 
and promising route to incorporate Sr2+ ions into the HA crystal structure during the cement 
setting reaction in comparison to using Sr2+ containing salts. This approach has previously been 
explored using Sr2+ substituted α-TCP [206].  
In one of the few reports where Sr2+ substituted HA forming cements were prepared 
using TTCP and either DCPA or DCPD rather than α-TCP, Guo et. al prepared SrHPO4 (DSP) 
by precipitation and studied the cements formed using ternary mixtures of TTCP, DCPA, and 
DSP [203]. As a result of the varying solubility and particle sizes of DSP and DCPA, unreacted 
DSP was detected in the cements formed after up to one week in 100% humidity. Further work 
studying these cements indicated improved in vitro cytocompatibility and in vivo degradation 
when implanted intramuscularly and in a femoral defect in rabbits with increasing Sr2+ content 
[207]. However, the incorporation of Sr2+ ions into the HA crystal structure is once again 
dependent upon the relative solubility of the two acidic precursors, DCPA and DSP. 
Therefore, in the current study, Sr2+ substituted DCPD (SrDCPD) of varying levels of 
substitution were prepared by precipitation reaction conducted under aqueous conditions and 
further reacted with TTCP to form Sr2+ directly substituted into HA (SrHA) forming cements. It 
was hypothesized that the use of SrDCPD would lead to not only the incorporation of Sr2+ 
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directly into the HA formed during the cement setting reaction, but more importantly, introduce 
Sr2+ in a very controlled manner during the acid-base reaction between TTCP and DCPD. The 
influence of varying the Sr2+ content in cement scaffolds on the setting kinetics, phase 
composition, and compressive strength was characterized. In addition, the capability of Sr2+ 
containing cements to support the in vitro osteoblastic and osteoclastic differentiation of mouse 
preosteoblasts and monocytes was also studied and discussed in detail in this Chapter. 
7.2 MATERIALS AND METHODS 
7.2.1 Synthesis of Strontium Substituted Dicalcium Phosphate Dihydrate 
All reagents were acquired from Sigma-Aldrich and used in the form in which they were 
received. DCPD was precipitated under aqueous conditions using a method previously described 
[81]. Briefly, a mixture of calcium and strontium salts dissolved in DI water was added dropwise 
to a phosphate containing solution under constant stirring at room temperature. The mixture was 
then stirred for ten minutes. The precipitate formed was then centrifuged and washed using DI 
water. The final washing step was performed with ethanol and the precipitate was dried at room 
temperature under vacuum to avoid the formation of DCPA. 
7.2.2 Powder Characterization 
The phase composition of the powders formed after precipitation was determined using X-ray 
diffraction. X-ray diffraction patterns were collected using a Philips X-Pert PRO diffractometer 
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employing Cu Kα radiation (λ=1.5406 Å) with a Si-detector (X’celerator). The X-ray generator 
was operated at 45 kV and 40 mA at a 2θ range of 10-70˚ with a step size of 0.0167˚ and a time 
per step of 3s. Elemental analysis of the precipitated powders was performed using inductively 
coupled plasma optical emission spectrometry (ICP-OES, iCAP duo 6500, Thermo Scientific). 
Briefly, 10 mg of powder samples were dissolved in 3.5% HNO3. These solutions were further 
diluted and analyzed using ICP-OES with known standards for Ca2+, Sr2+, and PO43-, also 
prepared using a 3.5% HNO3 stock solution. Scanning electron microscopy (SEM, Philips XL30 
FEG ESEM) was used to analyze the particle size and microstructure of the powders formed 
after precipitation. Samples were sputter coated with palladium (Cressington, 108) prior to 
analysis using SEM. 
7.2.3 Cement Scaffold Characterization 
Powder mixtures of DCPD and TTCP (< 53 μm, HIMED, Old Bethpage, NY), by weight, were 
prepared using a mortar and pestle. Cement pastes were formed by combining TTCP-DCPD 
powder mixtures with either DI water or a 1.25% Na2HPO4 solution using a powder to liquid 
ratio of 2.2 g ml-1. The resulting pastes were filled into 10 mm diameter cylindrical molds and 
allowed to fully set at 37˚C. The cement reaction between TTCP and DCPD resulting in the 
formation of HA is illustrated in Equation 7.1. 
Equation 7.1 
Ca4(PO4)2O + CaHPO4•2H2O       Ca5(PO4)3OH + 2H2O 
The initial and final setting times were determined using a Gillmore Needle Apparatus 
(ASTM C-266). After setting, the cements were immersed in phosphate buffered saline (PBS, 
Lonza, Allendale, NJ) and incubated at 37˚C for up to one week. At various time points during 
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the one week period, samples were collected and analyzed using X-ray diffraction. Rietveld 
refinement was used to quantitatively analyze the phase composition (HighScore Plus, Version 
3.0e) using the ICSD reference patterns for HA (22060), DCPD (16132), and TTCP (2631). The 
wet compressive strength of cement scaffolds after immersion in PBS was analyzed using a 2 kN 
load cell (Instron, Norwood, MA) and a cross head speed of 1.3 mm min-1. A minimum of six 
repeats were performed for each condition at each time point using 6 mm diameter cylindrical 
scaffolds which were 12 mm long. The % porosity of cement scaffolds after immersion in PBS 
was determined using the formula illustrated in Equation 7.2. 
Equation 7.2 
% porosity  = 1-ρA/ρT 
The true density (ρT) was determined using helium pycnomtery (AccuPyc II 1340, 
Micromeritics, Norcross, GA) and the apparent density (ρA) was determined using an envelope 
density analyzer (GeoPyc, Micromeritics, Norcross, GA). A minimum of four independent 
repeats were analyzed for each condition. 
7.2.4 Cell Culture and Maintenance 
7.2.4.1 MC3T3-E1 Cell Culture  
MC3T3-E1 murine preosteoblast cell line was obtained from ATCC (Manassas, VA). Cells were 
cultured at 37˚C in 5% CO2 and 95% relative humidity in minimum essential medium alpha 
(MEMα, Gibco, Grand Island, NY) containing 10% fetal bovine serum (FBS, Atlanta 
Biologicals, Lawrenceville, GA) and 1% penicillin streptomycin (P/S, Gibco, Grand Island, NY). 
During direct culture experiments, cells were seeded at a density of 50,000 cells per well directly 
on cement scaffolds. For indirect culture, cells were seeded on tissue culture plastic and cement 
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scaffolds were placed on transwell permeable supports with a pore size of 0.4 µm and a nominal 
pore density of 4*106 pores cm-2 (Corning, Tewksbury, MA). In both cases, samples were 
sterilized using ethanol and ultraviolet light. Osteogenic differentiation was induced by culturing 
in growth media supplemented with 0.05 mM ascorbic acid, 10 mM β-glycerophosphate, and 
100 nM dexamethasone. 
7.2.4.2 RAW 264.7 Cell Culture  
RAW 264.7 murine monocyte cell line was also obtained from ATCC. The cells were cultured in 
Dulbecco’s Minimum Essential Medium (DMEM, ATCC, Manassas, VA) supplemented with 
10% FBS and 1% P/S at 37˚C in 5% CO2 and 95% relative humidity. Cells were seeded directly 
on cement scaffolds at a density of 10,000 cells per well. After 1 day of culture, the culture 
media was supplemented with 50 ng ml-1 of receptor activator of nuclear factor kappa-B ligand 
(RANKL, BioLegend, San Diego, CA) and was refreshed daily for the duration of the 
experiment. 
7.2.5 MC3T3-E1 Cell Proliferation 
The alamarblue cell viability assay (Invitrogen, Grand Island, NY) was used to evaluate MC3T3-
E1 proliferation on cements prepared with varying elemental compositions. At the time points of 
interest, the growth media was replaced by 1 ml of alamarblue diluted in growth media, 
according to the manufacturer’s protocol. Samples were then incubated with the alamarblue 
reagent for 6 hours. 50 µl aliquots of media were collected at the end of the incubation period 
and fluorescence was measured at an excitation wavelength of 540 nm and an emission 
wavelength of 590 nm. The cement scaffolds without cells were used as negative controls to 
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ensure that the release of Ca2+, Sr2+, and PO43- ions into the surrounding culture media did not 
influence the reduction of alamarblue. The concentration of Ca2+, Sr2+, and PO43- in the culture 
media during the viability experiment was determined using ICP-OES. Culture media samples 
were collected every other day and diluted in pH 7.4 tris buffer for analysis using ICP-OES using 
known standards. 
7.2.6 Alkaline Phosphatase Activity 
MC3T3-E1 cells were lysed using a commercially available lysis buffer according to the 
manufacturer’s protocol (CelLytic M, Sigma Aldrich). 170 µl of 1 g l-1 p-nitrophenyl phosphate 
(pNPP) dissolved in 0.2 M tris buffer (SIGMAFASTTM p-Nitrophenyl phosphate tablets, Sigma 
Aldrich) was added to 30 µl of cell lysate. Samples were incubated at 37˚C for one hour prior to 
stopping the reaction by adding 20 µl of 0.3 M NaOH. The concentration of p-nitrophenyl in 
solution after 1 hour of incubation was determined by measuring the absorbance at 405 nm. ALP 
activity was normalized with respect to the total protein concentration in the collected cell lysate. 
7.2.7 Osteogenic Protein Expression 
The intracellular expression of osteopontin (OPN) and osteocalcin (OCN) of MC3T3-E1 cells 
cultured on the CaP cements was quantified using a MAGPIX instrument (Luminex, Austin, 
TX). Cell lysates were incubated overnight at 4˚C with antibody conjugated magnetic beads 
(EMD Millipore, Billerica, MA) according to the manufacturer’s protocol. After incubation, the 
well contents were washed and exposed to a biotinylated detection antibody followed by 
streptavidin-phycoerythrin to complete the surface reaction. Protein concentrations were 
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determined by using known standards. Measurements were conducted in triplicate for each 
sample and were normalized with respect to the total protein concentration. 
7.2.8 Tartarate Resistant Acidic Phosphatase (TRAP) Activity 
Cell lysates were collected as previously described. 100 µl of RAW 264.7 cell lysate, collected 
after 5 and 10 days of culture on cement scaffolds in the presence of RANKL, were added to 50 
µl of 5 mM pNPP in 25 mM sodium acetate/20 mM sodium tartarate at pH 4.9. Samples were 
incubated at 37˚C for one hour prior to stopping the reaction by adding 200 µl of 0.5 M NaOH. 
The concentration of p-nitrophenyl in solution after 1 hour of incubation was determined by 
measuring absorbance at 405 nm. 
7.2.9 RAW264.7 Morphology 
After 10 days of culture on the cements with varying Sr2+ content in the presence of RANKL, 
RAW264.7 cells were fixed using 4% paraformaldehyde and washed with PBS. Prior to staining, 
the cell membranes were permeabilized using 0.1% Triton-X diluted in PBS for ten minutes. 
Actin staining was performed by incubating the samples in phalloidin (Phalloidin 
tetramethylrhodamine B isothiocyanate, Sigma Aldrich) diluted in PBS for forty minutes. DAPI 
(4′,6-Diamidino-2-phenylindole dihydrochloride, Sigma Aldrich) was similarly diluted in PBS 
and used to stain the cell nuclei according to the manufacturer’s protocol. Samples were then 
imaged using fluorescence (Olympus CXK41). 
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7.2.10 Statistical Analysis  
A one way analysis of variance (ANOVA) was used to determine statistical significance. The 
mean and standard deviation were reported. The Tukey-Kramer test was used for all pairwise 
comparisons and a p value < 0.05 was considered significant. 
7.3 RESULTS AND DISCUSSION 
7.3.1 Dicalcium Phosphate Dihydrate Characterization 
X-ray diffraction was used to study the phase composition and crystallinity of the powders 
formed by the chemical precipitation reaction at room temperature after drying under vacuum 
(Figure 7.1). For all of the compositions, DCPD (JCPDS 09-0077) was the only crystalline phase 
detected. The increased intensity of the peak near 12˚ 2θ for all of the conditions employed in the 
synthesis in comparison to the reference spectra is indicative of a preferred orientation along the 
(020) direction. A similar preferred orientation has previously been reported when DCPD was 
precipitated under aqueous conditions [81, 208]. Based on these results, it appears that up to 10% 
Sr could be incorporated into the lattice without inducing any phase separation. 
Elemental analysis of the precipitated powders was performed to more accurately 
determine the amount of Sr2+ incorporated into the DCPD crystal structure. Powder samples 
were dissolved in dilute acidic solutions and analyzed using ICP-OES with known standards for 
Ca2+, Sr2+, and PO43-. Four batches for each condition were analyzed independently (Table 7.1). 
As expected, Sr2+ was not detected in undoped DCPD. However, 4.30 and 8.84% Sr/(Ca+Sr) 
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values were obtained for samples precipitated with 5 and 10% Sr/(Ca+Sr), respectively. In all 
cases, the measured (Ca+Sr)/P ratio was also close to 1, that of DCPD, further confirming the 
formation of single phase DCPD. 
Due to the similar ionic radii of Sr2+ (0.12 nm) in comparison to Ca2+ (0.099 nm), a 
relatively high retention of Sr2+ in the various CaP phases has been reported in comparison to 
other elements [118, 209]. Despite the fact that Sr2+ can occupy all of the Ca2+ sites in the DCPD 
crystal lattice, the majority of work reported on the ionic substitution of Sr2+ in CaPs has focused 
on HA [210]. The influence of Sr2+ substitution on the microstructure of DCPD particles was 
also analyzed since the reactant particle size and shape are known to influence the cement 
properties (Figure 7.2). For undoped DCPD, the characteristic broad plate like morphology of 
DCPD was observed (Figure 7.2 a)) [211]. The particles imaged were approximately 10-15 μm 
in width. A similar morphology was also observed for DCPD prepared with both 5 and 10% Sr 
(Figure 7.2 b) and c)). However, a slight reduction in the particle size was observed for DCPD 
particles prepared with 10% Sr in comparison to those precipitated either without Sr or with 5% 
Sr. 
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Figure 7.1 The X-ray diffraction patterns of i) DCPD (JCPDS 09-0077), ii) undoped DCPD, iii) 5% Sr 
DCPD, and iv) 10% Sr DCPD after drying under vacuum. 
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Table 7.1 The elemental compositions of DCPD precipitated with and without Sr, determined using 
ICP. 
 
7.3.2 Cement Scaffold Characterization 
7.3.2.1 Setting Time 
Single phase DCPD with varying levels of Sr2+ substitution were combined with commercially 
available TTCP powder in a 45:55 DCPD:TTCP mixture by weight. The powder mixtures were 
thoroughly mixed by hand using a mortar and pestle and combined with either DI water or a 
Na2HPO4 solution using a P/L ratio of 2.2 g ml-1. The resulting pastes were allowed to fully set at 
37˚C during which setting times were determined using a Gillmore Needle Apparatus (Table 
7.2). The cements prepared using undoped DCPD set after approximately 26 minutes when using 
water as the liquid component. The final setting times for the undoped cements were however 
reduced to 6 minutes when using 1.25% Na2HPO4. The final setting times with both water and 
Na2HPO4 increased in comparison to undoped cements when the cements were prepared using 
either 5 or 10% SrDCPD. Furthermore, a similar decrease in setting time was also observed 
when using Na2HPO4 rather than water for both Sr2+ containing cement compositions. 
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Figure 7.2 The microstructure of DCPD particles precipitated a) without Sr, b) with 5% Sr, and c) with 
10% Sr.  
 
The TTCP-DCPD setting reaction is initiated by the dissolution of DCPD particles [212]. 
Therefore, the use of Na2HPO4 rather than water accelerates the cement setting due to the 
enhanced solubility of DCPD under slightly basic conditions and provides the increased PO43- 
concentration necessary to support the formation of apatite [84, 213]. In studying the TTCP-
DCPA cement setting reaction, Greish et. al concluded that DCPA was first completely 
consumed while TTCP was only partially consumed, resulting in the formation of calcium 
deficient HA (CDHA) [214]. The subsequent further consumption of TTCP and the increasing 
pH then resulted in the formation of stoichiometric HA from CDHA. Therefore, the increased 
setting time observed upon increasing Sr2+ content may be due to either the reduced solubility of 
SrDCPD or the inhibition of CDHA formation in the presence of Sr2+ ions. A similar increase in 
setting time was observed by Guo et. al upon increasing Sr2+ content in the TTCP-DCPA-DSPA 
system using various concentrations of phosphoric acid as the liquid component [203]. The 
increased setting time was attributed to the inhibition of the deposition of HA by Sr2+ ions. 
However, the influence of Sr2+ on the solubility of DCPD is largely unexplored and the present 
study appears to be the first to the best of our knowledge. 
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Table 7.2 The setting times at 37˚C for cements prepared with a 55:45 TTCP:DCPD ratio by weight 
and a P/L ratio of 2.2 g ml-1.  
 
7.3.2.2 Phase Composition 
To further analyze the consumption of the cement precursors and formation of HA, X-ray 
diffraction of the cement scaffolds after setting and after immersion in PBS, kept at 37˚C, for up 
to one week was performed. Figure 7.3 illustrates the diffraction data collected from the samples 
after the final setting was reached and for all of the compositions studied . After setting, peaks 
indicative of the presence of unreacted DCPD (JCPDS 09-0077) and TTCP (25-1137) were 
clearly identified. The XRD data collected after 3 days in PBS is illustrated in Figure 7.4. After 
immersion in PBS for 3 days, a reduction in the intensity of DCPD peaks was clearly observed 
while poorly crystalline peaks indicative of the formation of increased amounts of HA (JCPDS 
09-0432) were also detected. Similar peaks corresponding to unreacted TTCP were also 
observed. 
To more quantitatively study the phase composition of the cement scaffolds both after 
setting and after immersion in PBS, Rietveld refinement was employed (Figure 7.5). After 
setting, a reduced amount of HA was detected in the cements prepared with increasing Sr2+ 
content in comparison to undoped cements (Figure 7.5 a)), which would also suggest an increase 
in setting time for Sr2+ containing cements, as was previously observed (Table 7.2). However, 
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after immersion in PBS a similar amount of HA was detected for all of the compositions at later 
time points. After setting, the wt. % of both DCPD and TTCP in Sr2+ containing cements 
increased upon increasing Sr2+ content due to the reduced consumption of the reactants during 
the initial setting reaction (Figure 7.5 b) and c)). After immersion in PBS, SrDCPD was 
consumed more rapidly in comparison to undoped DCPD, particularly within the first 24 hours, 
and little or no DCPD remained after 7 days while greater than 25 wt. % TTCP remained after 7 
days for all of the compositions studied.   
In the current study, a non-stoichiometric ratio of the reactants was used to enhance the 
influence of Sr2+ substitution in DCPD on the cement properties. Despite the use of excess 
DCPD, the complete consumption of DCPD and remaining TTCP after 7 days in PBS at 37˚C 
suggests that large amounts of DCPD may be lost due to dissolution and do not react with TTCP. 
A possible explanation may be that an initial layer of HA is formed on the surface of TTCP 
particles which limits the diffusion of the DCPD dissolution products and retards the 
consumption of TTCP [215].  Increased TTCP reactivity may be achieved either by using a 
smaller particle size or by mechanical milling to form a thin layer of highly reactive amorphous 
calcium phosphate [80]. 
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Figure 7.3 X-ray diffraction patterns of i) DCPD (JCPDS 09-0077), ii) TTCP (JCPDS 25-1137), iii) HA 
(JCPDS 09-0432), and cement samples after setting prepared with iv) undoped DCPD, v) 5% Sr DCPD, and 
vi) 10% Sr DCPD. 
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Figure 7.4 X-ray diffraction patterns of i) DCPD (JCPDS 09-0077), ii) TTCP (JCPDS 25-1137), iii) HA 
(JCPDS 09-0432), and cement samples after 3 days in PBS prepared with iv) undoped DCPD, v) 5% Sr 
DCPD, and vi) 10% Sr DCPD. 
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Figure 7.5 The weight % of a) HA, b) DCPD, and c) TTCP in cement samples after setting and after 
immersion in PBS at 37˚C for 1, 3, and 7 days determined using Rietveld refinement. 
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7.3.2.3 Elemental Composition of Cement Scaffolds 
Due to concerns of large amounts of DCPD, the Sr2+ containing precursor, dissolving and not 
reacting with TTCP to form Sr2+ substituted HA, an elemental analysis of the cement scaffolds 
following setting and after immersion in PBS for 7 days was performed (Table 7.3). After the 
setting reaction and after 7 days in PBS, a slight reduction in the (Ca+Sr)/P ratio for all the 
conditions was observed. With respect to the Sr/(Ca+Sr) value, very similar amounts of Sr2+ 
were measured for both Sr2+ containing compositions at either time point. After 7 days, either 
very little or no DCPD remained in the cement scaffolds (Figure 7.5 b)). Therefore, the similar 
Sr2+ concentration measured prior to immersion in PBS and after 7 days in PBS confirms that 
most of the Sr2+ added is retained in the scaffold despite the near complete consumption of 
DCPD. Based on the phase composition after 7 days (Figure 7.5), it can therefore be concluded 
that the Sr2+ retained has indeed formed SrHA. This result confirms that the use Sr2+ substituted 
CaP precursors rather than Sr2+ containing salts may be a useful approach to efficiently 
incorporate Sr2+ ions into HA forming cements. 
 
Table 7.3 The elemental composition of cement powders after setting and after immersion in PBS at 
37˚C for 7 days. 
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7.3.2.4 Wet Compressive Strength and % Porosity 
The compressive strength and % porosity of cement scaffolds after immersion in PBS for 24 
hours and 7 days was also determined to correlate the phase composition with mechanical 
properties (Table 7.4). Preformed cylindrical samples were tested immediately following 
removal from PBS. After 24 hours of immersion in PBS, a compressive strength of 6.51 MPa 
was measured for the undoped cements while values of 5.74 and 4.73 MPa were obtained for 
cements prepared with 5 and 10% SrDCPD, respectively. After 7 days however, the compressive 
strength for all the conditions increased due to the enhanced formation of HA (Figure 7.5). 
Comparable values were obtained for the cements prepared with both undoped and 5% SrDCPD 
while a slightly increased compressive strength was measured for samples prepared using 10% 
SrDCPD although the amount of HA formed appeared to be quite similar (Figure 7.5). 
 
Table 7.4 The wet compressive strength and % porosity of cement samples after incubation in PBS at 
37˚C for 1 and 7 days. The % porosity was calculated using the formula 1-(ρA/ρT), where ρA is the apparent 
density and ρT  is the true density. 
 
 
The typical range of compressive strength values obtained for CaP cements is known to 
be within 10-100 MPa. That of trabecular bone, which cement scaffolds are in direct contact with 
when implanted in vivo, is also approximately 10 MPa  [83]. In many studies, cement pastes are 
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compressed prior to setting which is known to reduce the inherent porosity, thus increasing the 
compressive strength [216]. In the current study, cement pastes were not compressed prior to 
setting and despite that, compressive strength values similar to trabecular bone were achieved. 
To further analyze the cement scaffolds, the % porosity was determined by measuring ρT and ρA 
after 24 hours and 7 days in PBS (Table 7.4). As expected from the compressive strength results, 
the cements prepared with undoped and 5% SrDCPD had an increased porosity at both time 
points in comparison to those prepared with 10% SrDCPD.  
The reduced porosity and increased compressive strength for cements prepared with 10% 
SrDCPD may be due to the slightly reduced DCPD particle size with increasing Sr2+ content 
(Figure 7.2). In the TTCP-DCPA cement system, a 10:1 TTCP:DCPA ratio in particle size was 
found to form cements with the best mechanical stability [80]. While the optimum particle size 
ratio for the TTCP-DCPD system is not known, the reduced particle size of 10% SrDCPD may 
be closer to the optimum particle size ratio to obtain increased mechanical stability. 
Nevertheless, similar compressive strength values to trabecular bone were obtained for the 
cements formed. Despite the near 50% total porosity, the scaffolds formed for all conditions 
were stable under aqueous conditions. The relatively high porosity may lead to increased protein 
adsorption upon exposure to physiological fluids which may support increased cell attachment 
and proliferation. 
7.3.2.5 MC3T3-E1 Proliferation 
MC3T3-E1 cells were seeded directly on the pre-formed cement scaffolds and cultured for up to 
two weeks in growth media to determine whether or not the cement scaffolds would support 
proliferation. Cell proliferation was quantified using the alamarblue assay at various time points 
(Figure 7.6). After 1 day, similar levels of proliferation were measured for all the conditions. 
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After 3 days, an increase in proliferation was clearly measured in comparison to 1 day for all of 
the groups and a slight increase in fluorescence intensity was measured on cements prepared 
with increasing Sr2+ content. At later time points, a statistically significant increase in 
proliferation was measured on cements prepared with 10% SrDCPD in comparison to all other 
groups. This data thus suggests that the cements prepared with up to 10% SrDCPD support 
greater proliferation in comparison to the undoped cements while similar levels of proliferation 
were observed for cements prepared with 5% SrDCPD and undoped DCPD. 
 
 
Figure 7.6 MC3T3-E1 cell proliferation determined using the alamarblue assay after culturing on 
cements prepared using undoped, 5, and 10% Sr DCPD for up to 15 days in growth media. 
 
Sr2+ has previously been reported to stimulate the proliferation of both osteoblasts and 
mesenchymal stem cells [119, 158]. It has also been demonstrated to influence the cellular 
processes through interactions with the calcium sensing receptor (CaSR) resulting in an 
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increased gene expression of c-fos and egr1, which are both involved in the regulation of 
osteoblast proliferation [217]. Therefore, it is not surprising that cements prepared with increased 
Sr2+ stimulated the increased proliferation of mouse preosteoblast cells. However, Sr2+ 
concentrations greater than 1 mM have been shown to suppress the proliferation of mesenchymal 
stem cells drastically [124]. Therefore, based on these results it can be concluded that amounts of 
Ca2+, Sr2+, and PO43- released into the culture media from these HA forming cements prepared 
using a non-stoichiometric ratio of TTCP and SrDCPD are non-toxic to MC3T3-E1 cells. 
7.3.2.6 Ionic Concentrations in Media 
During the cell proliferation experiments, the culture media was collected on the days it was 
changed and analyzed. The pH and concentrations of Ca2+, Sr2+, and PO43- in the culture media 
were measured (Figure 7.7). Despite the use of excess DCPD, it is important to note that the pH 
remained slightly basic and similar to physiological conditions throughout the experiment for all 
the conditions studied (Figure 7.7 a)). The basal concentrations of Ca2+ and PO43- in the MC3T3-
E1 growth media were approximately 1.7 and 0.9 mM, respectively. After 1 day of incubation 
with cement samples, Ca2+ concentration was approximately 1 mM for all the conditions and 
gradually decreased throughout the 15 day culture period (Figure 7.7 b)). A sustained release of 
Sr2+ ranging from 0.02-0.05 mM during the culture period was observed for cements prepared 
with SrDCPD (Figure 7.7 c)). In contrast to Ca2+ concentration, a gradual increase in PO43- 
concentration was also observed throughout the culture period (Figure 7.7 d)).  
The reduced Ca2+ concentration from basal levels suggests that mineral was deposited 
from the culture media onto the surface of the cement samples throughout the two week 
experiment. Although PO43- was also consumed during mineral formation, the increase in PO43- 
concentration from basal levels is most likely due to dissolution of excess DCPD since a non-
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stoichiometric amount of DCPD was used and little or no DCPD was detected after 7 days 
during immersion in PBS (Figure 7.5 b)). Although either very little or no DCPD remained after 
7 days in PBS, a sustained release of Sr2+ was detected at time points greater than 7 days in 
culture media. This result is most likely due to different rates of dissolution of the various 
calcium phosphate phases in the presence of culture media containing Ca2+ and serum proteins in 
comparison to PBS, which did not contain either Ca2+ or serum proteins [218]. 
 
 
Figure 7.7 The a) pH and concentrations of b) Ca2+, c) Sr2+, and d) PO4
3- in culture media during 
MC3T3-E1 viability experiments on cements prepared with undoped, 5% Sr, and 10% Sr DCPD. 
 
In a study where postmenopausal women were treated with strontium ranelate, the 
baseline concentration of Sr2+ in serum was 0.3 µM and after three months of treatment it had 
risen to 117.9 µM [219]. Previous work by Schumacher et. al has also shown that with human 
mesenchymal stem cells a slight increase in proliferation was observed when cells were cultured 
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in media containing up to 0.1 mM of Sr2+ [124]. In the same study, with respect to osteogenic 
differentiation, increased ALP activity was observed at earlier time points for mesenchymal stem 
cells cultured in osteogenic media containing between 0.01-0.1 mM Sr2+, which is similar to the 
serum concentration observed during strontium ranelate treatment. Although MC3T3-E1 cells 
were used in the current study, the amount of Sr2+ released into culture media throughout the 
experiment from cement scaffolds is well within the optimum range of Sr2+ concentration to 
support likely both mesenchymal stem cell proliferation and differentiation based on the 
previously published data. 
7.3.2.7 MC3T3-E1 Osteogenic Differentiation 
After confirming that Sr2+ containing cements were capable of supporting MC3T3-E1 
proliferation and released sufficient amounts of Sr2+ that may also support osteogenic 
differentiation, MC3T3-E1 differentiation was evaluated by measuring ALP activity and the 
intracellular concentrations of OPG and OCN. The ALP activity of cells cultured for 10 and 21 
days in osteogenic media seeded directly on pre-formed cement scaffolds is illustrated in Figure 
7.8 a). Similar to the results observed from the alamarblue proliferation assay, comparable levels 
of ALP activity were observed between all groups at earlier time points. However, after 21 days 
increased levels of ALP activity were measured from cells cultured on cements prepared with 
both 5 and 10% SrDCPD in comparison to undoped cements. A near 50% increase in 
comparison to undoped cements was observed for the cells cultured on cement scaffolds 
prepared with 10% SrDCPD.  
The expression of two osteogenic proteins, OPG and OCN, was measured after 21 days 
to further assess osteogenic differentiation on cements prepared with varying amounts of Sr2+  
(Figure 7.8 b)). For cells cultured directly on cement substrates, significantly increased levels of 
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OPG were measured on cements prepared with both 5 and 10% SrDCPD in comparison to 
undoped cements. A similar trend was also observed in OCN expression after 21 days. Elevated 
levels of OCN were measured on cements prepared with 5 and 10% SrDCPD while much lower 
concentrations of OCN were measured on undoped cements.  
The capability of Sr2+ containing cements to support osteogenic differentiation may be 
due to either the chemical or physical cues provided by the scaffold during direct culture. 
Therefore, to study osteogenic differentiation in the absence of physical contact with cement 
substrates while maintaining similar ionic concentrations to direct cell culture experiments, 
permeable transwell inserts were used. ALP activity and the expression of OPG and OCN after 
21 days in osteogenic media were once again determined. In contrast to the results observed 
during direct culture experiments, similar levels of ALP activity were measured for cells cultured 
indirectly with all cement compositions after both 10 and 21 days (Figure 7.8 c)). OPG and OCN 
concentration after 21 days also exhibited similar trends to those observed for ALP activity 
where a comparable expression of both osteogenic proteins was observed for all the conditions 
(Figure 7.8 d)). 
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Figure 7.8 Alkaline phosphatase activity and osteogenic protein expression after 21 days of MC3T3-E1 
cells cultured a)-b) directly on cement scaffolds and c)-d) indirectly with cement scaffolds in osteogenic 
media. 
 
This data suggests that cells cultured directly on cement scaffolds prepared with Sr2+ 
experience increased levels of differentiation either due to the microstructure of Sr2+ containing 
cement scaffolds or the increased local Sr2+ concentration cells are exposed to near the scaffold 
surface. Sr2+ ions are known to interact with cells through either the CaSRs or non-selective Ca2+ 
channels which may initiate Wnt and other signaling pathways that regulate osteogenic 
differentiation [141]. However, in addition to Ca2+, PO43-, and Sr2+ concentration, CaP 
microstructure has also been demonstrated to influence cell proliferation and differentiation 
[220]. Therefore, to further assess the role of Sr2+ release and scaffold microstructure in 
supporting osteogenic differentiation, the blocking of either CaSRs or the signaling pathways 
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known to be activated upon exposure to Sr2+ ions is required and will be performed in future 
studies. 
7.3.2.8 RAW 264.7 TRAP Activity and Morphology 
In addition to osteoblasts, osteoclasts also play a key role in bone remodeling. In the current 
study RAW264.7 cells, a murine monocyte cell line, were seeded directly on cement samples. 
The cells were cultured for up to 10 days in media supplemented with 50 ng ml-1 of RANKL, a 
key growth factor in osteoclast development [22]. TRAP activity and cell morphology were 
analyzed to study the influence of varying Sr2+ content in HA forming CaP cements on the 
osteoclastic differentiation of RAW264.7 cells. With respect to TRAP activity, after 5 days 
similar values were observed between the three conditions (Figure 7.9). After 10 days a two to 
three fold increase in TRAP activity was observed. At both time points, no statistically 
significant differences were observed upon varying Sr2+ content.  
In addition to increased TRAP activity, the formation of multinucleated cells is 
characteristic of the differentiation of monocytes towards mature osteoclasts. Therefore, after 10 
days of culture in RANKL, the cells cultured on cement scaffolds were fixed using 
paraformaldehyde and cytoskeletal staining was performed (Figure 7.10). On tissue culture 
plastic several 200 μm or greater multinucleated cells were observed (Figure 7.10 a)). However, 
on cement samples similar cell aggregates were observed but the large well defined actin rings 
observed for the cells cultured on tissue culture plastic were not detected (Figure 7.10 b)-d)). In 
comparing the cement samples, slightly larger cell aggregates were observed on cements 
prepared with 10% SrDCPD. However, no substantial differences were observed. 
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Figure 7.9 Tartarate resistant acidic phosphatase (TRAP) activity of RAW 264.7 cells cultured directly 
on cement scaffolds in media supplemented with 50 ng*ml-1 of RANKL. 
 
Similar to osteoblasts, osteoclasts can also be stimulated by many ions through CaSRs [119]. 
Interestingly, Sr2+ has been reported to inhibit the differentiation of monocytes towards mature 
osteoclasts. However, in the current study no statistically significant differences TRAP activity 
or multinuclear cell formation was observed. This result suggests that the amount of Sr2+ released 
into the culture media may be too low to inhibit osteoclastic differentiation in comparison to 
cells cultured on undoped HA forming cements. 
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Figure 7.10 Cytoskeletal staining of RAW 264.7 cells cultured a) on culture plastic, and directly on 
cement scaffolds prepared with b) undoped DCPD, c) 5% Sr DCPD, and d) 10% Sr DCPD in media 
supplemented with 50 ng*ml-1 of RANKL for 10 days. 
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7.4 CONCLUSIONS 
Sr2+ substituted HA forming cements were prepared using TTCP and chemical synthesized Sr 
incorporated DCPD as cement precursors. The setting time increased with increasing Sr2+ 
content which may be due to the inhibition of HA formation in the presence of Sr2+. Similar 
amounts of Sr2+ were measured in the cements formed both after setting and after immersion in 
PBS for up to one week suggesting that most of the Sr2+ introduced was incorporated into the 
HA formed. An increase in compressive strength was also measured for cements prepared with 
increasing Sr2+ content after immersion in PBS for 7 days. Sr2+ substituted cements supported 
increased MC3T3-E1 proliferation and differentiation in comparison to undoped cements. 
Interestingly, both the release of Sr2+ ions and cement microstructure appeared to support 
osteogenic differentiation. Despite the differences in the amount of Sr2+ incorporated into and 
released from cement scaffolds, no statistically significant difference in the osteoclastic 
differentiation of RAW264.7 cells was observed. These results indicate that the use of chemicall 
introduced Sr2+ substituted calcium phosphate precursors rather than Sr2+ containing salts may be 
a simplified approach to preparing Sr2+ substituted HA forming cements. The favorable setting 
characteristics, mechanical properties, and in vitro cytocompatibility indicate that these self-
setting cements could serve well for further in vivo applications. These studies will be conducted 
in the near future. 
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8.0  GENERAL CONCLUSIONS AND FUTURE WORK 
Biphasic mixtures of amorphous calcium magnesium phosphate and Mg2+ substituted β-TCP 
were prepared using a low temperature chemical synthesis technique for a wide range of 
substitution levels for Ca2+. The compositions prepared with increasing Mg2+ concentrations 
resulted in the formation of increased amorphous content. Interestingly, the scaffolds prepared 
with increased amorphous content were also observed to enhance MC3T3-E1 mouse 
preosteoblast osteogenic differentiation in comparison to those prepared with commercially 
available β-TCP. The presence of increased amorphous content is most likely to also result in the 
greater dissolution of β-TCMP thereby resulting in the increased release of Mg2+ and PO43- ions 
into the culture media, which are known to play an important role in the osteogenic 
differentiation of osteoblast progenitor cells. It was concluded that the enhanced differentiation 
observed may be due to either the physical cues provides by the scaffold surface or the release of 
increased Mg2+ and PO43- ions after immersion in culture media.   
 The composition prepared with 50% β-TCMP, which facilitated increased MC3T3-E1 
proliferation and differentiation in comparison to commercially available β-TCP and all other β-
TCMPs, was then compared to Mg2+-Sr2+ co-substituted β-TCP scaffolds prepared using the 
same low temperature synthesis approach. Interestingly, the addition of Sr2+ ions to the system 
did not stimulate enhanced hMSC differentiation in comparison to 50% β-TCMP, as was 
expected. However, a slight increase in the expression of osteogenic markers was observed for 
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samples synthesized with the same Mg2+ concentration upon adding Sr2+. Using permeable 
transwell inserts, it was also concluded that the release of increased amounts of bioactive ions 
rather than the physical contact between hMSCs and the scaffold surfaces rather than the surface 
microstructure supported enhance osteogenic differentiation. Due to similar Ca2+ concentrations 
among all conditions, it was concluded that the enhanced Mg2+ and PO43- ions released from the 
scaffolds prepared using 50% β-TCMP were acting to support the enhanced osteogenic 
differentiation observed. However, it was not determined which of these two ions were more 
influential in supporting differentiation or whether or not the release of these two ions provides a 
synergistic effect.  
A qRT-PCR array was also used to study the influence of Mg2+ substitution in β-TCP on 
TGF-β and BMP signaling to gain further insight on the mechanisms through which β-TCMP 
supported enhanced osteogenic differentiation. It was concluded that the scaffolds prepared with 
50% β-TCMP supported enhanced differentiation through increased hMSC SMAD dependent 
TGF-β and BMP signaling in comparison to scaffolds prepared using commercially available β-
TCP. Therefore, in future studies the blocking of SMAD signaling may be a useful approach to 
determine whether or not β-TCMP scaffolds are still capable of supporting differentiation. 
Since experiments with transwell inserts indicated that the release of bioactive ions 
supported enhanced differentiation on β-TCMPs rather than the contact with scaffold surfaces, 
approaches to alter the release of bioactive ions from β-TCMPs were explored. The modification 
of the pH during the synthesis of β-TCMP to a value of 8 was observed to result in the formation 
of completely amorphous β-TCMP. hMSCs seeded on the scaffolds prepared using these fully 
amorphous powders exhibited improved proliferation and the expression of ALP, an early 
osteogenic differentiation marker, in comparison to both β-TCP and β-TCMP prepared using 
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50% Mg. However, a similar gene expression of mature osteoblast markers between amorphous 
β-TCMP and β-TCMP was also observed. Therefore, it was concluded that the enhanced release 
of bioactive ions from fully amorphous β-TCMP supported enhanced proliferation but was 
incapable of further enhancing differentiation in comparison to β-TCMP. 
To determine whether or not the increased release of Mg2+ and PO43- ions had a 
synergistic effect on osteogenic differentiation, hMSC growth media was supplemented with 5 
mM Mg2+, 5 mM PO43-, or a combination of both ions. The influence of varying ionic 
concentration on both hMSC proliferation and osteogenic differentiation was characterized. As 
previously reported, the addition of Mg2+ resulted in an increase in cell proliferation. 
Interestingly, the addition of 5 mM PO43- to growth media also resulted in a similar level of 
mineral formation in comparison to hMSCs cultured in osteogenic media while little or no 
mineral was observed for all other conditions, including the cells cultured in the combination of 
5 mM Mg2+ and 5 mM PO43-. As a result, it appears that Mg2+ inhibits the osteogenic 
differentiation observed upon exposure to PO43- ions. Therefore, it was concluded that the 
presence of increased Ca2+ concentrations at later time points in the media collected from β-
TCMP may also be playing a role to support differentiation in the presence of Mg2+ and PO43- 
which was previously overlooked. 
Cationic substitutions in β-TCP were also observed to enhance its cytocompatibility. 
Therefore, the strategies employed to improve the performance of bulk β-TCP scaffolds were 
also applied to other clinically relevant forms of β-TCP. Accordingly, cationic substituted β-
TCPs were studied as bioactive coatings on biodegradable Mg based metallic substrates to 
provide improved osseointegration and temporary corrosion resistance under physiological 
conditions. Despite the use of varying pretreatment conditions, the coatings prepared with 
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increased Sr2+ concentrations also supported increased MC3T3-E1 and hMSC osteogenic 
differentiation. The Mg2+ concentration measured in the culture media was similar among all 
groups. Therefore, in this system Mg2+ ions did not contribute to the differences observed 
between groups as was observed for the systems described in Chapters 3, 4, and 5. Interestingly, 
both pretreatment conditions and coating composition were observed to influence the capability 
of the coating to provide corrosion protection. In summary, cationic substituted CaP coatings 
were successfully deposited on degradable substrates and were demonstrated to be capable of 
providing corrosion protection and enhancing cytocompatibility. 
Finally, cationic substituted HA forming self-setting cements were also studied. Due to 
the inhibition of HA crystal formation in the presence of Mg2+ ions, Sr2+ and not Mg2+ 
substituted HA forming cements were studied. Sr2+ substituted DCPD was prepared using the 
same chemical technique described in Chapters 3 and 4 prior to refluxing and forming β-TCP. 
The cements prepared with 10% Sr DCPD had a slightly increased compressive strength in 
comparison to those prepared without Sr2+ and supported increased MC3T3-E1 proliferation and 
differentiation. Interestingly, when using permeable transwell inserts to determine the roles of 
the physical and chemical cues in supporting differentiation, a comparable expression of 
osteogenic markers was observed for all conditions, despite the release of increased amounts of 
Sr2+ from Sr2+ containing cements. It was therefore concluded that both the chemical and physical 
cues provided by the scaffold supported increased osteogenic differentiation since previous 
reports have demonstrated that culture media supplemented with Sr2+ supports enhanced 
differentiation. Thus from these results the influence of the scaffold surface properties could not 
be eliminated. The differentiation of RAW264.7 murine monocyte like cells to mature 
osteoclasts, or bone resorbing cells, on these cement scaffolds was also studied. No statistically 
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significant differences in TRAP activity or cell morphology were observed between any of the 
conditions studied. Therefore, it was concluded that increased Sr2+ concentrations in these self-
setting cements is required to influence both osteoblastic and osteoclastic differentiation. 
Despite the improvement in the expression of osteogenic markers in comparison to 
commercially available gold standards, the use of relevant animal models is required to confirm 
the efficacy of treatments using cationic doped CaPs. Although in vivo work with the systems 
described in Chapters 3-7 was not performed, several publications have attempted to correlate in 
vitro differentiation of hMSC with in vivo bone formation in the presence of ceramic scaffolds 
and coatings [221, 222]. For example, hMSC in vitro differentiation on a calcium magnesium 
silicate ceramic and in vivo bone regeneration in a rabbit femoral defect model, both in 
comparison to β-TCP, have been reported [223]. In this work, a lesser fold increase in hMSC 
ALP and OPN expression (Figure 8.1) was observed in comparison to β-TCP with that reported 
in the data illustrated in Figure 4.10, Figure 4.11, and Figure 5.7. However, a significant 
improvement in the in vivo bone regeneration in comparison to β-TCP was observed. Therefore, 
based on this data it could be concluded that scaffolds fabricated with the materials developed in 
the current work may also support possibly enhanced in vivo bone regeneration in comparison to 
β-TCP. These are studies to be planned in the future. 
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Figure 8.1 The a) alkaline phosphatase activity and b) OPN expression of hMSCs cultured with 
scaffolds prepared using β-TCP and a calcium magnesium silicate bioceramic (akerminate) [223]. 
 
In summary, the efficacy of Mg2+ and Sr2+ containing CaPs as bulk scaffolds, bioactive 
coatings, and self-setting cements was demonstrated. It was concluded that amorphous rather 
than crystalline magnesium phosphate compounds may be more useful in tissue engineering 
applications due to the capability to release sufficient Mg2+ and PO43- ions to provide a 
microenvironment necessary to support osteogenic differentiation. Sr2+ containing scaffolds were 
also demonstrated to support osteogenic differentiation. However, the concentrations of Sr2+ 
required to support differentiation are much lower than that of either Mg2+ or PO43-. Therefore, 
Sr2+ containing crystalline CaPs, which dissolve at a much slower rate, are capable of delivering 
sufficient amounts of Sr2+. However, due to the dilute concentrations of Sr2+ in the bulk solutions 
when performing indirect culture experiments, it is difficult to confirm whether the physical or 
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chemical cues provided by these scaffolds support enhanced osteogenic differentiation. The 
exact roles of cationic substitutions in all of the materials studied are worth further exploring to 
determine the mechanisms through which they support enhanced differentiation. These 
mechanisms will be explored in future studies. 
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APPENDIX A 
DICALCIUM PHOSPHATE DIHYDRATE CEMENTS FROM MAGNESIUM 
SUBSTITUTIED Β-TRICALCIUM PHOSPHATE 
A.1 INTRODUCTION 
In addition to the hydroxyapatite forming cements described in Chapter 7, calcium phosphate 
cements are also capable of forming DCPD upon setting under acidic conditions. DCPD 
cements, although less mechanically stable and more acidic, are much more resorbable that HA 
forming cements under physiological environments. Mg2+ substitution in HA forming cements 
was not studied in Chapter 7 due to the inhibition of HA crystal formation in the presence of 
Mg2+ ions. However, Sr2+ ions are a much less potent inhibitor of HA crystal formation. Mg2+ 
substitution in DCPD forming cements has previously been studied using Mg2+ substituted β-
TCP prepared by high temperature approaches. In the current work, Mg2+ substituted DCPD 
forming cements were also studied. Biphasic mixtures of β-TCMP and amorphous calcium 
magnesium phosphates were prepared using the low temperature approach described in Chapters 
3-5 was employed as a source of Mg2+ ions. 
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A.2 MATERIALS AND METHODS 
A.2.1 Cement Preparation and Characterization 
An equimolar mixture of either commercially available β-TCP or low temperature synthesized β-
TCMP and monocalcium phosphate monohydrate (MCPM) was combined and mixed thoroughly 
by hand using a mortar and pestle. The powder mixture was then combined with water deionized 
using a powder to liquid ratio of 2 g ml-1 and allowed to set at 37˚C using Teflon molds. The 
cement paste setting time was determined using a Gilmore Needle Apparatus. The specific 
surface area of the β-TCMP precursor and the powder samples once the cements had fully set 
was determined using a BET surface area analyzer (Micromeritics, Norcross GA). 
A.3 RESULTS AND DISCUSSION 
DCPD cements are known to set relatively quickly due to the use of highly soluble acidic 
calcium phosphate precursors. The dissolution of these precursors and precipitation of DCPD 
crystals, which become entangled, results in the setting of the paste formed upon exposure to 
aqueous environments. As expected, the cements prepared using commercially available β-TCP 
fully set in less than 10 minutes (Figure A.1). Due to the rapid setting times, additives such as 
sodium citrate, and pyrophosphate salts are added to the liquid component to retard the setting 
reaction. Interestingly, the cements prepared with 35% β-TCMP took much longer to fully set, 
requiring almost 50 minutes utilizing the same powder to liquid ratio as commercially available 
β-TCP. Upon increasing the Mg content in β-TCMP, the setting time significantly reduced. 
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Cement scaffolds prepared with 50% β-TCMP fully set in less than 5 minutes, much quicker 
than even those prepared with commercially available β-TCP. 
 
 
Figure A.1 The setting times of DCPD forming cements prepared using deionized water and a powder 
to liquid ratio of 2 g ml-1 at 37˚C. 
 
In addition to the dissolution rate of calcium phosphate cement precursors, the particle 
size of the powders used is also known to influence the setting kinetics. To determine the 
variation in particle size of the precursors used, their specific surface areas were determined 
using BET (Table A.1). The commercially available β-TCP powders have an extremely low 
surface area, less than 1 m2/g, due to the high temperature processing required in preparing these 
materials and the high degree of sintering which subsequently occurs. For β-TCMP, the surface 
area increased upon increasing Mg2+ content. As a result of this increasing surface area for the 
same mass of β-TCMP, a much larger amount of liquid is required to sufficiently hydrate the 
surface of β-TCMP particles prepared with increasing Mg2+ content. Therefore, the cement 
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pastes prepared with β-TCMP containing increased amounts of Mg2+ are much more viscous in 
comparison to those prepared with less Mg2+. As a result, a reduced setting time was observed at 
37˚C.  
 
Table A.1 BET surface areas of β-TCMP prior to forming DCPD cements and the surface area of the 
cement powders after setting. 
 
A.4 CONCLUSIONS AND FUTURE WORK 
Cements with varying Mg2+ content were formed by reacting β-TCMP, prepared with varying 
amounts of Mg2+ and monocalcium phosphate monohydrate. The cement scaffold initial and 
final setting times varied depending on the amount of Mg2+ incorporated. The variation in setting 
time observed may be due to the varying particle size of β-TCMP upon varying Mg2+ content. 
Future studies will focus on determining the in vitro cytocompatibility of these cements using 
osteoblast progenitor cells. Particularly of interest will be the pH upon incubation in cell culture 
media due to the acidic degradation products of DCPD cements. In the event that cement 
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scaffolds are too acidic for static culture experiments. The stoichiometry of the cement reaction 
will be varied to ensure that unreacted β-TCMP, which is less acidic than DCPD, remains to 
facilitate enhanced cell proliferation and differentiation, as was observed in Chapters 3-5 when 
studying the either the biphasic mixtures of crystalline β-TCMP and amorphous calcium 
magnesium phosphate formed or fully amorphous β-TCMP scaffolds. 
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APPENDIX B 
AQUEOUS DEPOSITION OF CALCIUM PHOSPHATES AND SILICATE 
SUBSTITUTED CALCIUM PHOSPHATES ON MAGNESIUM ALLOYS 
B.1 INTRODUCTION 
CaP coatings deposited through phosphating solutions were investigated on two alloy systems, 
AZ31 (96% Mg, 3% Al, and 1% Zn by wt.) and Mg-4Y (96% Mg and 4% Y by wt.). Previous 
work has explored the use of phosphating bath approaches to deposit CaPs onto AZ31, however, 
they are yet to be reported on Mg-Y alloy systems [224, 225]. Mg-Y and rare earth alloys, such 
as WE43 (93% Mg, 4% Y, and 3% rare earths), have shown improved degradation and 
mechanical strength in comparison to other Mg-alloy systems, specifically for degradable stent 
applications [226]. The deposition of silicon substituted CaPs on Mg alloys through the 
phosphating bath approach was also investigated, which to the best of our knowledge has not yet 
been reported. In vivo studies have shown that silicon substituted CaPs were more capable of 
recruiting osteoclasts over short periods of time and possessed a greater bone contact percent 
compared to undoped CaPs [227]. It has also been hypothesized that Si is a trace element 
essential for bone regeneration, however, there is indeed a great paucity of information on the 
mechanisms and the true effect of Si on bone metabolism [228]. The present study was 
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conducted as a preliminary attempt to shed light on the generation of CaP coatings by 
phosphating bath and also its effect on osteoblast cell viability. 
B.2 MATERIALS AND METHODS 
B.2.1 Material Preparation and Coating Protocol 
A sheet of hot rolled AZ31 was acquired from Alfa Aesar (Ward Hill, MA) and was used as 
received. An ingot of Mg-4Y was cast and acquired from the GKSS Research Institute 
(Geesthacht, Germany) kindly provided by Dr. Norbert Hort, and was further homogenized by 
heat treatment to 525˚C in an inert atmosphere prior to cleaning and coating. ACS reagent grade 
calcium chloride dihydrate, sodium dihydrogen phosphate, and sodium hydroxide pellets were 
acquired from Acros Organics (Morris Plains, NJ). Sodium metasilicate was acquired from 
Fisher Scientific (Fair Lawn, NJ). Substrates were cut into 1.25 x 1.25 x 0.08 cm samples and 
were cleaned by first acid etching in a 3% nitric acid solution in ethanol. They were then rinsed 
in acetone and polished with up to 4000 grit SiC paper followed by sonication in acetone. 
Cleaned substrates were then subjected to an alkaline treatment by immersion in 50 g/L NaOH 
solution kept at 65˚C for 1h followed by drying at 60˚C in air. The pre-treated samples were 
immersed in phosphating bath solutions modified to those described by Gray-Munro et al. [225] 
with 3.0 mM CaCl2 and 1.8 mM NaH2PO4 maintaining a Ca/P ratio of 1.67, identical to that of 
hydroxyapatite (HA). Silicon was incorporated as silicates by substituting corresponding 
amounts of Na2SiO3 for NaH2PO4 maintaining the Ca/(P+Si) ratio of 1.67 identical to HA, as is 
further illustrated in detail in Table B.1. The pH of all the phosphating bath solutions was 
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decreased to 4.5 with hydrochloric acid. The samples were stored in phosphating solutions for up 
to 72 h at 37˚C and were finally dried at 60˚C prior to further experiments and characterization. 
  
Table B.1 The phosphating bath ionic concentrations  
 
B.2.2 Characterization Methods 
Coated substrates were rinsed and dried overnight at 60°C and were then evaluated by attenuated 
total reflectance Fourier transform infrared spectroscopy (ATR-FTIR, Nicolet 6700 Thermo 
Scientific) using a diamond ATR smart orbit with a spectral resolution of 2 cm-1. An average of 
64 scans was recorded for each sample in the frequency range of 400 to 4000 cm-1. X-ray 
diffraction (XRD) was performed using a Philips X-Pert PRO diffractometer employing Cu Kα 
radiation with a Si-detector (X’celerator). The X-ray generator operated at 45 kV and 40 mA at a 
2θ range of 10-90 utilizing a step size of 0.016 and 20.9 sec time step. Samples were sputter 
coated with palladium (Cressington sputter coater 108A) prior to performing scanning electron 
microscopy (Philips XL30 FEG ESEM) to analyze the coating microstructure and morphology 
along with energy dispersive X-ray (EDX, EDAX Genesis) which was used to perform elemental 
analysis of the coated substrates. Elemental analysis of the media collected after immersion of 
the coated samples in the medium was performed by inductively coupled plasma optical 
emission spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher). 
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B.2.3 In-Vitro Degradation 
Coated and control samples were immersed in 2 ml of Dulbecco’s modified eagle medium 
(DMEM), which was refreshed daily, and kept at 37˚C in a 5% CO2 atmosphere for up to 2 
weeks. Collected media was then analyzed by measuring pH (Ф 350 pH Meter, Beckman 
Coulter) as well as ionic concentrations of magnesium, yttrium, aluminum, and zinc by ICP-
OES. The surfaces of coated and control substrates were also analyzed by FT-IR after incubation 
in DMEM in order to determine the degradation products formed for various conditions. 
B.2.4 Cell Culture 
Murine osteoblast cell line, MC3T3-E1, was obtained from ATCC (Manassas, VA). Cells were 
cultured under 37°C, 5% CO2, and 95% relative humidity in Dulbecco’s modified eagle medium 
(DMEM, Cellgro, Manassas, VA) containing 10% fetal bovine serum (FBS, Atlanta Biologicals, 
Lawrenceville, GA) and 1% penicillin streptomycin (P/S, Gibco, Grand Island, NY). Cells after 
fourth passage were used in experiments. After initial seeding of 60,000 cells/ml, cells were then 
cultured in minimum essential medium alpha (MEM α, Gibco, Grand Island, NY) containing 
ascorbic acid, 10% FBS, and 1% P/S. 
B.2.5 Live/dead Staining 
Cell viability was assessed using live/dead staining (Invitrogen, Live/Dead Staining Kit). After 3 
days of culture, during which media was changed daily, samples were washed with phosphate 
buffered saline (PBS) and then incubated for 40 minutes with the live/dead stain diluted in PBS. 
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After incubation, samples were once again gently washed with PBS prior to imaging using 
fluorescence (Olympus CKX41). Cells were then fixed by using 4% paraformaldehyde followed 
by incubation for 20 minutes. After fixing, samples were subjected to alcohol dehydration and 
coated with palladium in order to observe the cell morphology by SEM. 
B.3 RESULTS AND DISCUSSION 
B.3.1 Coating Characterization 
Upon drying and visual inspection, the substrates appeared to be coated inhomogeneously with a 
white precipitate which was deposited either due to the further corrosion or the precipitation of 
Ca, P, and Si from the phosphating bath due to the local increase in pH during incubation. There 
was also an accumulation of precipitates at the bottom of the flasks in which the substrates were 
immersed, which probably suggests that not all of the Ca, P, and Si that precipitated from the 
phosphating bath solutions were deposited on the surface of the substrates. The pH of the coating 
bath solutions was monitored throughout the coating process and it was observed to stabilize at 
approximately 8.3 for all conditions after 24 h for both alloy systems. X-ray diffraction was used 
to analyze the crystallinity and phase composition of the coated substrates, however, due to 
either the inhomogeneity or incomplete coverage of the substrate surface or the amorphous 
nature of the deposited coatings, there were no extra peaks observed in the XRD spectra besides 
those of the substrate itself.  
While XRD results were inconclusive, FT-IR was used in order to confirm the presence 
of phosphates on the coated substrates and to observe whether or not the incorporation of silicate 
 225 
ions in the phosphating bath solutions affected the bonding between calcium and phosphate on 
the coated substrates. Due to the visual inhomogeneity of the coating, for each condition a 
minimum of 4 spectra, each from different samples, were collected and averaged. Figure B.1 a) 
and b) illustrate the FT-IR spectra for all three coating conditions on AZ31 and Mg-4Y in 
comparison to β-TCP. While the Ca/P or Ca/(P+Si) ratio of the phosphating bath solutions was 
kept constant at 1.67, characteristic of HA, in the FT-IR spectra of the coated samples it was 
difficult to detect the weak band at ~3600 cm-1, indicative of the hydroxyl bending band of HA, 
for all of the coated samples suggesting that the coated phase were not identical to HA but 
structurally closer to tri-calcium phosphate (β-TCP) and the formation of mixed HA and b-TCP 
phases as a valid possibility. However, in some cases the broad band between 2500 and 3500 cm-
1, due to absorbed moisture, may be overlapping with the weak hydroxyl bending band. This 
structural inhomogeneity also suggests the possible formation of β-TCP since Mg ions are well 
known to stabilize its structure and the major peaks indicative of PO43- can indeed be detected 
[81]. Of the other possible CaP phases that could be formed, brushite (CaHPO4•2H2O) was 
probably not deposited due to its instability at elevated pH, and the fact that this basic pH was 
achieved after only 24 hours in phosphating bath solutions. Peaks in the range 570 and 605 cm-1 
are due to O-P-O bending mode and the intense band in the range 960-1088 can be attributed to 
P-O stretching vibration modes.  
While the crystallinity of the coatings remained unknown and FT-IR confirmed the 
presence of PO43-, in order to estimate the phase composition of the deposited coatings, 
elemental analysis by EDX was utilized to determine the Ca/P and Ca/(P+Si) ratios. SEM 
confirmed the formation of inhomogeneous coatings for all conditions, as is illustrated in Figure 
B.2 a) and b) with a thickness ranging from 10-20 μm obtained by observing the cross sections 
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of the coated substrates. EDX results on AZ31 coated samples for all three conditions showed 
that the Ca/P ratios were between 1.3-1.5, and the (Ca+Mg)/(P+Si) ratios ranged from 1.4-1.6 
indicating that the chemical composition was closer to β-TCP. Similar to the observations made 
from the FT-IR spectra, this may suggest that mixed Mg and Si doped CaP phases of HA and β-
TCP are being deposited on the surface of the alloy. Work by Gray-Munro et. al on AZ31 using a 
similar method suggested that Mg doped HA was being formed, however, upon including 
silicates this does not appear to yield purely HA [225]. 
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Figure B.1 FT-IR spectra of iv) β-TCP, iii) PB1, ii) PB2, and i) PB3 coated samples as prepared on a) 
AZ31 and b) Mg-4Y. Also included are the FT-IR spectra of iv) uncoated, iii) PB1, ii) PB2, and i) PB3 
samples after incubation for one week in DMEM on c) AZ31 and d) Mg-4Y are also shown. 
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On Mg-4Y the Ca/P ratios were again between 1.3 and 1.5, however, on PB1 and PB2 the 
(Ca+Mg)/(P+Si) ratios were between 1.5 and 1.6, while on PB3 they were much closer to 1.3. 
This is due to a much larger amount of Si being deposited on Mg-4Y compared to AZ31, as is 
illustrated in Figure B.2 e) and f). The Si/(P+Si) ratios on PB2 and PB3 for AZ31 were close to 
0.02 whereas on Mg-4Y they were closer to 0.07 and 0.2, respectively. Figure B.2 c) and d) 
illustrates representative EDX plots for data obtained from PB1 and PB3 coated Mg-4Y samples, 
where the Si peak can be observed at approximately 1.75 KeV and is correspondingly absent for 
the PB1 coated samples. Therefore, by FT-IR and EDX it can be confirmed that Ca, P, and Si 
have been deposited on the surface of both alloys. 
Such large amounts of Si probably indicate that magnesium and calcium silicates are also 
being deposited. This is not of concern with respect to bioactivity as calcium and magnesium 
silicates have also been shown to have favorable bioactive properties [78, 229]. The increased 
amounts of silicon may be due to the varying stabilities of the hydroxide layers formed on the 
two alloys. Yttrium is known to increase the protectiveness of the surface layer of Mg alloys due 
to the formation of the tenacious Y2O3 coating, however, Y intermetallics may accelerate 
corrosion [230]. Perhaps once the hydroxide layer reacted with acidic environment in the 
phosphating bath, the surface of the pristine Mg-4Y substrate becomes more corrosive. This 
enhancement in the corrosion of the substrates will increase the local pH of the solution and will 
accelerate the deposition of Ca, P, and Si by nucleation and precipitation. Thus the presence of Y 
intermetallics possibly explains the increased presence of Si on the CaPs coating on Mg-4Y 
compared to AZ31. 
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B.3.2 In-Vitro Degradation 
Coated and uncoated substrates were then immersed in DMEM, which was refreshed daily, and 
kept in in vitro conditions in order to determine the effect of the various coating conditions on 
stability. Interestingly, the coatings did not appear to have a significant impact on corrosion 
protection based on pH measurements alone. For both alloys at all conditions, the pH remains 
approximately 8.4-8.7 over the two week period. Therefore, one hypothesis may be that the 
formation of a Mg(OH)2 layer on the uncoated samples occurs rapidly enough that after 24 
hours, for which the first measurement was taken, there is not a measurable difference observed 
between coated and uncoated groups. Also based on pH measurements, it appears that it is the 
presence of this protective layer that governs degradation as well as the interactions of cells and 
biological fluids with Mg alloy substrates. 
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Figure B.2 SEM images of Mg4Y samples coated in a) PB1 and b) PB3 as well as EDX plots taken from 
Mg4Y samples coated in c) PB1 and d) PB3. EDX mapping was also performed illustrating the distribution of 
Ca (blue), P (green), and Si (pink) for (e) AZ31 coated in PB3 and (f) Mg-4Y coated in PB3. Scale bars are 
500 μm. 
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Figure B.3 The ICP-OES measurements of a) Mg, b) Zn, and c) Al in collected DMEM from AZ31 
coated and uncoated samples as well as d) Mg and e) Y from MgY coated and uncoated samples. 
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ICP was used to determine ionic concentrations of collected DMEM in order to further 
evaluate the effect of coatings on the degradation of both substrates. Measurements of the ionic 
concentrations by ICP not only gives the degradation characteristics of the substrate, but also can 
be used to assist in the evaluation of toxicity. Ionic toxicity in vivo is of great concern as studies 
have shown that aluminum may accelerate brain aging and may be neurotoxic in larger 
concentrations. Excess aluminum can lead to increased levels of inflammatory cytokines and 
eventually the onset of Alzheimer’s disease [231]. In the case of Zn, the adult body naturally 
consists of 2-3 g and Zn is an essential dietary supplement, however, excess amounts of Zn can 
also be toxic [232]. There have been fewer reports on the long term toxicity of yttrium, but its 
more frequent use as an alloying element in magnesium based implant devices increases the 
necessity for such studies.  
For AZ31 coated samples (Figure B.3: a, b, and c), ICP-OES measurements show that the 
pristine alloy released larger amounts of Mg, Al, and Zn compared to the coated samples over 
the period of interest. Also for the pristine uncoated alloy, the release profiles of Mg, Al, and Zn 
do not show similar trends, which may indicate that intermetallics exist and alter the rate of 
release of individual ions due to varying composition and solubility. For Mg, the coated samples 
show a similar release profile and appear to have stabilized at approximately 300 ppm, however, 
the uncoated samples appear to stabilize between 600-800 ppm. Al showed a very interesting 
release profile with the uncoated samples reaching a maximum of 14 ppm and then decreasing to 
similar concentrations of the coated samples, which were consistently less than 1 ppm for the 
entire period of interest. This extremely high release of Al from uncoated AZ31 is alarming due 
to the fact that Al is a well-known neurotoxin, as mentioned previously. This may perhaps 
indicate that AZ31 is not the best choice of alloy for the repair of craniofacial defects, 
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considering the large amounts of Al that will be released in close proximity to neural tissues 
during degradation. For Zn, there is an initial burst release for the uncoated alloy that appears to 
decrease upon application of the CaP coatings since the coated samples appear to stabilize at 
approximately 1 ppm much sooner than the uncoated sample. Interestingly, PB2 and PB3, both 
Si containing coatings, also have a slight initial burst release, whereas no initial burst was 
detected for PB1. This may suggest that PB1 is the coating condition on AZ31 that is most stable 
and likely desirable. 
ICP-OES measurements on Mg-4Y (Figure B.3: d and e) coated samples showed the 
opposite trend compared to AZ31 with the coated samples releasing almost four times Mg and an 
order of magnitude more Y in comparison to the uncoated samples for the time period of interest. 
A similar release profile is observed for both Mg and Y for the uncoated samples where the 
concentrations are initially high and then decrease and become stable. This period between 1 and 
3 days is perhaps when a passivation layer of Mg(OH)2 is formed on Mg-4Y, limiting the 
degradation of the alloy and reducing the transport of Mg ions into the surrounding DMEM. ICP 
measurements for Mg concentration for both alloys were not corrected for the Mg already 
present in media in order to show the total amount of Mg cells may potentially be exposed to 
during experiments although serum proteins are known to inhibit corrosion. 
It is interesting in both cases that although the coated and uncoated samples have such 
different concentration values and profiles in DMEM, there is no great difference between pH 
for the coated and uncoated samples as well as between the two different alloy systems. In both 
cases the pH is slightly basic, 8.4-8.7, which can only be due to the dissolution of Mg(OH)2 as a 
corrosion product. The coated samples are subjected to an alkaline treatment and are coated in 
aqueous environments, therefore there will be Mg(OH)2 present on the surface of these alloys 
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prior to observing their behavior in DMEM. For AZ31, the difference in Mg concentration 
between coated and uncoated groups is much smaller than that for Mg-4Y, for which the coated 
samples appear to release almost 4 times as much Mg and approximately 10 times more Y. 
Therefore, the trends in behavior must be due to the presence of intermetallics of the alloying 
elements as well as the stability of the corrosion products. 
The fact that Mg concentrations for the AZ31 uncoated samples are only slightly higher 
than the coated samples suggests that the corrosion products of AZ31 are fairly stable. The 
opposite is true for Mg-4Y since for the coated samples, which already contain Mg(OH)2  on 
their surface, the Mg concentrations were much higher than the uncoated samples. Although 
evident from the ICP-OES results, this change is probably too small to be shown by pH 
measurements alone, perhaps if DMEM was not refreshed daily this change would be more 
noticeable by pH measurements as well. 
The drastic difference in the dissolution behavior of Mg-4Y coated samples irrespective 
of the coating containing Si in comparison to the pristine Mg-4Y sample could be attributed to 
several factors such as film thickness, instability of the corrosion products, poor adhesion on the 
film, and compositional in homogeneity of the Mg-4Y alloy. The exact reason for the variation 
in the dissolution behavior in the two alloy systems used is unclear at the moment warranting 
more work which is currently on-going.  
The surfaces of both uncoated and coated substrates were analyzed by FT-IR after 
incubating in DMEM for one week and are illustrated in Figure B.1 c) and d). For CaP coated 
AZ31 samples (Figure B.1, a: i), ii), and iii) and c: i), ii), and iii)), there is not a significant 
difference in the FT-IR spectra prior to and after immersion in DMEM. For uncoated AZ31 
(Figure B.1, c: iv)), the broad peak due to moisture adsorbed to the surface of the samples made 
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it difficult to detect the presence of the hydroxyl bending band at 3600 cm-1, however, the 
presence of PO43- stretching and bending modes, as seen with coated samples, were detected 
along with those of CO32- at 1500 cm-1 and 900 cm-1, as were previously reported on pure Mg 
kept in HBSS with and without FBS [233]. For CaP coated Mg-4Y samples (Figure B.1, b: i), ii), 
and iii) and d: i), ii), and iii)), after immersion in DMEM increased amounts of CO32- appeared to 
form on the coated substrates. Similarly to uncoated AZ31, for uncoated Mg-4Y (Figure B.1 d: 
iv)) CO32- and PO43- were once again confirmed to have formed and the presence of OH- was 
difficult to confirm by the FT-IR spectra alone. These results confirm those observed by ICP 
where CaP coatings appear to protect AZ31 to a greater extent in comparison to Mg-4Y. 
Standard solutions to be used to study the in vitro degradation of Mg alloys, closely 
mimicking in vivo conditions, are yet to be generally accepted. Significantly slower corrosion 
rates have been observed during in vivo experiments in comparison to those performed under in 
vitro conditions, which is believed to be due to the interactions of proteins with the degrading 
alloy [187]. Furthermore, for in vitro experiments there is a strong dependence on the 
composition of the solution being used, more specifically, the concentrations of chloride ions and 
serum proteins [234]. In the current study, the major goal was to compare the capability of 
various coating conditions to protect the underlying substrate. As a result, a physiologically 
relevant solution which didn’t slow down corrosion to the point where it may be difficult to 
observe differences between groups was required. In order to meet these criteria DMEM without 
FBS was used, however, further studies are required to evaluate the interaction of proteins with 
the alloy surface and the capability CaP coatings to adsorb specific proteins which may influence 
cell adhesion and degradation characteristics. 
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B.3.3 In-Vitro Cytocompatibility 
MC3T3-E1 murine osteoblasts were then used in order to study cell attachment on coated and 
uncoated alloys. After 3 days of culture for AZ31 coated and uncoated samples in osteogenic 
media, PB1 and PB3 were the conditions that showed the best cell attachment (Figure B.4: a), b), 
c), and d)). This result was confirmed by SEM as there were quite a few cells on PB1 and PB3 
which appeared to be attached and well spread, however, on the uncoated AZ31 there were fewer 
attached cells (Figure B.5: a), b), c), and d)). In contrast, after 3 days of culture in osteogenic 
media, for Mg-4Y coated and uncoated samples, the uncoated substrate and PB3 were the 
conditions that showed the best cell attachment (Figure B.4: e), f), g), and h)). From SEM this 
result was also confirmed as it is clearly evident that cells are well attached to the uncoated 
substrate and much fewer were observed on the coated substrates for which PB3 was the best 
condition (Figure B.5: e), f), g), and h)). 
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Figure B.4 Live/dead imaging at a magnification of 10X of a) uncoated AZ31 and AZ31 immersed in b) 
PB1, c) PB2, and d) PB3 as well as uncoated e) Mg4Y and Mg4Y immersed in f) PB1, g) PB2, and h) PB3 
after 3 days of culture. 
   
ICP-OES results confirmed that the uncoated Mg-4Y substrates released the lowest 
amounts of Mg and Y for the period of interest. The much lower yttrium amounts released 
perhaps contribute to the increased cell attachment over the 3 day period since yttrium may be 
toxic in higher concentrations. Previous studies have shown that the physical properties of the 
surfaces of biomaterials, such as surface roughness, and not just its chemical functionality can 
greatly influence cell attachment and proliferation [165, 235, 236]. Uncoated samples were 
polished with a relatively high grit SiC polishing paper, up to 4000. Surface roughness is not 
something that has been taken into account between conditions and may be influencing cell 
attachment since there is potentially a large discrepancy in roughness between the uncoated and 
coated samples. This may explain the relatively high attachment seen on uncoated Mg-4Y in 
comparison to the uncoated AZ31 samples wherein the larger amounts of Zn and especially Al 
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released from AZ31 in comparison to the coated samples may explain the discrepancy between 
coated and uncoated samples for that system. 
 
 
Figure B.5 SEM images of fixed samples at a magnification of 500X on a) uncoated AZ31 and AZ31 
immersed in b) PB1, c) PB2, and d) PB3 as well as uncoated e) Mg4Y and Mg4Y immersed in f) PB1, g) PB2, 
and h) PB3 after 3 days of culture. 
 
In comparing the two alloys it appears that the Mg-4Y alloy itself is more biocompatible 
than AZ31 based on the results for the two uncoated samples. Interestingly, after 3 days of cell 
culture, bubbles are clearly visible on the degrading Mg-4Y and AZ31 control samples and less 
on most of the coated sample live/dead images. On the coated substrates it is interesting that the 
PB2 condition for both alloy systems showed the least cell attachment. This coating procedure 
was optimized for AZ31, which is evident by the increased attachment on the two best AZ31 
conditions in comparison to the two best Mg-4Y conditions, however, it is obvious that the 
presence of silicon in the coating indeed plays a role in increasing cell attachment as PB3, the 
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coating with the greatest silicon substitution, consistently shows an increased cell attachment 
compared to the other conditions on both alloys. 
B.4 CONCLUSIONS 
Ca, P, and Si were deposited onto the surface of both AZ31 and Mg-4Y by phosphating bath 
methods. A much larger amount of Si was deposited on Mg-4Y. These fairly inhomogeneous 
coatings did not greatly reduce the corrosion of magnesium alloys based on the pH 
measurements alone, however, the amount of Mg and Zn released from coated AZ31 surfaces 
were much lower than the uncoated control. As a result, PB coatings were much more effective 
at influencing the bioactivity of AZ31 substrates compared to Mg-4Y possibly due to the surface 
condition and compositional variations on the surface of Mg-4Y alloys. While the phase 
composition and crystallinity remain unknown, the presence of silicon in the coatings appeared 
to have a favorable influence on cell attachment for both alloy systems. Therefore, these results 
illustrate that the doping of CaP coatings on degradable alloy substrates with Si may be a useful 
approach to enhance cell attachment and proliferation. 
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APPENDIX C 
NOVERL SOL-GEL DERIVED CALCIUM PHOSPHATE COATINGS ON A MG4Y 
ALLOY 
C.1 INTRODUCTION 
Each year a few million patients need a bone graft or bone graft substitute to repair and remodel 
a bone defect resulting from trauma or disease. In spite of a large number of available bone graft 
substitutes, resorbable implants with adequate mechanical strength have gained considerable 
interest in the field of orthopedic and craniofacial bone regeneration [101, 237]. Recently, many 
researchers have advocated the use of magnesium alloys as a promising biodegradable metal 
based implant material. The interest in magnesium alloys has been particularly motivated due to 
their comparable mechanical properties to natural bone [59, 187, 238]. The biocompatibility and 
biodegradability of Mg also make them attractive. Recently, many researchers have reported the 
in vitro and in vivo biocompatibility and degradability of magnesium based alloys [59, 187, 188, 
239-243], however, the clinical applications of Mg based implants at present are very limited due 
to their relatively high degradation rate accompanied by hydrogen evolution under physiological 
conditions and limited bioactivity [188, 238, 244]. One approach to control the high corrosion 
rates of magnesium based alloys is the development of novel alloy compositions [59, 243, 245, 
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246]. Witte et al reported that Mg alloys containing rare earth elements seemed to be suitable for 
orthopedic applications [59, 243, 245, 246]. Recently, MgZnCa metallic glasses have been 
reported to have excellent degradation characteristics without any clinically observable hydrogen 
evolution and better cyto-compatibility in comparison to pure magnesium and other crystalline 
magnesium alloys [188, 247]. Another approach to reduce the corrosion rates of these novel 
alloys is coating with aluminum or titanium, and magnesium fluoride [114, 225, 240-242, 248, 
249]. 
Although these different techniques of alloying, processing, and coating may improve the 
bio-corrosion resistance of magnesium alloys to a great extent, it is unlikely that these techniques 
can significantly alter the cell and tissue response, especially at the early stage of the implant 
[250]. Therefore, distinct alterations of implant surfaces may lead to different and unique 
chemical as well as physical surface properties, that eventually could lead to changes in the 
bone-to-implant interactions [250]. Thus, tailoring of the magnesium based biomaterials surfaces 
with a suitable inorganic and organic coatings may be of immense importance in increasing 
biocompatibility and osteo-conductivity [250, 251]. These goals can be achieved by coating the 
Mg alloy surface with a porous layer of bioactive materials of calcium phosphates (CaPs), 
especially hydroxyapatite (HA), which is the major inorganic mineralized component of natural 
bone. To improve the bioactivity of these calcium phosphate coatings further, elements such as 
Zn, Mg, Si, etc. can be incorporated into the calcium phosphate structure [238, 252-257]. In this 
regard, several studies have alluded to the important role of silicon on bone formation and 
growth under in vitro and in vivo conditions [253]. It is also well established that bio-ceramics 
including Bioglass [252], calcium silicate [258, 259] as well as Si-containing calcium phosphates 
[253] show superior bio-activity and bone forming ability. However, it should be noted that the 
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exact role of silicon on bone formation remains controversial [228]. In recent years, some efforts 
have been made to coat and modify surfaces of different Mg alloys using various phases of 
calcium phosphates (CaPs). Many methods are known for generating CaPs coatings on metallic 
substrates, especially on Ti alloys, namely immersion in simulated body fluids, wet chemical 
method, sol-gel method, plasma spraying method, RF sputtering, electrophoresis, cathodic 
deposition, etc [63, 251]. However, only a few of these techniques can be used to coat 
magnesium based alloys as most of these alloys are reactive to water based solutions and are 
very sensitive to high temperature processes due to their low melting points. To minimize some 
of these problems most of the techniques used so far to coat magnesium alloys have been electro-
deposition, deposition in simulated body fluids and phosphating bath (solution of phosphoric 
acid, calcium phosphate, zinc phosphate and sodium nitrates) coatings [115, 225, 248, 249, 260-
262]. Results showed that these CaPs based coatings improve the in vitro and in vivo bio-activity 
and biocompatibility of the Mg-based alloys [241, 261-264]. Although it has been reported that 
these coatings also alter the corrosion characteristics of native alloys, most of these CaPs based 
coatings are porous and contain cracks, therefore, they are not expected to significantly alter 
corrosion characteristics [114, 115, 225, 241, 249, 260, 261]. 
Sol-gel coatings are well studied for coating titanium-based orthopedic complex shaped 
scaffolds and generally result in porous, nano-crystalline, and thin to thick coatings with 
controlled micro-structure at relatively low processing temperatures [63, 265-267]. The other 
major advantage of sol-gel coating is that different elements can easily be included in the gel 
formation process and thus can be incorporated in the final structure of CaPs coatings. 
Interestingly, to the best of our knowledge no attempts so far have been reported on coating Mg 
alloys with CaPs structures using the sol-gel technique. This article reports the preliminary 
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results on an ethanol based sol-gel derived un-substituted calcium phosphates (CaPs) and 
different Si-containing CaPs (Si-CaPs) coatings on Mg-4Y substrates and subsequent 
characterization of the obtained coated films using different analytical techniques. Furthermore, 
this work also evaluates the in vitro biocompatibility and the influence of these coatings on the 
degradation characteristics of the alloy. 
C.2 MATERIALS AND METHODS  
C.2.1 Preparation of CaPs and Si-CaPs Coatings 
Mg containing 4% Y (Mg4Y) ingots were obtained from GKSS Research Centre, Institute of 
Materials Research. These ingots were machined to obtain substrates of 10 mm x 10 mm x 0.8 
mm and these substrates were annealed at 525oC under an inert atmosphere for 8 h to avoid any 
segregation of the alloying elements prior to coating. The substrates were cleaned using acid 
etching (3% nitric acid in ethanol) and washed repeatedly with acetone. The substrates were then 
polished with 800 grit and finally with 1200 grit SiC paper and cleaned under ultra-sonication 
using acetone. Calcium phosphate sol-gels were synthesized using calcium nitrate (Acros 
Organics, Thermo Fisher Scientific, USA) and phosphorus pentoxide (Sigma Aldrich) as 
precursors, with a Ca/P ratio of 1.67 as described by Kim et al. [267], corresponding to the 
hydroxyapatite (HA) composition, Ca10(PO4)6(OH)2. Si-containing samples were prepared by 
mixing 0.01 mol of calcium nitrate, (6-x) X 0.0005 mol of phosphorus pentoxide, and x X 0.001 
mol of Tetraethyl orthosilicate (TEOS, Aldrich) in 5ml 190 proof ethanol (Pharmco-AAPER), 
where x= 0.0, 1, 2, and 3 and Ca/P+Si ratio of 1.67. The wt% of silicon was calculated assuming 
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full conversion of TEOS into silicon dioxide (SiO2) using Equation C.1, where MSi and MSiO2 are 
the molecular weights of Si and SiO2, respectively, and MHA is the gram molecular weight of HA 
expressed as Ca10(PO4)6(OH)2. The value of wt. % of Si for x=0.0, 1, 2 and 3 were found to be 
0.0, 2.6, 5.0 and 7.1, respectively. 
Equation C.1 Wt. % Si = (xMSi100)/(MHA+xMSiO2) 
For all the compositions, viscous gels were formed and these viscous gels were heated to 
60oC and coated on the substrates using a dip coater (Desktop Dip Coater, Model No. EQ-
HWTL-01-A, MTI Corporation, USA) with a withdrawal speed of 450 µm/sec. Coated 
substrates were dried at 60oC for 1.0 h and subsequently heat treated to 450 °C for 24.0 h in 
argon, depositing a layer of CaPs onto the surface of the alloy. These singly coated substrates 
were used for all the materials characterizations and in-vitro studies except X-ray diffraction. 
Multiple coated films (three coatings) were used for X-ray diffraction studies. For multiple gel 
coated films substrates were dried at 60oC for 1.0 h after each coating and re-coated. Total three 
gel coatings were done before heat treatment to 450 oC for 24 h in argon. 
C.2.2 Characterization of CaPs and Si-CaPs Coatings and Powders 
After completion of the coatings, the gels were dried overnight on a hot plate at 60oC in air. A 
part of the as dried gel powders were heated to 450oC for 24.0 h in argon and the other part of the 
as dried gels were heated to 750oC for 6.0 h in argon. The as dried powder, heat treated powders 
and coatings were characterized by X-ray diffraction (XRD) in a Philips X’Pert PRO 
diffractometer using Cu Kα radiation with a Si-detector (X’celerator). The X-ray generator was 
operated at 45 kV and 40 mA at a 2Θ range of 10-90 employing a step size of 0.033 and 90.17 
sec time step. The surface morphology of the coatings were studied using a scanning electron 
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microscope (Philips-XL30 FEG, Philips) operating at 10.0 kV and all the samples used for SEM 
analysis were coated with Pd using a sputter coater system. FT-IR was performed on the 
different heat treated sample powders as well as on the obtained films using a Nicolet 6700 
spectrophotometer (Thermo Electron Corporation) using a diamond ATR Smart orbit. Spectra 
were obtained at 1.0 cm-1 resolution averaging 32 scans. The chemical compositions of the films 
were studied by energy dispersive X-ray spectroscopy (EDX Genesis, EDAX Inc.). The thermal 
analysis (TG-DSC) of the dried gel powders were carried out in a STA 409 PC thermal analyzer 
(NETZSCH Instruments) under argon atmosphere employing a heating rate of 10oC-min-1. 
C.2.3 In-Vitro Biodegradation 
The in vitro degradation characteristics of the uncoated and coated substrates (weight 175 ± 25 
mg) were tested in DMEM media without 10% Fetal Bovine Serum (FBS). In order to determine 
the pH, magnesium ion and yttrium ion concentration, each scaffold was completely immersed in 
2.0 ml of media and the media was changed and replaced with fresh media after each 24.0 h. For 
each coating groups (i.e. x=0.0, 1, 2 and 3), three samples were used. The extracted media was 
used to measure the pH (φ 350, Beckman Coulter) and was stored at 4oC before they were used 
for Mg and Y ions concentration analysis using Inductively Coupled Plasma (ICP, iCAP 6000 
series, Thermo Electron Corporation). Each ICP sample was measured in triplicate. The surface 
morphology of the uncoated and coated samples kept for a desired period of time in media were 
dried overnight in air and analyzed using SEM and EDX. 
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C.2.4 Cell Culture 
Murine osteoblast cell line, MC3T3-E1, was obtained from ATCC (Manassas, VA). Cells were 
cultured under 37°C, 5% CO2, and 95% relative humidity in minimum essential medium alpha 
(MEM α, Gibco, Grand Island, NY) containing 10% fetal bovine serum (FBS, Atlanta 
Biologicals, Lawrenceville, GA) and penicillin streptomycin (P/S, Gibco, Grand Island, NY). 
Cells at third to seventh passage were used in this experiment. For each group, at each time 
points, three coated substrates were used. All the substrates were sterilized under UV for at least 
60 min. These sterilized substrates were placed in 12 well plates following which cells were 
seeded on them at a concentration of 120,000 cells/well. 1 milliliter of media per cm2 of surface 
area was used and the culture media was changed daily. 
C.2.5 Live-Dead Assay 
Cell viability was assessed using live/dead staining (Invitrogen, Live/Dead Staining Kit). After 
day 1, 2 and 3 of culture during which media was changed daily, each sample was washed with 
phosphate buffered saline (PBS, Lonza BioWhittaker* Buffers and Buffered Salines, 1x, 
0.0067M (PO4) without Calcium or Magnesium) and then incubated for 40 minutes with the 
live/dead stain diluted in PBS. After incubation, samples were washed twice with PBS prior to 
imaging. Cells were then imaged by an inverted microscope with the fluorescence illuminator 
(CKX41, Olympus, Olympus America Inc.). Photos of the cells were obtained with a digital 
camera (Olympus DP25 Microscope Camera, Olympus, Olympus America Inc.). For each 
substrate images were taken from three to six different locations to obtain an overview of the cell 
attachments. Numbers of live, dead cells and % area coverage by live cells were counted from 
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the images using ImageJ software (National Institutes of Health, USA, rsbweb.nih.gov). For live 
dead analysis at least 2000 cells were counted for each sample. Cells were then fixed by using 
4% paraformaldehyde and incubating for 20 minutes. After fixing, samples were subjected to 
alcohol dehydration and coated with palladium in order to observe cell morphology by SEM. 
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Figure C.1  FT-IR spectra of (a) Ca(NO3)2·4H2O, (b) P2O5, (c) tetraethyl orthosilicate (TEOS), (d) dried 
gel of x = 0, (e) dried gel of x = 1, (f) dried gel of x = 2, and (g) dried gel of x = 3. 
C.2.6 Cytoskeletal Staining 
Cells were fixed with 4% paraformaldehyde for 15 minutes at room temperature. After washing 
three times with PBS to remove any remnants of paraformaldehyde, cells were stained with 
Tetramethylrhodamine B isothiocyanate conjugated phalloidin (Sigma-Aldrich) and washed with 
PBS three times. Subsequently, cells were counterstained with DAPI for nuclear staining. The 
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stained cells were viewed by an inverted microscope with the fluorescence illuminator (CKX41, 
Olympus, Olympus America Inc.). Photos of the cells were obtained with a digital camera 
(Olympus DP25 Microscope Camera, Olympus, Olympus America Inc.). 
C.3 RESULTS AND DISCUSSION 
The reaction of calcium nitrate with phosphorous pentoxide or with stoichiometric mixture of 
P2O5 and TEOS in ethanol resulted in the formation of a transparent gel at ambient temperature. 
All these gels showed a reversible and reproducible flow behavior, i.e. high viscosity at low 
temperature and low viscosity on heating; only when the heating and cooling operations were 
performed under an air tight sealed glass containers. On heating these gels in air lead to the 
formation of a translucent gel due to formation of few nanometers sized small colloidal sols, and 
upon further heating over time, this translucent gel changed to a sol solution. In order to 
understand the gelation process, FTIR analyses were performed on the dried gel powders 
together with the starting precursors and are shown in Figure C.1. The presence of a broad band 
3450 (not shown) and 1638 cm-1 can be assigned to -OH stretching modes for all the dried gels 
[265-269]. The presence of bands at 741, 812, 1045, 1350 and 1450 cm-1 are the characteristics 
peaks of the nitrate as evident from the spectrum of calcium nitrate as shown in Figure C.1a 
[268]. The presence of bands from 925 to 1080 cm-1 is related to the P-O-C stretching modes 
[265-269]. It is generally believed that during dissolution in ethanol, phosphorous pentoxide and 
calcium nitrate react to form a complex compound [(OCH2CH3)y’ (NO3)2-y’ Ca]z[P(OCH2CH3)5-
x’(OH)x’]z’ where the z/z’ ratio is determined by the Ca/P ratio and the degree of the 
polymerizations determined by the gel structure [265-269]. The addition of TEOS in the gelation 
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process does not change the FTIR spectra much, however, the peaks between 850 and 1250 cm-1 
becomes more distinct with the appearance of two peaks at 540 and 445 cm-1 for x=3 (Figure 
C.1, g). The peak at 540 cm-1 is due to the Si-O-Si vibration and peak at 445 cm-1 assigned to a 
combination of Si-O-P and Si-O-Si bending vibrations [270, 271]. The weak and broad bands ~ 
1100 cm-1 can be assigned to a combination of P-O stretching of the P-O-P and P-O-Si bridging 
units [270, 271]. From these results it can be said that the structure of the Si containing gels 
consists of a mixed frame work, built of [SiO4] and [PO4] tetrahedral networks, and can thus be 
constituted to be integrated with the complex polymeric chain discussed above. 
Figure C.2 shows the results of DSC-TG analysis for as prepared dried gel for pure (x=0) 
and for a representative Si-containing (x=2) dried gel powders in the temperature range 25 to 
1000oC under argon atmosphere. The nature of the DSC-TG curves for un-substituted and Si-
containing gels do not show any striking differences and the plots look similar to those reported 
in the literature [267, 269]. The TG curves for both the samples show a constant weight loss up 
to 550oC and the weight remains constant on further increase in temperatures. However, there are 
some changes in the exothermic peak positions in the temperature ranges of 250-400 0C for the 
pure and Si-containing gels and these changes reflect some major rearrangements in the bonding 
and interactions in the gel structures due to the incorporation of the silicon. The major 
endothermic peak at 550oC associated with a rapid weight loss in the TG (Figure C.2) is believed 
to be due to the decomposition of nitrates and organics [267, 269]. From these thermal analysis 
results it appears that a temperature of ~ 550oC is required for the formation of calcium 
phosphate. Hence it was concluded that the gel coated substrates should be heated to at least at 
550oC to get an impurity free coating. However, present experimental studies indicate that 
heating the Mg4Y substrates to higher temperatures, especially above 500 oC for extended period 
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of time, may lead to deformation of the substrates due to the temperatures being close to the 
melting point, and thus demand a lower gel decomposition temperature. Since the major 
decomposition peak due to the nitrates decomposition occurs at ~ 450oC, it is reasonable to 
believe that maintaining coatings at 450oC for a long time would result in complete 
decomposition of the precursors. 
 
 
Figure C.2 The DSC and TG curves of the as dried gels.  
 
To verify this, as dried gel powders were heated to 450oC for 24 h in argon and thermal analyses 
were performed on these heat treated gel powders. The DSC-TG of the heated treated samples 
show (not shown here) a weight loss of ~ 4% and ~ 6% in TG, for x=0 and x=3, respectively, 
and absence of any characteristics endo- or exothermic peaks for decomposition of the 
precursors. This weight change can be due to the presence of some un-decomposed nitrates and 
 252 
carbonates [268]. These results indicate that the decompositions of the precursors were not fully 
completed and all the gel coated Mg4Y substrates were heated to 450 oC for 24 h in argon 
atmosphere may contain traces of impurities, however, any higher temperature heat treatments 
were not performed to avoid any deformation of the substrates.  
The X-ray diffraction (XRD) patterns of the heat treated multiple-coated Mg4Y 
substrates are shown in Figure C.3. XRD patterns of the film corresponding to x=0 (Figure C.3b) 
shows presence of peaks other than the substrates corresponding closely to β-tricalcium 
phosphate (β-TCP) and hydroxyapatite (HA). The presence of β-TCP in the multiple coated 
films can be due to the diffusion of magnesium from the substrate underneath. It is well known 
that magnesium ions stabilize β-TCP in preference over HA [134]. It should be also noted that 
the reaction of magnesium with phosphate leads to the generation of excess calcium, the overall 
Ca/P ratio goes up and hence can favor the formation of HA. For all the silicon containing films, 
XRD patterns show the presence of HA only (Figure C.3d-f). The XRD results also indicate that 
silicon possibly stabilizes the HA phase and diffusion of magnesium from the substrate has no 
effect on the crystalline phase evaluation. It is generally believed that single phase silicon 
substituted HA (Si-HA) can be formed for Si addition up to 1.97 wt% [253, 272]. Addition of 
excess silicon generally leads to a mixed phase system of Si-TCP, Si-HA, β-TCP and an 
amorphous phase of variable Si-Ca-P composition [253, 273]. In the present work, the amounts 
of Si that have been used (2.6 and 7.1wt % for x=1 and x=3, respectively) are in excess than the 
amount of silicon that can be incorporated into the HA structure, and thus formation of mixed 
phases can be expected. However, the absence of any crystalline peaks other than HA in the 
coated films heated to 450oC does not obviate the presence of amorphous phases and the 
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presence of amorphous phase of variable Si-Ca-P compositions or amorphous SiO2 cannot 
certainly be discounted. 
FTIR spectra of the coated substrates corresponding to x=0, 1, 2 and 3 heated to 450oC 
for 24 h in argon are shown in Figure C.4. For all the samples the major bands in the range 570 
and 605 cm-1 are due to O-P-O bending mode and the intense band in the range 960-1088 can be 
attributed to P-O stretching vibration modes [265, 266, 269]. Carbonate group substituting the 
PO43- ions in the apatite structure can be detected in all the heat treated coatings by the 
appearance of bands at 875, 1410 and 1450 cm-1[270]. In spite of these similarities in the FTIR 
spectra between the non-silicon and silicon containing coatings (Figure C.4 b, d-f), some 
differences can also be observed. A weak absorption band at 630 cm-1 attributable to the OH-1 
vibration mode can be seen in the spectra corresponding to the x=0, but absent in samples where 
silicon is introduced. This is due to the substitution of PO43- by SiO44- which will lead to a 
decrease in OH-1 group to maintain the charge balance. For the silicon substituted samples, 
appearance of a weak band at ~ 520 cm-1 can be observed and this band can be assigned to Si-O-
Si vibration [270, 271]. The substitution of phosphate by silicon will lead to incorporation of 
silicate ions into some of the phosphate sites of the lattice, which will consequently change the 
bonding and symmetry of the PO43- groups and this should be reflected in the FTIR spectra of 
these Si-substituted samples. 
 
 
 
 
 254 
 
Figure C.3 X-ray diffraction patterns of coated samples heat treated to 450◦C, 24 h, in argon together 
with the standard diffraction patterns (a) JCPDS# 9-169 of β-tricalcium phosphate (β-TCP), (b) x = 0, (c) 
JCPDS #9-432 for hydroxyapatite, (d) x = 1, (e) x = 2, and (f) x = 3. 
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Figure C.4 FTIR spectra for the standard β-tricalcium phosphate (β-TCP), standard hydroxyapatite 
(HA) powders and gel coated substrates treated to 450˚C, 24 h, in argon (a) β-TCP (HIMED, New York, 
USA), (b) x = 0, (c) HA (ACROS organics), (d) x = 1, (e) x = 2, and (f) x = 3. 
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These changes were indeed observed in the FTIR spectra for silicon containing coatings, 
the contribution of the intense Si–O–Si asymmetric stretching mode around 1080 cm-1 leads to 
broadening of the bands and the appearance of three weak additional peaks at 940, 890 and 830 
cm-1 [270, 271]. Presence of these peaks leads to broadening of the band between 780 to 1140 
cm-1 (Figure C.4, b-d). Similar observations have also been reported for Si-HA powders and 
coatings [270, 274]. From the analysis of XRD and FTIR results it can be concluded that Si-
containing CaPs coatings on the Mg4Y substrates are of calcium phosphate having 
hydroxyapatite structure (HA) and also confirm the incorporation of silicate ions into the apatite 
lattice. The present coatings contain excess Si than required to substitute into the HA structure 
completely as discussed above and thus there may be some other phases of Ca-Si-P and SiO2 
which may also be present in the coatings. However, from these FTIR results it is difficult to 
confirm that all these phases are indeed present. From these XRD and FTIR results it is also 
difficult to ascertain that all the silicate ions have entered into the apatite lattice and there is a 
possibility that certain amount of silicon remains on the HA surface in the form of monomeric or 
polymeric SiO44- [275].  
Figure C.5 shows the surface microstructure and the EDX results of the calcium 
phosphate coated Mg4Y substrates. The thickness of these coatings from the cross sectional 
SEM images were found to be ~ 50 (±10) µm. Although the coating looks continuous and 
homogeneous at low magnification for un-substituted coatings (Figure C.5 a), several cracks can 
be seen at higher magnifications (Figure C.5 b). Also at higher magnifications, a porous netlike 
coating was clearly observed and the coating layer consists of nano-sized calcium phosphate 
(Figure C.5c, 5f). Very similar results were obtained for all the Si-CaPs coated substrates, 
however, with higher silicon content more cracks on the coatings can be seen (Figure C.5e). The 
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EDX spectrum, as shown in Figure C.5g, for the un-substituted coating shows the presence of Ca 
and P and the ratio of Ca/P was ~1.6, thus confirming the presence of calcium phosphate. For the 
Si-containing coatings, the EDX clearly show the presence of silicon in these coatings and the 
amounts (weight percentage) of silicon in the coatings were very close to the starting 
stoichiometric amounts (Figure C.5h). Thus the EDX and FTIR results show the incorporation of 
silicon in the coatings. 
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Figure C.5 SEM micrographs at different magniﬁcations and EDX results on the coated substrates heat 
treated to 450◦C, 24 h, argon, (a) SEM of x = 0 coatings; scale bar = 100 m, (b) SEM of x = 0 coatings; scale 
bar = 10 m, (c) SEM of x = 0 coatings; scale bar = 500 nm, (d) SEM of x = 2 coatings; scale bar = 100 m, (e) 
SEM of x = 2 coatings; scale bar = 10 m, (f) SEM of x = 2 coatings; scale bar = 500 nm, (g) EDX spectrum of x 
= 0 coatings, and (h) EDX spectrum of x = 2 coatings.  
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The pH values of the DMEM solutions (without any protein) in which the bare and 
coated substrates were immersed are shown in Figure C.6 a. For all samples the pH values were 
close to 8.2 and no definitive trend in the changes to the pH value changes can be observed. The 
magnesium and yttrium ions concentrations, as determined by the ICP, have been shown in 
Figure C.6 b and c, respectively. Similar to pH, no trend can be observed for these ions. It should 
also be noted that the concentration of both these ions, especially yttrium, varies over few orders 
of magnitudes. This large variation of yttrium concentration is most probably due to the irregular 
corrosion behavior of the native Mg4Y alloy itself and this corrosion rate is not affected much by 
the presence of calcium phosphate coatings. 
These results clearly indicate that the CaPs coatings hardly play any role in changing the 
degradation behavior of the Mg4Y substrates as the pH and the concentration of Mg and Y ions 
are very similar for both the bare metal and coated substrates. These observations are not very 
surprising as all the coated films are porous in nature and these films contain many cracks. The 
presence of pores and cracks do not prevent the underlying bare substrate from being exposed to 
the surrounding DMEM and thus the coated substrates behave in a very similar manner to the 
uncoated substrate when it is in contact with media.  
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Figure C.6 SEM micrographs at different magniﬁcations and EDX results on the coated substrates heat 
treated to 450◦C, 24 h, argon, (a) SEM of x = 0 coatings; scale bar = 100 m, (b) SEM of x = 0 coatings; scale 
bar = 10 m, (c) SEM of x = 0 coatings; scale bar = 500 nm, (d) SEM of x = 2 coatings; scale bar = 100 m, (e) 
SEM of x = 2 coatings; scale bar = 10 m, (f) SEM of x = 2 coatings; scale bar = 500 nm, (g) EDX spectrum of x 
= 0 coatings, and (h) EDX spectrum of x = 2 coatings.  
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Other reports of CaPs based coating on magnesium alloys were also found to be porous 
and contain cracks and thus are not expected to alter the corrosion characteristics of the Mg 
alloys drastically [114, 115, 225, 241, 249, 260, 261]. Previous studies have reported the 
formation of a degradation layer during the corrosion process of magnesium alloys and it is 
assumed that this degradation layer itself also reduces the rate of the corrosion [240, 243, 245, 
264]. Witte et al. assumed that this layer is composed of calcium phosphate precipitates and 
other corrosion products such as magnesium oxide or magnesium hydroxide [245]. A solution 
with high calcium and magnesium concentration appear to be good environmental conditions for 
the formation of calcium phosphate precipitates due to the increase in pH of the solution [240]. 
Thus, in this present study it is reasonable to assume that a similar protective layer should form 
on the coated and uncoated substrates which may alter the degradation characteristics of the 
substrates in vitro with time.  
Figure C.7 shows the SEM images of the bare and coated samples kept in DMEM under 
in vitro conditions. The polished surface of the bare metal was slowly covered with layers of 
corrosion products. SEM studies also indicate that the coatings grew thicker with time. The FTIR 
results show the presence of Mg(OH)2 and PO43- on these coatings, whereas EDX shows the 
presence Ca and P together with Mg on the coatings formed on the pristine metals. Interestingly, 
the atomic percentage of phosphorous was always much higher than calcium, albeit the amount 
of calcium in DMEM contains twice the amount of phosphorous. This possibly indicates that 
presence of phosphate in the media not only allows the calcium phosphate to precipitate out due 
to increase in pH value, but also reacts with the magnesium hydroxide coating that formed 
initially by reacting with water to deposit a coating of magnesium phosphate. 
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Figure C.7 SEM images of the pristine Mg4Y, CaPs coated (x=0) and Si-CaPs coated (x=3) substrates 
after incubation in DMEM for different times. The scale bar for all the images is 100 m. 
 
For CaPs and Si- CaPs coated samples, the coating seems to be very stable up to 3 days 
and at 7 days some part of the coating begins to peel off. At 14 days, although some of the 
coatings have degraded, most of the substrates remain coated with HA. Interestingly, the 
coatings were found to be much more adherent to the substrates for the Si-substituted HA 
coatings, especially for high silicon containing samples (x=2, 3). However, the exact role of 
silicon on adherence properties of the coatings is not very clear. As discussed earlier all these 
CaPs films are porous in nature and thus it is unlikely that they will be able to prevent the 
interaction between the substrates and the media. This will lead to the degradation of the 
substrates and eventually detachment of the coatings. This may cause the appearance of loose 
crystalline CaPs particles and debris around the implant that may cause a foreign body response 
[276-278]. Resorption of the CaPs coating and particles occurs in most clinical cases; initially by 
dissolution followed by cell mediated resorption [63, 279] . The biodegradation of these CaPs 
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particles is controlled by numerous factors, including crystal structure, microporosity, 
crystallinity, chemical compositions, Ca/P ration, lattice defects, particle size, and purity [63, 
277, 280]. In the case of non-degradable alloys such as Ti-6Al-4V, it is generally believed that 
CaPs coatings should be mechanically stable and strongly adherent to the surface [63]. In the 
case of degradable metals such as magnesium alloys both the metal and the CaPs coatings should 
degrade and replaced by natural bone. Thus the CaPs coatings for degradable metals should have 
high dissolution and re-precipitation rates, so that it locally provides an ideal site for the cell to 
adhere, grow and form new bone. In the present study we believe that the coatings peel off due 
the rapid corrosion of the Mg4Y in the serum free DMEM, as have been shown by the ICP 
analyses. The rate of degradation of the alloy can change considerably in the presence of 
different proteins as shown recently [187, 281]. Thus it is reasonable to assume that the 
magnesium alloys, and hence the CaP coatings, can be more stable in-vivo than in-vitro. The 
present CaPs coatings can be resorbed at a much faster rate due to nano-crystalline particle sizes 
as well the presence of Si in the structure. It has been reported that Si inhibits the growth of HA 
crystal and this effect is more significant as the Si level increased [228, 282, 283]. It has also 
been suggested that increased Si content would cause the HA crystal to be more soluble, 
releasing more Ca2+, P5+, and Si4+ ions into the surroundings [284]. The release of Si4+ions has 
been shown to alter the surface properties of Si-containing HA [285, 286], which in turn have a 
positive effect on protein adsorption [287] and hence bioactivity of the coatings [284]. Many 
published reports suggest that CaPs particles, if present, would not cause any adverse problems 
as nano-particles can be easily resorbed by macrophages and bone cells [288, 289], and larger 
particle agglomerates act like a bone graft surrounded by new bone [279, 290].  
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Cell adhesion to the scaffolds is essential to the development, maintenance, and 
remodeling of osseous tissues. Adhesive interactions play a critical role in osteoblast survival, 
proliferation, differentiation, and matrix mineralization. These interactions also play an 
important role in bone formation, osteoclast function, and bone resorption [291-296]. 
Fluorescence microscopy in Figure C.8 shows that the live cell attachment was higher on 
scaffolds with coatings than on bare metal surfaces at day 1 and the number of dead cells are also 
high on the bare metal in comparison to the coated samples and tissue culture plastics. On day 3, 
comparatively, more live cells can be seen on the bare metal than the day 1 samples; however, 
there are also many dead cells. Figure C.8 clearly shows that the number of live cells (green) on 
the coated substrates is much more than on day 1 and only few dead cells (red) can be seen. The 
ratio of live cells to dead cells and the average percentage area covered by the live cells on the 
bare (Mg4Y), CaPs, Si-CaPs coated and normal tissue culture plastics (control) at different time 
point are shown in Figure C.9. Figure C.9a shows that the ratios of live to dead cells for the 
coated samples are always better compared to bare metal, especially at 48 h. The number of live 
cells on Si-CaPs coating seem to be better than the non-Si- containing or low Si-containing 
coatings. The percentage area covered by the live cells on the substrate increases with time for 
all the coated substrates and is shown in Figure C.9b. The area covered by the live cells in the 
case of bare metal was very similar to the CaPs coated substrates after 24 h of cell seeding; 
however, this value for bare metal does not change much with time. This is also consistent with 
the ratio of the live to dead cells as shown in Figure C.9a. These live to dead cells ratio values 
and percentage area coverage by live cells results demonstrate that cells adhered more easily to 
the coated substrates and grew considerably with time on these substrates in comparison to the 
bare metal. For the coated substrates the area coverage by the live cells increased considerably 
 265 
with time. Similar to live to cell ratio results, the Si-CaPs coatings, especially x=2 and 3, show 
better area coverage by the live cells compare to bare metal and CaPs coating. These live dead 
ratio and live cell area coverage possibly indicate better in-vitro bioactivity of the Si-CaPs 
coatings. These results do not reflect any possible cytotoxic effect of any un-decomposed nitrates 
and carbonates that may remain in the coatings as found by the DSC-TG analyses. From these 
results it is also not possible to assess the role and effect of any amorphous Ca-Si-P or SiO2 
phases that may present in the Si-containing coated substrates on the cytotoxicity and cell 
viability. 
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Figure C.8 MC3T3-E1 cells were seeded onto uncoated, CaPs coated (x=0) and Si-CaPs coated (x=2) 
substrates, and tissue culture polystyrene plate, incubated for 24h and 72h, and double-stained to be green 
for live cells and red for dead cells. The scale bar for all the images is 100 m.  
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Figure C.10 shows the SEM images of the osteoblast cells cultured for 1 day and after 3 
days on CaPs coated magnesium substrates. The images show that the number of cells attached 
to the coated substrates after 3 days is much larger compared to the cells seen on day 1 and very 
similar to the results obtained by direct live-dead cell imaging. For uncoated samples however, 
not many cells were found after 1-day of incubation and only few cells can be seen after 3 days 
of culture. For CaPs coated 1 day culture samples, many cells were observed and cells seemed to 
be interconnected. After 3 days of culture on CaPs and Si-CaPs coated samples, more cells were 
found on the surface and the cells have connected each other and covered most of the samples 
(Figure C.10, b and d). Also, after 3 days of culture, the cells and the excreted matrixes were 
connected together and it is hard to distinguish between the cell and the matrix. 
 
 
Figure C.9 Plots of (a) live to dead MC3T3-E1 cells ratio and (b) % area coverage by live MC3T3-E1 
cells for bare metal (Mg4Y). CaPs coated (x = 0) and Si-CaPs coated (x = 1, 2, and 3) substrates together with 
tissue culture plastics as control. 
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In some parts of the coatings as shown in the high magnification SEM image (Figure 
C.10, c), the cell develop cytoplasmic extensions with lengths of 20–30 µm that appear to anchor 
onto the CaPs coating. These cytoplasmic extensions are regions of the cell plasma membrane 
that contain a meshwork or bundles of actin-containing microfilaments which permit the 
movement of the migrating cells along a substratum [102, 297]. Figure C.10 c also shows that 
the cells have formed cell–cell junctions (shown by arrow) and developed extensions that 
bridged the cracks of the porous films. In some cases (figure not shown) it was also observed that 
the cells had resided into a crack of the films and the tip of the cytoplasmic extension attached 
firmly to the CaPs and Si-CaPs coatings. Thus these SEM results together with live dead results 
on the cell attachment clearly demonstrate that CaPs and Si-CaPs coated substrates show better 
cell response in contrast to the pristine uncoated Mg4Y samples during the whole incubation 
time. 
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Figure C.10 SEM images of MC3T3-E1 cells on (a) CaPs coated (x=0) substrate at day 1, (b) CaPs coated 
(x=0) substrate at day 3, (c) CaPs coated (x=0) substrate at day 3, arrow showing cell junction and extension 
that bridges the crack in the porous ﬁlms, and (d) Si-CaPs coated (x = 3) substrate at day 3. 
 
 
 
 
 
 
 
 270 
The surface bioactivity of any biomaterial is mainly controlled by the physical and 
chemical properties of the surface [291-296]. It is generally accepted that a porous surface 
contributes greatly to the increased cell adhesion and growth resulting in a significantly stronger 
bond to the host tissue. Moreover, the porous structure of the coatings consists of nano-sized 
calcium phosphates with increased surface area, boundaries, and roughness that most likely 
facilitate an increase in numerous protein interactions and adsorption, thereby aiding cell 
adhesion, alignment, and finally tissue integration [291-296, 298]. In the present study, porous 
surface coatings consisting of nano-sized CaPs were successfully prepared on magnesium 
substrates by the sol-gel method, as shown in Figure C.5, which would definitely contribute to 
the good surface bioactivity. 
In addition to the physical properties, chemical properties of the surface also play a very 
important role in determining the surface bioactivity. In order to improve the surface 
biocompatibility, various calcium phosphate coatings including brushite, tricalcium phosphate 
and hydroxyapatite have been successfully applied to magnesium alloys and it has been shown 
that the bioactivity of these coated substrates are better compared to the bare magnesium alloys 
[241, 261-264]. Our current results also show that cells attach and grow more favorably on the 
CaPs or Si-CaPs coated substrates than the bare metal as shown in Figure C.8, Figure C.9 and 
Figure C.10. The present work also indicates that Si-containing CaPs coatings show slightly 
improved bioactivity compared to non-Si-containing CaPs coating. 
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C.4 CONCLUSIONS 
Porous thick (~50 µm) coatings consisting mostly of nano-sized calcium phosphate and Si-
containing calcium phosphate were successfully deposited on magnesium alloy by sol-gel 
technique to improve the bioactivity of the magnesium alloy surfaces. Structural 
characterizations using XRD and FTIR show the formation of β-TCP and HA for non-Si 
containing coating and formation of mainly HA for Si-containing coatings. In vitro 
biodegradation test show that these films were not efficient in reducing the degradation of the 
substrate which is due to the porous nature as well presence of several cracks in the films. The 
films were found to be stable on the surfaces for at least 3 days under in vitro conditions and then 
some parts of the coatings were observed to peel off from the substrates. This is most probably 
due the corrosion of the underlying alloy surface due to the porosity and cracked nature of the 
coatings. In vitro biocompatibility experiments clearly demonstrate that the CaPs and Si-CaPs 
coated substrates are more cytocompatible than the uncoated alloy surfaces and thus can be 
useful for rapid osseo-integration in vivo. 
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APPENDIX D 
CALCIUM PHOSPHATE COATINGS FORMED ON MICROARC OXIDIZED 
MAGNESIUM ALLOY SUBSTRATES 
D.1 INTRODUCTION 
 
In the previous work studying calcium phosphate coatings on magnesium alloys using aqueous 
approaches, it was observed that pretreatment processing is crucial to the overall coating stability 
and microstructure. Pretreatment using phosphate containing solutions and HF were studied. In 
the current Section, the use of micro-arc oxidation (MAO), also referred to as plasma electrolytic 
oxidation (PEO), was studied as a pretreatment protocol to subsequently deposit calcium 
phosphate coatings. MAO treatment results in the formation of highly porous, several micron 
thick, homogeneous oxide coatings with good adhesion on Mg alloys. To date, MAO coatings 
have only recently been studied as a pretreatment option to deposit CaP coatings. The coatings 
deposited on MAO treated substrates are yet to be studied either in vitro or in vivo.  
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D.2 MATERIALS AND METHODS 
D.2.1 Formation of MAO Coatings 
AZ31 substrates were etched and polished, as previously described. Electrical contacts were then 
prepared using a conductive silver paste and epoxy to provide insulation upon exposure to 
aqueous media. The electrolyte solution consisted of 9 g L-1 Na2SiO3, 6 g L-1 KF, and 3 g L-1 
Na3PO4. Insulated samples were immersed into this solution while connected to a power supply. 
Once fixed, a potential of approximately 200 V was applied. The coatings were deposited for 5, 
10, and 20 minute periods. 
D.2.2 Formation of CaP Coatings on MAO Treated Substrates 
CaP coatings were deposited on MAO treated substrates by immersing these substrates into 
solutions kept at 70˚C prepared with CaCl2, Na2HPO4, and SrCl2, as previously described. The 
substrates were immersed in these solutions for a period of 6 hours resulting in the deposition of 
CaP on their surfaces. 
D.2.3 Analysis of Coating Microstructure 
After applying CaP coatings, the samples were then sputter coated with palladium ((Cressington 
sputter coater 108A). The coating microstructure was then analyzed by imaging using scanning 
electron microscopy (Philips XL30 FEG ESEM). 
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D.2.4 Electrochemical Corrosion Analysis 
Electrochemical corrosion experiments were performed at 37˚C in Hank’s buffered solution 
using a CH604a electrochemical workstation (CH Instruments, Austin TX). A three electrode 
cell comprising of platinum as a counter electrode and a Ag/AgCl reference electrode was used. 
Open circuit potential (OCP) was first established for all the samples after at least 1 h of 
stabilization in 125 ml of DMEM. Potentiodynamic polarization tests were then performed at a 
scan rate of 1 mV s-1. Corrosion current and potential were determined using a Tafel 
extrapolation added into the OriginPro 8 data analysis and graphing software. 
D.2.5 MC3T3-E1 Cell Culture 
Murine preosteoblast cell line, MC3T3-E1, was obtained from ATCC (Manassas, VA). Cells 
were cultured under 37°C, 5% CO2, and 95% relative humidity in minimum essential medium 
alpha (α-MEM, Gibco, Grand Island, NY) containing 10% FBS and 1% penicillin streptomycin 
(P/S, Gibco, Grand Island, NY). Cells after third passage were used in experiments and were 
seeded at a density of 50,000 cells per pellet/scaffold. 
D.2.6 Live/Dead Staining 
Cell viability was assessed using live/dead staining (Invitrogen, Live/Dead Staining Kit). After 3 
days of culture on heat treated pellets, samples were washed with phosphate buffered saline 
(PBS) and incubated for 40 minutes with the live/dead stain. After incubation, the samples were 
once again gently washed with PBS prior to imaging using fluorescence (Olympus CKX41).  
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D.3 RESULTS AND DISCUSSION 
The corrosion protection provided by the coatings formed on polished AZ31 substrates after 
subjecting to MAO treatment was analyzed using Tafel analysis. The data collected for bare 
AZ31 and the coatings formed after 5, 10, and 20 minutes are illustrated in Figure D.1. The 
experiments were performed using Hank’s buffer solution kept at 37˚C. Interestingly, a more 
negative corrosion potential (Ecorr) was observed for all coated samples in comparison to AZ31. 
However, the greatest difference in potential observed between two conditions was roughly 100 
mV. Therefore, this difference in potential alone may be too small to confirm which coating 
condition provides the best corrosion potential. 
-1.60 -1.55 -1.50 -1.45 -1.40
-9
-8
-7
-6
-5
-4
-3
-2
L
og
 (C
ur
re
nt
)
Potential (V)
 AZ31
 5 mins
 10 mins
 20 mins
 
 
 
Figure D.1 Tafel plots of MAO treated AZ31 for coatings deposited after various amounts of time in 
Hank’s buffer solution kept at 37˚C.  
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The corrosion current was therefore analyzed to further study the capability of these 
MAO coatings to provide corrosion protection. In comparison to AZ31, a substantially reduced 
corrosion current (Icorr) was observed for all MAO coatings conditions. A slightly lower Icorr was 
obtained upon increasing the time of coating deposition. The decrease observed with increasing 
time may be due to the formation of coatings with increased thickness. Nonetheless, for all future 
experiments, the coatings formed after 10 minutes were chosen as the condition to deposit CaP 
coatings on due to the similar Icorr value in comparison to the coating deposited after 20 minutes 
and the more positive Ecorr obtained.  
 
 
Figure D.2 The microstructure of a) MAO coated AZ31 after 10 minutes, b) the CaP coating formed on 
top of MAO treated AZ31, and c) the CaP coating formed in the presence of 10% Sr on MAO treated AZ31 
at 1000X. 
 
The microstructure of the coatings formed after 10 minutes of MAO treatment and 
subsequent CaP treatment with or without Sr is illustrated in Figure D.2. As expected, the typical 
porous structure of MAO coatings was observed prior to depositing CaP coatings (Figure D.2 
a)). After immersion in CaP containing solutions (Figure D.2 b) and c)), a quite different 
microstructure consisting of plate like particles was observed. The coated substrates were then 
imaged at a slightly higher magnification (Figure D.3). The 2-5 µm pores of the coating formed 
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after MAO treatment were clearly observed (Figure D.3 a)). For the CaP coated substrates, in 
addition to the plate like particles previously detected, much smaller round particles were also 
observed (Figure D.3 b) and c)).  
 
 
Figure D.3 The microstructure of a) MAO coated AZ31 after 10 minutes, b) the CaP coating formed on 
top of MAO treated AZ31, and c) the CaP coating formed in the presence of 10% Sr on MAO treated AZ31 
at 2000X. 
  
After confirming the formation of CaP coatings on the MAO treated substrates, MC3T3-
E1 murine preosteoblasts were seeded directly on the coated substrates to evaluate the capability 
of these coatings to support cell proliferation. Live/dead staining was performed after 3 days 
(Figure D.4). Quite a few live cells were observed on tissue culture plastic, used as a positive 
control (Figure D.4 a)). However, very few live cells were observed on the MAO treated 
substrates without CaP coatings (Figure D.4 b)). A substantial improvement in live cell 
attachment was observed on both CaP coated substrates (Figrue D.4 c) and d)). In comparing the 
CaP coatings formed with and without Sr, very little difference was observed between the two 
different coating conditions. 
 The live/dead assay was performed once again after 7 days of culture. The images 
collected are illustrated in Figure D.5. In comparison to the data collected after 3 days, the cells 
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seeded on culture plastic are much more confluent and very few dead cells were observed. 
(Figure D.5 a)). For the MAO coated substrates, several rounded dead cells were observed and 
either very few or no live cells were detected (Figure D.5 b)). For the CaP coated substrates, an 
increase in live cell density was observed for both conditions (Figure D.5 c) and d)).  However a 
much larger increase in live cell density was observed on the substrates prepared with Sr in 
comparison to those prepared without Sr.  
 
 
Figure D.4 Live/dead staining of MC3T3-E1 cells on a) tissue culture plastic, b) MAO treated AZ31, c) 
CaP coated MAO treated AZ31, and d) SrCaP coated MAO treated AZ31 after 3 days of culture. Scale bars 
are 200 μm. 
 
In summary, CaP and SrCaP coatings were formed on MAO treated AZ31 substrates. 
MAO coated substrates alone were incapable of supporting MC3T3-E1 proliferation. This is 
most likely due to the highly porous nature of these coatings resulting in increased Mg2+ 
concentration. Both CaP and SrCaP coatings supported cell attachment and proliferation. 
Increased proliferation was observed on the coating prepared with Sr in comparison to those 
prepared without Sr.  
 279 
 
Figure D.5 Live/dead staining of MC3T3-E1 cells on a) tissue culture plastic, b) MAO treated AZ31, c) 
CaP coated MAO treated AZ31, and d) SrCaP coated MAO treated AZ31 after 7 days of culture. Scale bars 
are 200 μm. 
D.4 CONCLUSIONS 
MAO treatment proved to be a useful pretreatment technique to prior to depositing CaP coatings 
on AZ31 degradable substrates. Although the presence of Sr in the CaP coatings deposited has 
not been confirmed, the coatings prepared in Sr containing solutions were capable of supporting 
enhanced proliferation. In future work, this pretreatment protocol will be compared to other 
pretreatment regimes, such as Na2HPO4 immersion and heat treatment, previously studied to 
determine its role in providing corrosion protection and supporting improved cytocompatibility 
on CaP coated AZ31 with and without Sr.  
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